| C00304 |
Kanamycin |
(P) unclassified |
| C04227 |
Octopamine; 1-(4-Hydroxyphenyl)-2-aminoethanol; p-Hydroxyphenylethanolamine |
(P) unclassified |
| C04931 |
Argatroban; (2R,4R)-4-Methyl-1[Nalpha-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperadinecarboxylic acid |
(P) unclassified |
| C06174 |
Codeine; (5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
(P) unclassified |
| C06921 |
Clorazepate; Clorazepic acid |
(P) unclassified |
| C07005 |
Flunisolide; Flunisolide anhydrous |
(P) unclassified |
| C07051 |
Indinavir |
(CI,P) unclassified |
| C07370 |
Prednisone; 1,2-Dehydrocortisone; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione |
(P) unclassified |
| C07533 |
Prenalterol |
(P) unclassified |
| C08859 |
Cymarin; Strophanthidin 3-O-beta-D-cymaroside |
(P) unclassified |
| D00058 |
gamma-Aminobutyric acid (JAN); Gammalon (TN) |
(P) unclassified |
| D00059 |
Levodopa (JP19/USP/INN); Dopar (TN) |
(P) unclassified |
| D00066 |
Progesterone (JP19/USP/INN); Crinone (TN); Prometrium (TN) |
(P) CYP induction: CYP3A4 |
| D00067 |
Estrone (JAN/USP/INN) |
(P) CYP induction: CYP3A4 |
| D00076 |
Noradrenaline (JP19); Norepinephrine (INN) |
(P) unclassified |
| D00088 |
Hydrocortisone (JP19/USP/INN); HC; Acticort (TN); Anusol HC (TN); Colocort (TN); Cortef (TN); Hytone (TN); Plenadren (TN) |
(P) unclassified |
| D00094 |
Tretinoin (JAN/USP/INN); Avita (TN); Renova (TN); Retin A (TN) |
(CI,P) unclassified |
| D00095 |
Epinephrine (USP/INN); Adrenaline (JP19); Auvi-q (TN); Epipen (TN) |
(P) unclassified |
| D00104 |
Chloramphenicol (JP19/USP/INN); Amphicol (TN); Chloromycetin (TN); Econochlor (TN) |
(P) unclassified |
| D00105 |
Estradiol (JAN/USP/INN); Climara (TN); Divigel (TN); Estrace (TN); Estraderm (TN); Estrasorb (TN); Estring (TN); Estrogel (TN); Innofem (TN); Vagifem (TN); Vivelle (TN) |
(P) CYP induction: CYP3A4 |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP19); Prograf (TN); Protopic (TN) |
(P) CYP induction: CYP3A4 |
| D00112 |
G-Strophanthin (JAN); Ouabain octahydrate |
(P) unclassified |
| D00124 |
Ephedrine (USP) |
(P) unclassified |
| D00125 |
Etoposide (JP19/USP/INN); Vepesid (TN) |
(CI,P) unclassified |
| D00135 |
Capreomycin sulfate (JAN/USP); Capastat sulfate (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP19/USP/INN); Haldol (TN) |
(P) CYP induction: CYP3A4 |
| D00138 |
Scopolamine (INN); Transderm scop (TN) |
(P) unclassified |
| D00140 |
Erythromycin (JP19/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00142 |
Methotrexate (JP19/USP/INN); Otrexup (TN); Xatmep (TN) |
(CI,P) unclassified |
| D00144 |
Pyrazinamide (JP19/USP/INN) |
(P) unclassified |
| D00155 |
Pentostatin (JAN/USAN/INN); Nipent (TN) |
(CI,P) unclassified |
| D00161 |
Mercaptopurine (USP); Mercaptopurine hydrate (JP19); Purinethol (TN); Purixan (TN) |
(CI,P) unclassified |
| D00162 |
Aminosalicylic acid (USP); Pamisyl (TN); Paser (TN) |
(P) unclassified |
| D00165 |
Hydrocortisone acetate (JP19/USP); Cortifoam (TN); U-cort (TN) |
(P) unclassified |
| D00168 |
Cytarabine (JP19/USP/INN); ARA-C; Depocyt (TN) |
(CI,P) unclassified |
| D00178 |
Octopamine hydrochloride (JAN) |
(P) unclassified |
| D00181 |
Argatroban (USP); Argatroban hydrate (JP19); Novastan (TN) |
(P) CYP induction: CYP3A4 |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP19); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) CYP induction: CYP3A4 |
| D00195 |
Codeine (USP); Codeine hydrate |
(P) unclassified |
| D00197 |
Reserpine (JP19/USP/INN); Apoplon (TN); Serpalan (TN) |
(P) unclassified |
| D00198 |
Rescinnamine (JAN/INN); Tsuruselpi S (TN) |
(P) unclassified |
| D00199 |
Ajmaline (JP19) |
(P) unclassified |
| D00208 |
Mitomycin (USP/INN); Mitomycin C (JP19); MMC; Jelmyto (TN); Muamycin (TN) |
(CI,P) unclassified |
| D00211 |
Rifampin (USP); Rifampicin (JP19/INN); Rifadin (TN); Rimactane (TN) |
(P) unclassified |
| D00214 |
Dactinomycin (USP); Actinomycin D (JP19); Cosmegen (TN) |
(CI,P) unclassified |
| D00216 |
Acarbose (JAN/USAN/INN); Precose (TN) |
(P) unclassified |
| D00217 |
Acetaminophen (JP19/USP); Paracetamol (INN); Tylenol (TN) |
(P) unclassified |
| D00219 |
Acetohexamide (JP19/USP/INN); Dymelor (TN) |
(P) unclassified |
| D00225 |
Alprazolam (JP19/USP/INN); Xanax (TN) |
(P) unclassified |
| D00231 |
Inamrinone (USP); Amrinone (JAN/INN); Amcoral (TN) |
(P) unclassified |
| D00235 |
Atenolol (JP19/USP/INN); Tenormin (TN) |
(P) unclassified |
| D00236 |
Atovaquone (JAN/USP/INN); Mepron (TN) |
(P) unclassified |
| D00244 |
Betamethasone (JP19/USP/INN); Celestone (TN); Rinderon (TN) |
(P) unclassified |
| D00246 |
Budesonide (JP19/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) CYP induction: CYP3A4 |
| D00248 |
Busulfan (JP19/USP/INN); Myleran (TN) |
(CI,P) unclassified |
| D00252 |
Carbamazepine (JP19/USP/INN); Equetro (TN); Tegretol (TN) |
(P) CYP induction: CYP3A4 |
| D00253 |
Carbidopa hydrate and levodopa; Parcopa (TN); Sinemet (TN) |
(P) unclassified |
| D00254 |
Carmustine (JAN/USP/INN); Bicnu (TN); Gliadel (TN) |
(CI,P) unclassified |
| D00255 |
Carvedilol (JP19/USP/INN); Artist (TN); Coreg (TN) |
(P) CYP induction: CYP3A4 |
| D00265 |
Chloral hydrate (JP19/USP); Noctec (TN) |
(P) unclassified |
| D00266 |
Chlorambucil (JAN/USP/INN); Leukeran (TN) |
(CI,P) unclassified |
| D00267 |
Chlordiazepoxide (JP19/USP/INN); Libritabs (TN) |
(P) unclassified |
| D00271 |
Chlorpropamide (JP19/USP/INN); Diabinese (TN) |
(P) unclassified |
| D00275 |
Cisplatin (JP19/USP/INN); Platinol (TN) |
(CI,P) unclassified |
| D00276 |
Clarithromycin (JP19/USP/INN); Biaxin (TN) |
(P) CYP induction: CYP3A4 |
| D00279 |
Clofibrate (JP19/USP/INN); Atromid-S (TN) |
(P) unclassified |
| D00280 |
Clonazepam (JP19/USP/INN); Klonopin (TN) |
(P) unclassified |
| D00281 |
Clonidine (JAN/USP/INN); Catarpres-TTS (TN) |
(P) unclassified |
| D00282 |
Clotrimazole (JP19/USP/INN); Lotrimin (TN); Mycelex (TN) |
(P) unclassified |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) CYP induction: CYP3A4 |
| D00287 |
Cyclophosphamide (USP); Cyclophosphamide hydrate (JP19); Cytoxan (TN); Neosar (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00288 |
Dacarbazine (JAN/USP/INN); DTIC-Dome (TN) |
(CI,P) unclassified |
| D00292 |
Dexamethasone (JP19/USP/INN); Decadron (TN); Maxidex (TN) |
(P) CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) CYP induction: CYP3A4 |
| D00294 |
Diazoxide (JAN/USP/INN); Hyperstat (TN); Proglycem (TN) |
(P) unclassified |
| D00296 |
Didanosine (JAN/USP/INN); Videx (TN) |
(CI,P) unclassified |
| D00297 |
Digitoxin (JAN/USP/INN); Crystodigin (TN) |
(P) Transporter induction: ABCB1 |
| D00298 |
Digoxin (JP19/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) Transporter induction: ABCB1 |
| D00302 |
Dipyridamole (JP19/USP/INN); Persantine (TN) |
(P) unclassified |
| D00303 |
Disopyramide (JP19/USAN/INN); Rythmodan P (TN) |
(P) CYP induction: CYP3A4 |
| D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
| D00311 |
Estazolam (JP19/USP/INN); ProSom (TN) |
(P) unclassified |
| D00312 |
Estrone sodium sulfate; Sodium estrone sulfate |
(P) CYP induction: CYP3A4 |
| D00319 |
Felodipine (JP19/USP/INN); Plendil (TN) |
(P) CYP induction: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) CYP induction: CYP3A4 |
| D00321 |
Finasteride (JAN/USP/INN); Propecia (TN); Proscar (TN) |
(P) CYP induction: CYP3A4 |
| D00322 |
Fluconazole (JP19/USP/INN); Diflucan (TN) |
(P) unclassified |
| D00324 |
Flunisolide (JAN/USP); Aerospan (TN); Nasalide (TN) |
(P) CYP induction: CYP3A4 |
| D00325 |
Fluocinonide (JP19/USP/INN); Lidex (TN); Vanos (TN) |
(P) unclassified |
| D00328 |
Flurandrenolide (USP); Fludroxycortide (JAN/INN); Cordran (TN) |
(P) unclassified |
| D00329 |
Flurazepam (JAN/INN); Insumin (TN) |
(P) unclassified |
| D00335 |
Glipizide (USP/INN); Glucotrol (TN) |
(P) unclassified |
| D00336 |
Glyburide (USP); Glibenclamide (JP19/INN); Diabeta (TN); Glynase (TN); Micronase (TN) |
(P) CYP induction: CYP3A4 |
| D00338 |
Halazepam (USAN/INN); Paxipam (TN) |
(P) unclassified |
| D00341 |
Hydroxyurea (USP); Hydroxycarbamide (JAN/INN); Droxia (TN); Hydrea (TN); Siklos (TN) |
(CI,P) unclassified |
| D00343 |
Ifosfamide (JAN/USP/INN); Ifex (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00346 |
Isoniazid (JP19/USP/INN); Laniazid (TN) |
(P) unclassified |
| D00349 |
Isradipine (USP/INN); Dynacirc (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP19/USP); Itrizole (TN); Sporanox (TN) |
(P) CYP induction: CYP3A4 |
| D00351 |
Ketoconazole (JP19/USP); Nizoral (TN); Xolegel (TN) |
(P) CYP induction: CYP3A4 |
| D00353 |
Lamivudine (JAN/USP/INN); Epivir (TN) |
(CI,P) unclassified |
| D00354 |
Lamotrigine (JAN/USP/INN); Lamictal (TN) |
(P) unclassified |
| D00355 |
Lansoprazole (JP19/USP/INN); Prevacid (TN) |
(P) CYP induction: CYP3A4 |
| D00358 |
Lidocaine (JP19/USP/INN); Dentipatch (TN); Xylocaine (TN) |
(P) CYP induction: CYP3A4 |
| D00359 |
Lovastatin (USP/INN); Mevacor (TN) |
(P) CYP induction: CYP3A4 |
| D00363 |
Lomustine (JAN/USP/INN); Gleostine (TN) |
(CI,P) unclassified |
| D00364 |
Loratadine (JAN/USP/INN); Claritin (TN) |
(P) CYP induction: CYP3A4 |
| D00365 |
Lorazepam (JP19/USP/INN); Ativan (TN) |
(P) unclassified |
| D00369 |
Melphalan (JP19/USP/INN); Alkeran (TN) |
(CI,P) unclassified |
| D00370 |
Temazepam (USP/INN); Restoril (TN) |
(P) unclassified |
| D00371 |
Theophylline (JP19); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) unclassified |
| D00372 |
Thiabendazole (USP); Tiabendazole (JAN/INN); Mintezol (TN) |
(P) unclassified |
| D00375 |
Mephenytoin (USP/INN); Mesantoin (TN) |
(P) unclassified |
| D00376 |
Meprobamate (JAN/USP/INN); Equanil (TN); Miltown (TN) |
(P) unclassified |
| D00378 |
Timolol (USAN); Timolol hemihydrate; Betimol (TN) |
(P) unclassified |
| D00379 |
Tolazamide (JAN/USP/INN); Tolinase (TN) |
(P) unclassified |
| D00380 |
Tolbutamide (JAN/USP/INN); Orinase (TN) |
(P) unclassified |
| D00385 |
Triamcinolone (JP19/USP/INN); Aristocort (TN); Kenacort (TN) |
(P) unclassified |
| D00387 |
Triazolam (JP19/USP/INN); Halcion (TN) |
(P) CYP induction: CYP3A4 |
| D00388 |
Triclofos sodium (JP19/USAN); Tricloryl (TN) |
(P) unclassified |
| D00392 |
Trimethadione (JP19/INN); Tridione (TN) |
(P) unclassified |
| D00395 |
Troglitazone (JAN/USAN/INN); Rezulin (TN) |
(P) unclassified |
| D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
| D00404 |
Methsuximide (USP); Mesuximide (INN); Celontin (TN) |
(P) unclassified |
| D00405 |
Methyldopa (USP); Methyldopa hydrate (JP19); Aldomet (TN) |
(P) unclassified |
| D00407 |
Methylprednisolone (JP19/USP/INN); Medrol (TN) |
(P) CYP induction: CYP3A4 |
| D00412 |
Zalcitabine (JAN/USP/INN); Hivid (TN) |
(CI,P) unclassified |
| D00413 |
Zidovudine (JP19/USP/INN); Azidothymidine; Retrovir (TN) |
(CI,P) unclassified |
| D00416 |
Miconazole (JP19/USP/INN); Monistat (TN); Oravig (TN) |
(P) unclassified |
| D00417 |
Milrinone (JAN/USP/INN); Milrila (TN) |
(P) Enzyme induction: UGT |
| D00418 |
Minoxidil (JAN/USP/INN); Loniten (TN); Riup (TN); Rogaine (TN) |
(P) unclassified |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(CI,P) unclassified |
| D00424 |
Rifabutin (JAN/USP/INN); Mycobutin (TN) |
(P) CYP induction: CYP3A4 |
| D00426 |
Risperidone (JP19/USP/INN); Risperdal (TN) |
(P) CYP induction: CYP3A4 |
| D00427 |
Ritonavir (JAN/USP/INN); Norvir (TN) |
(CI,P) unclassified |
| D00429 |
Saquinavir (JAN/USP/INN); Fortovase (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00430 |
Secobarbital (USP/INN); Seconal (TN) |
(P) unclassified |
| D00432 |
Nadolol (JP19/USP/INN); Corgard (TN) |
(P) unclassified |
| D00434 |
Simvastatin (JP19/USP/INN); MK-733; Zocor (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00437 |
Nifedipine (JP19/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) CYP induction: CYP3A4 |
| D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) CYP induction: CYP3A4 |
| D00445 |
Stavudine (USAN/INN); Sanilvudine (JAN); Zerit (TN) |
(CI,P) unclassified |
| D00453 |
Ofloxacin (JP19/USP/INN); Floxin (TN) |
(P) CYP induction: CYP3A4 |
| D00454 |
Olanzapine (JAN/USP/INN); Zyprexa (TN) |
(P) unclassified |
| D00455 |
Omeprazole (JP19/USP/INN); Prilosec (TN) |
(P) unclassified |
| D00456 |
Ondansetron (JAN/USP/INN); Zofran ODT (TN) |
(P) CYP induction: CYP3A4 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) CYP induction: CYP3A4 |
| D00458 |
Quetiapine fumarate (JP19/USP); Seroquel (TN) |
(P) CYP induction: CYP3A4 |
| D00464 |
Oxazepam (JAN/USP/INN); Serax (TN) |
(P) unclassified |
| D00465 |
Oxybutynin (USAN/INN); Anturol (TN); Oxytrol (TN) |
(P) CYP induction: CYP3A4 |
| D00467 |
Pipobroman (JAN/USAN/INN); Vercyte (TN) |
(CI,P) unclassified |
| D00468 |
Plicamycin (USAN/INN); Mithracin (TN) |
(CI,P) unclassified |
| D00470 |
Prazepam (JP19/USAN/INN); Centrax (TN) |
(P) unclassified |
| D00471 |
Praziquantel (JAN/USP/INN); Biltricide (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00472 |
Prednisolone (JP19/USP/INN); Delta-cortef (TN) |
(P) unclassified |
| D00473 |
Prednisone (USP); Prednisone monohydrate; Deltasone (TN); Meticorten (TN); Rayos (TN) |
(P) unclassified |
| D00474 |
Primidone (JP19/USP/INN); Mysoline (TN) |
(P) unclassified |
| D00477 |
Procainamide hydrochloride (JP19/USP); Procan SR (TN); Procanbid (TN); Pronestyl (TN) |
(P) unclassified |
| D00478 |
Procarbazine hydrochloride (JP19/USP); Matulane (TN) |
(CI,P) unclassified |
| D00483 |
Propranolol hydrochloride (JP19/USP); Inderal (TN); Innopran XL (TN) |
(P) unclassified |
| D00491 |
Paclitaxel (JAN/USP/INN); Abraxane (TN); Taxol (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00495 |
Paramethadione (INN); Paradione (TN) |
(P) unclassified |
| D00499 |
Pentobarbital (USP/INN); Nembutal (TN) |
(P) unclassified |
| D00500 |
Pentobarbital sodium (JAN/USP); Nembutal sodium (TN) |
(P) unclassified |
| D00502 |
Pergolide mesylate (USP); Pergolide mesilate (JAN); Permax (TN) |
(P) unclassified |
| D00504 |
Phenacemide (JAN/INN); Phenurone (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00508 |
Phensuximide (USP/INN); Milontin (TN) |
(P) unclassified |
| D00511 |
Phenylephrine hydrochloride (JP19/USP); Neo-synephrine (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00513 |
Pindolol (JP19/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) |
(P) unclassified |
| D00514 |
Dexmedetomidine (USAN/INN); Dexdor (TN); Precedex (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP19); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00529 |
Montelukast sodium (JP19/USP); Singulair (TN) |
(P) CYP induction: CYP3A4 |
| D00530 |
Zaleplon (JAN/USP/INN); Sonata (TN) |
(P) CYP induction: CYP3A4 |
| D00531 |
Nitrazepam (JP19/USAN/INN); Benzalin (TN); Nitrazepam (TN) |
(P) unclassified |
| D00532 |
Glutethimide (JAN/INN); Doriden (TN) |
(P) unclassified |
| D00533 |
Oxcarbazepine (JAN/USP/INN); Oxtellar (TN); Trileptal (TN) |
(P) unclassified |
| D00535 |
Vigabatrin (JAN/USP/INN); Sabril (TN) |
(P) unclassified |
| D00536 |
Felbamate (USPINN); Felbatol (TN) |
(P) unclassified |
| D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) CYP induction: CYP3A4 |
| D00538 |
Zonisamide (JP19/USP/INN); Excegran (TN) |
(P) unclassified |
| D00539 |
Ethosuximide (JP19/USP/INN); Zarontin (TN) |
(P) CYP induction: CYP3A4 |
| D00542 |
Halothane (JP19/USP/INN); Fluothane (TN) |
(P) CYP induction: CYP3A4 |
| D00544 |
Methoxyflurane (USP/INN); Penthrane (TN) |
(P) CYP induction: CYP3A4 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) CYP induction: CYP3A4 |
| D00553 |
Prilocaine (USP/INN); Propitocaine (JAN) |
(P) unclassified |
| D00554 |
Ethinyl estradiol (USP); Ethinylestradiol (JP19/INN); Estinyl (TN) |
(P) CYP induction: CYP3A4 |
| D00555 |
Amobarbital (JP19/INN); Isomytal (TN) |
(P) unclassified |
| D00557 |
Methaqualone (JAN/USAN/INN) |
(P) unclassified |
| D00558 |
Carbidopa (USP); Carbidopa hydrate (JP19); Lodosyn (TN) |
(P) unclassified |
| D00559 |
Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) |
(P) unclassified |
| D00560 |
Pimozide (JP19/USP/INN); Orap (TN) |
(P) CYP induction: CYP3A4 |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) CYP induction: CYP3A4 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) unclassified |
| D00567 |
Celecoxib (JP19/USP/INN); Celebrex (TN); Onsenal (TN) |
(CI,P) unclassified |
| D00570 |
Colchicine (JP19/USP) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00578 |
Voriconazole (JP19/USP/INN); Vfend (TN) |
(CI,P) unclassified |
| D00583 |
Thiotepa (JAN/USP/INN); Thioplex (TN); Tepadina (TN); Rethio (TN) |
(CI,P) unclassified |
| D00584 |
Fluorouracil (JP19/USP/INN); 5-FU (TN); Adrucil (TN); Carac (TN); Fluoroplex (TN) |
(CI,P) unclassified |
| D00585 |
Mifepristone (JAN/USAN/INN); Korlym (TN); Mifeprex (TN) |
(P) CYP induction: CYP3A4 |
| D00588 |
Levofloxacin (USP); Levofloxacin hydrate (JP19); Levofloxacin hemihydrate; Iquix (TN); Levaquin (TN); Quixin (TN) |
(P) unclassified |
| D00591 |
Ethionamide (JP19/USP/INN); Trecator (TN) |
(P) unclassified |
| D00592 |
Dapsone (USP); Diaphenylsulfone (JAN); Aczone (TN) |
(P) CYP induction: CYP3A4 |
| D00593 |
Glimepiride (JP19/USP/INN); Amaryl (TN) |
(P) unclassified |
| D00594 |
Repaglinide (JAN/USP/INN); Prandin (TN); Surepost (TN) |
(P) unclassified |
| D00595 |
Buformin (USAN/INN) |
(P) unclassified |
| D00596 |
Rosiglitazone maleate (JAN/USP); Avandia (TN) |
(P) unclassified |
| D00597 |
Acebutolol hydrochloride (JP19/USP); Sectral (TN) |
(P) unclassified |
| D00598 |
Betaxolol hydrochloride (JP19/USP); Betoptic (TN); Kerlone (TN) |
(P) unclassified |
| D00599 |
Carteolol hydrochloride (JP19/USP); Cartrol (TN); Ocupress (TN) |
(P) unclassified |
| D00601 |
Metoprolol tartrate (JP19/USP); Lopressor (TN) |
(P) unclassified |
| D00602 |
Penbutolol sulfate (JP19/USP); Levatol (TN) |
(P) unclassified |
| D00603 |
Timolol maleate (JP19/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) unclassified |
| D00604 |
Clonidine hydrochloride (JP19/USP); Nexiclon (TN); Kapvay (TN); Duraclon (TN); Catapres (TN) |
(P) unclassified |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) CYP induction: CYP3A4 |
| D00608 |
Doxazosin mesylate (USP); Doxazosin mesilate (JP19); Cardura (TN) |
(P) unclassified |
| D00609 |
Prazosin hydrochloride (JP19/USP); Minipress (TN) |
(P) unclassified |
| D00611 |
Mecamylamine hydrochloride (USP); Inversine (TN) |
(P) unclassified |
| D00612 |
Trimetaphan camsilate (JAN/INN); Trimetaphan camsylate; Arfonad (TN) |
(P) unclassified |
| D00614 |
Sodium nitroprusside (USP); Sodium nitroprusside hydrate (JAN); Nitropress (TN) |
(P) unclassified |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP19); Norvasc (TN) |
(P) CYP induction: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP19/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) CYP induction: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP19/USAN); Cardene (TN) |
(P) CYP induction: CYP3A4 |
| D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) CYP induction: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00621 |
Enalapril maleate (JP19/USP); Renivace (TN); Vasotec (TN) |
(P) unclassified |
| D00625 |
Miglitol (JP19/USAN/INN); Glyset (TN) |
(P) unclassified |
| D00629 |
Nitrendipine (JP19/USAN/INN); Baypress (TN) |
(P) CYP induction: CYP3A4 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) CYP induction: CYP3A4 |
| D00632 |
Dobutamine hydrochloride (JP19/USP); Dobutrex (TN) |
(P) unclassified |
| D00633 |
Dopamine hydrochloride (JP19/USP); Actopamin (TN); Intropin (TN) |
(P) unclassified |
| D00634 |
Bisoprolol fumarate (JP19/USP); Zebeta (TN) |
(P) unclassified |
| D00635 |
Metoprolol succinate (USP); Toprol XL (TN) |
(P) unclassified |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) CYP induction: CYP3A4 |
| D00637 |
Disopyramide phosphate (JAN/USP); Norpace (TN) |
(P) CYP induction: CYP3A4 |
| D00638 |
Flecainide acetate (JP19/USP); Tambocor (TN) |
(P) unclassified |
| D00639 |
Mexiletine hydrochloride (JP19/USP); Mexitil (TN) |
(P) unclassified |
| D00640 |
Propafenone hydrochloride (JP19/USP); Rythmol (TN) |
(P) CYP induction: CYP3A4 |
| D00642 |
Quinidine gluconate (USP); Quinaglute (TN) |
(P) CYP induction: CYP3A4 |
| D00643 |
Quinidine polygalacturonate; Cardioquin (TN) |
(P) CYP induction: CYP3A4 |
| D00644 |
Esmolol hydrochloride (JAN/USP); Brevibloc (TN) |
(P) unclassified |
| D00645 |
Bretylium tosylate (USP); Bretylium tosilate (INN); Bretylol (TN) |
(P) unclassified |
| D00646 |
Tolterodine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D00647 |
Dofetilide (JAN/USP/INN); Tikosyn (TN) |
(P) unclassified |
| D00648 |
Ibutilide fumarate (USP); Corvert (TN) |
(P) unclassified |
| D00653 |
Dorzolamide hydrochloride (JP19/USP); Trusopt (TN) |
(P) CYP induction: CYP3A4 |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) CYP induction: CYP3A4 |
| D00670 |
Donepezil hydrochloride (JP19/USP); Aricept (TN) |
(P) CYP induction: CYP3A4 |
| D00672 |
Hydroxyzine hydrochloride (JP19/USP); Hydroxyzine dihydrochloride; Atarax (TN); Vistaril (TN) |
(P) unclassified |
| D00674 |
Naratriptan hydrochloride (JAN/USP); Amerge (TN) |
(P) CYP induction: CYP3A4 |
| D00677 |
Granisetron hydrochloride (JAN/USP); Kytril (TN) |
(P) CYP induction: CYP3A4 |
| D00678 |
Ondansetron hydrochloride hydrate (JAN/USP); Ondansetron hydrochloride; Ondansetron hydrochloride dihydrate; Zofran (TN) |
(P) CYP induction: CYP3A4 |
| D00679 |
Ergotamine tartrate (JP19/USP); Ergomar (TN) |
(P) CYP induction: CYP3A4 |
| D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP19); Methergine (TN) |
(P) CYP induction: CYP3A4 |
| D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) CYP induction: CYP3A4 |
| D00689 |
Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP19); Beclovent (TN); Qnasl (TN); Vanceril (TN) |
(P) CYP induction: CYP3A4 |
| D00690 |
Mometasone furoate (JAN/USP); Asmanex (TN); Elocon (TN) |
(P) CYP induction: CYP3A4 |
| D00693 |
Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) |
(P) unclassified |
| D00694 |
Clorazepate dipotassium (JP19/USP); Tranxene (TN) |
(P) unclassified |
| D00695 |
Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) |
(P) unclassified |
| D00696 |
Midazolam hydrochloride (USAN); Versed (TN) |
(P) CYP induction: CYP3A4 |
| D00698 |
Aprobarbital (INN); Alurate (TN) |
(P) unclassified |
| D00700 |
Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00702 |
Buspirone hydrochloride (USP); Buspar (TN) |
(P) unclassified |
| D00704 |
Ethchlorvynol (JAN/USP/INN); Placidyl (TN) |
(P) unclassified |
| D00705 |
Paraldehyde (USP); Paral (TN) |
(P) unclassified |
| D00706 |
Zolpidem tartrate (JP19/USP); Ambien (TN); Intermezzo (TN) |
(P) CYP induction: CYP3A4 |
| D00708 |
Ethotoin (JAN/USP/INN); Accenon (TN); Peganone (TN) |
(P) unclassified |
| D00709 |
Levetiracetam (JP19/USP/INN); Keppra (TN); E keppra (TN) |
(P) unclassified |
| D00710 |
Valproate sodium (USAN); Sodium valproate (JP19); Depakene (TN); Selenica (TN) |
(P) unclassified |
| D00712 |
Methohexital sodium (USP); Brevital sodium (TN) |
(P) unclassified |
| D00714 |
Thiopental sodium (JP19/USP/INN); Pentothal (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP19); Ditropan (TN); Gelnique (TN) |
(P) CYP induction: CYP3A4 |
| D00724 |
Rabeprazole sodium (JP19/USP); Aciphex (TN); Pariet (TN) |
(P) CYP induction: CYP3A4 |
| D00725 |
Dolasetron mesylate (USP); Anzemet (TN) |
(P) unclassified |
| D00726 |
Metoclopramide (JP19/INN); Elieten (TN); Terperan (TN) |
(P) unclassified |
| D00729 |
Loperamide hydrochloride (JAN/USP); Imodium (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00749 |
Leflunomide (JAN/USP/INN); Arava (TN) |
(P) CYP induction: CYP3A4 |
| D00751 |
Methylprednisolone sodium succinate (JAN/USP); A-methapred (TN); Solu-medrol (TN) |
(P) CYP induction: CYP3A4 |
| D00752 |
Mycophenolate mofetil (JAN/USP); Cellcept (TN) |
(P) unclassified |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00762 |
Metyrosine (USP); Metirosine (JAN/INN); Demser (TN) |
(P) unclassified |
| D00769 |
Clopidogrel bisulfate (USP); Clopidogrel sulfate (JP19); Clopidogrel sulfate tablets (JP19); Clopidogrel hydrogen sulphate; Isocover (TN); Plavix (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP19/USP); Zanaflex (TN) |
(P) unclassified |
| D00777 |
Amantadine hydrochloride (JP19/USP); Symmetrel (TN); Gocovri (TN); Osmolex er (TN) |
(P) unclassified |
| D00779 |
Biperiden (JAN/USP/INN); Akineton (TN) |
(P) unclassified |
| D00780 |
Bromocriptine mesylate (USP); Bromocriptine mesilate (JP19); Parlodel (TN) |
(P) CYP induction: CYP3A4 |
| D00781 |
Entacapone (JP19/USP/INN); Comtan (TN) |
(P) unclassified |
| D00784 |
Ropinirole hydrochloride (JAN/USP); Requip (TN) |
(P) unclassified |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) CYP induction: CYP3A4 |
| D00786 |
Tolcapone (JAN/USP/INN); Tasmar (TN) |
(P) unclassified |
| D00787 |
Trihexyphenidyl hydrochloride (JP19/USP); Artane (TN) |
(P) unclassified |
| D00794 |
Loxapine succinate (USP); Loxitane (TN) |
(P) CYP induction: CYP3A4 |
| D00804 |
Ivermectin (JAN/USP/INN); Sklice (TN); Soolantra (TN); Stromectol (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00809 |
Amitriptyline hydrochloride (JP19/USP); Elavil (TN) |
(P) CYP induction: CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP19/USP); Anafranil (TN) |
(P) CYP induction: CYP3A4 |
| D00815 |
Imipramine hydrochloride (JP19/USP); Tofranil (TN) |
(P) CYP induction: CYP3A4 |
| D00816 |
Nortriptyline hydrochloride (JP19/USP/INN); Pamelor (TN) |
(P) unclassified |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) CYP induction: CYP3A4 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) unclassified |
| D00822 |
Citalopram hydrobromide (USP); Celexa (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) CYP induction: CYP3A4 |
| D00829 |
Eflornithine hydrochloride (USAN); Iwilfin (TN); Vaniqa (TN) |
(CI,P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP19/USP); Buprenex (TN) |
(P) CYP induction: CYP3A4 |
| D00840 |
Levomethadyl acetate hydrochloride (USAN); Orlaam (TN) |
(P) CYP induction: CYP3A4 |
| D00847 |
Oxycodone hydrochloride (USP); Oxecta (TN); Oxycontin (TN); Roxicodone (TN) |
(P) CYP induction: CYP3A4 |
| D00866 |
Kanamycin sulfate (USP); Kanamycin monosulfate (JP19); Kantrex (TN) |
(P) unclassified |
| D00875 |
Aminosalicylate sodium (USP); Parasal sodium (TN) |
(P) unclassified |
| D00877 |
Cycloserine (JP19/USP/INN); Seromycin (TN) |
(P) unclassified |
| D00878 |
Ethambutol hydrochloride (JP19/USP); Myambutol (TN) |
(P) unclassified |
| D00879 |
Rifapentine (USAN/INN); Priftin (TN) |
(P) unclassified |
| D00880 |
Butoconazole nitrate (USP); Femstat (TN); Gynazole-1 (TN) |
(P) unclassified |
| D00881 |
Econazole nitrate (JAN/USP); Ecoza (TN); Spectazole (TN) |
(P) unclassified |
| D00882 |
Miconazole nitrate (JP19/USP); Micatin (TN); Monistat (TN) |
(P) unclassified |
| D00885 |
Oxiconazole nitrate (JAN/USAN); Oxistat (TN) |
(P) unclassified |
| D00886 |
Sulconazole nitrate (JAN/USP); Exelderm (TN) |
(P) unclassified |
| D00887 |
Atorvastatin calcium anhydorous; Lipitor (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D00888 |
Terconazole (USP/INN); Terazol 3 (TN) |
(P) unclassified |
| D00889 |
Cerivastatin sodium (JAN/USAN); Baycol (TN) |
(P) CYP induction: CYP3A4 |
| D00890 |
Tioconazole (JAN/USP/INN); Vagistat-1 (TN) |
(P) unclassified |
| D00891 |
Abacavir sulfate (JAN/USP); Ziagen (TN) |
(CI,P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 |
| D00894 |
Amprenavir (JAN/USAN/INN); Agenerase (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00895 |
Delavirdine mesylate (USAN); Delavirdine mesilate (JAN); Rescriptor (TN) |
(CI,P) unclassified |
| D00896 |
Efavirenz (JAN/USP/INN); Sustiva (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00897 |
Indinavir sulfate (USP); Crixivan (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00899 |
Nelfinavir mesylate (USAN/INN); Nelfinavir mesilate (JAN); Viracept (TN) |
(CI,P) CYP induction: CYP3A4 |
| D00944 |
Metformin hydrochloride (JP19/USP); Glucophage (TN) |
(P) unclassified |
| D00945 |
Pioglitazone hydrochloride (JP19/USP); Actos (TN) |
(P) unclassified |
| D00947 |
Linezolid (JAN/USAN/INN); Zyvox (TN) |
(P) unclassified |
| D00948 |
Estropipate (USP); Piperazine estrone sulfate; Ogen (TN) |
(P) CYP induction: CYP3A4 |
| D00950 |
Levonorgestrel (JAN/USP/INN); Mirena (TN); Norplant (TN); Skyla (TN) |
(P) unclassified |
| D00963 |
Exemestane (JAN/USP/INN); Aromasin (TN) |
(P) CYP induction: CYP3A4 |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) CYP induction: CYP3A4 |
| D00966 |
Tamoxifen citrate (JP19/USP); Nolvadex (TN); Soltamox (TN) |
(P) CYP induction: CYP3A4 |
| D00967 |
Toremifene citrate (JAN/USAN); Fareston (TN) |
(P) CYP induction: CYP3A4 |
| D00969 |
Meloxicam (JAN/USP/INN); Mobic (TN) |
(P) unclassified |
| D00972 |
Betamethasone sodium phosphate (JP19/USP); Celestone (TN) |
(P) unclassified |
| D00973 |
Cortisone acetate (JP19/USP); Cortone acetate (TN) |
(P) unclassified |
| D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) CYP induction: CYP3A4 |
| D00976 |
Hydrocortisone cypionate |
(P) unclassified |
| D00977 |
Hydrocortisone sodium phosphate (JP19/USP); Hydrocortone phosphate (TN) |
(P) unclassified |
| D00978 |
Hydrocortisone sodium succinate (JP19/USP); A-hydrocort (TN); Solu-cortef (TN) |
(P) unclassified |
| D00979 |
Methylprednisolone acetate (JAN/USP); Depo-medrol (TN) |
(P) CYP induction: CYP3A4 |
| D00980 |
Prednisolone acetate (JP19/USP/INN); Econopred (TN); Pred forte (TN) |
(P) unclassified |
| D00981 |
Prednisolone sodium phosphate (JP19/USP); Pediapred (TN) |
(P) unclassified |
| D00982 |
Prednisolone tebutate (JAN/USP); Hydeltra-TBA (TN) |
(P) unclassified |
| D00983 |
Triamcinolone acetonide (JP19/USP); Azmacort (TN); Kenalog (TN); Nasacort (TN) |
(P) unclassified |
| D00984 |
Triamcinolone diacetate (JAN/USP); Aristocort (TN) |
(P) unclassified |
| D00985 |
Triamcinolone hexacetonide (USP/INN); Aristospan (TN) |
(P) unclassified |
| D00986 |
Fludrocortisone acetate (JP19/USP); Florinef acetate (TN) |
(P) unclassified |
| D00987 |
Cabergoline (JP19/USP/INN); Cabaser (TN); Dostinex (TN) |
(P) CYP induction: CYP3A4 |
| D00996 |
Epinephrine hydrochloride (JAN); Adrenalin chloride (TN) |
(P) unclassified |
| D01007 |
Propiverine hydrochloride (JP19); Bup-4 (TN); Mictonorm (TN) |
(P) CYP induction: CYP3A4 |
| D01018 |
Mephentermine sulfate; Wyamine sulfate (TN) |
(P) unclassified |
| D01019 |
Metaraminol bitartrate (JAN/USP); Aramine (TN) |
(P) unclassified |
| D01020 |
Methoxamine hydrochloride (JAN); Vasoxyl (TN) |
(P) unclassified |
| D01025 |
Levobunolol hydrochloride (JAN/USP); Betagan (TN) |
(P) unclassified |
| D01026 |
Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) |
(P) unclassified |
| D01041 |
Sparteine (INN) |
(P) unclassified |
| D01055 |
Emivirine (USAN/INN); Coactinon (TN) |
(CI,P) unclassified |
| D01056 |
Benzbromarone (JP19/USAN/INN); Uroleap (TN) |
(P) unclassified |
| D01059 |
Nimustine hydrochloride (JAN); Nidran (TN) |
(CI,P) unclassified |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP19); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(CI,P) unclassified |
| D01064 |
Raltitrexed (JAN/USAN/INN); Tomudex (TN) |
(CI,P) unclassified |
| D01068 |
Vinblastine sulfate (JP19/USP); Exal (TN); Velban (TN) |
(CI,P) CYP induction: CYP3A4 |
| D01071 |
Hexobarbital (JAN/INN) |
(P) unclassified |
| D01072 |
Chloramphenicol palmitate (JP19/USP); Chloromycetin palmitate (TN) |
(P) unclassified |
| D01092 |
Lanoconazole (JP19/INN); Latoconazole; Astat (TN) |
(P) unclassified |
| D01096 |
Hydroxyzine pamoate (JP19/USP); Atarax-P (TN); Vistaril pamoate (TN) |
(P) unclassified |
| D01098 |
Maxacalcitol (JAN/USAN/INN); Oxarol (TN); Prezios (TN) |
(P) CYP induction: CYP3A4 |
| D01101 |
Bromperidol (JAN/USAN/INN); Impromen (TN) |
(P) CYP induction: CYP3A4 |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) CYP induction: CYP3A4 |
| D01111 |
Nateglinide (JP19/USP/INN); Starsis (TN) |
(P) unclassified |
| D01115 |
Eplerenone (JP19/USAN/INN); Inspra (TN) |
(P) CYP induction: CYP3A4 |
| D01121 |
Rebamipide (JP19/INN); Mucosta (TN) |
(P) CYP induction: CYP3A4 |
| D01131 |
Lafutidine (JP19/INN); Protecadin (TN) |
(P) CYP induction: CYP3A4 |
| D01133 |
Pimobendan (JAN/USAN/INN); Acardi (TN) |
(P) unclassified |
| D01145 |
Azelnidipine (JP19/INN); Calblock (TN) |
(P) CYP induction: CYP3A4 |
| D01148 |
Tolterodine tartrate (JAN/USP); Detrol (TN); Detrusitol (TN) |
(P) CYP induction: CYP3A4 |
| D01150 |
Methyprylon (JAN/INN); Noludar (TN) |
(P) unclassified |
| D01155 |
Gemcitabine hydrochloride (JAN/USP); Gemzar (TN) |
(CI,P) unclassified |
| D01160 |
Saquinavir mesylate (USP); Saquinavir mesilate (JAN); Invirase (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D01161 |
Fulvestrant (JAN/USP/INN); Faslodex (TN) |
(P) CYP induction: CYP3A4 |
| D01163 |
Ergonovine maleate (USP); Ergometrine maleate (JP19); Ergometrine (TN) |
(P) CYP induction: CYP3A4 |
| D01164 |
Aripiprazole (JP19/USP/INN); Abilify (TN) |
(P) CYP induction: CYP3A4 |
| D01173 |
Cilnidipine (JP19/INN); Atelec (TN) |
(P) CYP induction: CYP3A4 |
| D01176 |
Blonanserin (JP19/INN); AD 5423 |
(P) CYP induction: CYP3A4 |
| D01182 |
Alprenolol hydrochloride (JP19/USAN); Regletin (TN) |
(P) unclassified |
| D01190 |
Ethylphenacemide (JAN); Pheneturide (INN) |
(P) unclassified |
| D01195 |
Prothionamide (JP19); Protionamide (INN); Trevintix (TN) |
(P) unclassified |
| D01198 |
Toborinone (JAN/USAN/INN) |
(P) unclassified |
| D01199 |
Emtricitabine (JAN/USAN/INN); Emtriva (TN) |
(CI,P) unclassified |
| D01205 |
Dexmedetomidine hydrochloride (JAN/USP); Igalmi (TN); Precedex (TN) |
(P) unclassified |
| D01207 |
Omeprazole sodium (USAN); Losec sodium (TN) |
(P) unclassified |
| D01208 |
Aluminum clofibrate (JAN/INN); Alfibrate (TN) |
(P) unclassified |
| D01213 |
Tolvaptan (JP19/USAN/INN); Samsca (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D01217 |
Dydrogesterone (JP19/USP/INN); Duphaston (TN); Gynorest (TN) |
(P) CYP induction: CYP3A4 |
| D01223 |
Capecitabine (JAN/USP/INN); Xeloda (TN) |
(CI,P) unclassified |
| D01227 |
Bosentan (USAN); Bosentan hydrate (JAN); Tracleer (TN) |
(P) CYP induction: CYP3A4 |
| D01229 |
Paramethasone acetate (JAN/USAN); Haldrone (TN) |
(P) unclassified |
| D01230 |
Flunitrazepam (JP19/USAN/INN); Rohypnol (TN) |
(P) unclassified |
| D01231 |
Piroheptine hydrochloride (JAN); Trimol (TN) |
(P) unclassified |
| D01238 |
Bucladesine sodium (JAN); Actosin (TN) |
(P) unclassified |
| D01239 |
Prednisolone sodium succinate (JP19/USP); Kohakusanin (TN) |
(P) unclassified |
| D01240 |
Deslanoside (JP19/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01243 |
Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN); Citanest (TN) |
(P) unclassified |
| D01244 |
Tegafur (JP19/USAN/INN); Atillon (TN) |
(CI,P) unclassified |
| D01245 |
Bromazepam (JP19/USAN/INN); Lectopam (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) CYP induction: CYP3A4 |
| D01254 |
Tofisopam (JP19/INN); Emandaxin (TN) |
(P) unclassified |
| D01264 |
Daunorubicin hydrochloride (JP19/USP); Cerubidine (TN) |
(CI,P) unclassified |
| D01266 |
Difluprednate (JAN/USAN/INN); Durezol (TN) |
(P) unclassified |
| D01268 |
Cloxazolam (JP19/INN); Sepazon (TN) |
(P) unclassified |
| D01269 |
Solifenacin succinate (JAN/USAN/INN); Vesicare (TN) |
(P) CYP induction: CYP3A4 |
| D01270 |
Carboquone (JAN/INN); Esquinon (TN) |
(CI,P) unclassified |
| D01272 |
Clobetasol propionate (JP19/USP); Clobex (TN); Cormax (TN); Olux (TN) |
(P) unclassified |
| D01273 |
Clobetasone butyrate (JAN/USAN); Kindavate (TN) |
(P) unclassified |
| D01275 |
Doxorubicin hydrochloride (JP19/USP); Adriacin (TN); Adriamycin (TN); Doxil (TN); Rubex (TN) |
(CI,P) unclassified |
| D01276 |
Atazanavir sulfate (JAN/USAN); Reyataz (TN) |
(CI,P) unclassified |
| D01277 |
Droxidopa (JP19/USAN/INN); Dops (TN); Northera (TN) |
(P) unclassified |
| D01278 |
Oxazolam (JP19/INN); Serenal (TN) |
(P) unclassified |
| D01279 |
Flutoprazepam (JAN/INN); Restas (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP19); Athrombin-K (TN) |
(P) unclassified |
| D01286 |
Flutazolam (JAN/INN); Coreminal (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) CYP induction: CYP3A4 |
| D01292 |
Medazepam (JP19/INN); Pamnace (TN) |
(P) unclassified |
| D01293 |
Ethyl loflazepate (JP19/INN); Meilax (TN) |
(P) CYP induction: CYP3A4 |
| D01302 |
Hydralazine hydrochloride (JP19/USP); Apresoline (TN) |
(P) unclassified |
| D01303 |
Flunarizine hydrochloride (JAN/USAN) |
(P) unclassified |
| D01304 |
Amezinium metilsulfate (JAN); Risumic (TN) |
(P) unclassified |
| D01307 |
Midodrine hydrochloride (JP19/USP); Pro-Amatine (TN) |
(P) unclassified |
| D01308 |
Halcinonide (JAN/USP/INN); Halog (TN) |
(P) unclassified |
| D01310 |
Secobarbital sodium (JAN/USP); Seconal sodium (TN) |
(P) unclassified |
| D01316 |
Mexazolam (JAN/INN); Melex (TN) |
(P) CYP induction: CYP3A4 |
| D01322 |
Troleandomycin (USAN/INN); Triacetyloleandomycin (JAN); TAO; Tao (TN) |
(P) CYP induction: CYP3A4 |
| D01326 |
Aprindine hydrochloride (JP19/USAN); Aspenon (TN) |
(P) unclassified |
| D01327 |
Diflorasone diacetate (JP19/USP); Florone (TN); Psorcon (TN) |
(P) unclassified |
| D01328 |
Clotiazepam (JP19/INN); Rize (TN) |
(P) unclassified |
| D01333 |
Urapidil (JP19/INN); Ebrantil (TN) |
(P) unclassified |
| D01350 |
Streptomycin sulfate (JP19/USP) |
(P) unclassified |
| D01354 |
Fludiazepam (JP19/INN); Erispan (TN) |
(P) unclassified |
| D01355 |
Tramadol hydrochloride (JP19/USP); Ultram (TN) |
(P) CYP induction: CYP3A4 |
| D01356 |
Glymidine sodium (JAN/USAN/INN) |
(P) unclassified |
| D01357 |
Betamethasone valerate (JP19/USP); Beta-Val (TN); Luxiq (TN); Rinderon-V (TN) |
(P) unclassified |
| D01358 |
Mianserin hydrochloride (JAN/USAN); Tetramide (TN) |
(P) CYP induction: CYP3A4 |
| D01361 |
Erythromycin ethylsuccinate (JP19/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01363 |
Carboplatin (JP19/USP/INN); Paraplatin (TN) |
(CI,P) unclassified |
| D01367 |
Fluorometholone (JP19/USP/INN); NSC 33001; Fluor-op (TN); Fml (TN); Oxylone (TN) |
(P) unclassified |
| D01370 |
Cladribine (JAN/USP/INN); Leustatin (TN); Mavenclad (TN) |
(CI,P) unclassified |
| D01372 |
Zopiclone (JP19/INN); Amoban (TN) |
(P) CYP induction: CYP3A4 |
| D01379 |
Proscillaridin (JAN/USAN/INN); Talusin (TN) |
(P) unclassified |
| D01382 |
Metharbital (JAN/INN); Gemonil (TN) |
(P) unclassified |
| D01386 |
Ephedrine hydrochloride (JP19/USP) |
(P) unclassified |
| D01387 |
Amcinonide (JAN/USP/INN); Cyclocort (TN) |
(P) unclassified |
| D01390 |
Isoproterenol hydrochloride (USP); dl-Isoprenaline hydrochloride (JAN); Isuprel (TN); Proternol-S (TN) |
(P) unclassified |
| D01391 |
Bromovalerylurea (JP19); Bromisoval (INN); Bromisovalum; Bromural (TN); Brovarin (TN) |
(P) unclassified |
| D01399 |
Fentanyl citrate (JP19/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) CYP induction: CYP3A4 |
| D01402 |
Betamethasone acetate (JAN/USP) |
(P) unclassified |
| D01405 |
Norfenefrine hydrochloride (JAN); Zondel (TN) |
(P) unclassified |
| D01408 |
Flurazepam hydrochloride (JP19); Flurazepam monohydrochloride; Dalmate (TN) |
(P) unclassified |
| D01413 |
Estradiol valerate (JAN/USP/INN); Deladumone (TN) |
(P) CYP induction: CYP3A4 |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) CYP induction: CYP3A4 |
| D01425 |
Lopinavir (JAN/USP/INN) |
(CI,P) unclassified |
| D01429 |
Fosfluconazole (JAN/INN); Prodif (TN) |
(P) unclassified |
| D01434 |
Deprodone propionate (JAN); Allomidon (TN) |
(P) unclassified |
| D01441 |
Imatinib mesylate (USAN); Imatinib mesilate (JAN); Gleevec (TN); Glivec (TN) |
(CI,P) CYP induction: CYP3A4 |
| D01442 |
Hydrocortisone succinate (JP19) |
(P) unclassified |
| D01450 |
Bupivacaine hydrochloride (USP); Bupivacaine hydrochloride hydrate (JP19); Marcaine (TN) |
(P) CYP induction: CYP3A4 |
| D01453 |
Caffeine hydrate (JP19); Caffeine monohydrate |
(P) unclassified |
| D01454 |
Bupranolol hydrochloride (JP19) |
(P) unclassified |
| D01455 |
Cifenline succinate (USAN); Cibenzoline succinate (JP19); Cibenol (TN); Cipralan (TN) |
(P) CYP induction: CYP3A4 |
| D01464 |
Flumethasone pivalate (USP); Flumetasone pivalate (JAN/BAN); Locorten (TN) |
(P) unclassified |
| D01468 |
Nemonapride (JAN/INN); Emilace (TN) |
(P) CYP induction: CYP3A4 |
| D01471 |
Esatenolol (JAN/INN); (S)-Atenolol |
(P) unclassified |
| D01478 |
Ebastine (JP19/USAN/INN); Kestine (TN) |
(P) CYP induction: CYP3A4 |
| D01480 |
Isoconazole nitrate (JAN); Adestan-G (TN) |
(P) unclassified |
| D01481 |
Dihydrocodeine phosphate (JP19); Dihydro (TN) |
(P) unclassified |
| D01492 |
Bucumolol hydrochloride (JP19) |
(P) unclassified |
| D01501 |
Isoniazid calcium pyruvinate (JAN); Pyruvic acid calcium isoniazid |
(P) unclassified |
| D01504 |
Bufetolol hydrochloride (JP19); Adobiol (TN) |
(P) unclassified |
| D01510 |
Dexamethasone metasulfobenzoate sodium (JAN); Dexamethazone metasulfobenzoate sodium; Dexapos; Santeson (TN) |
(P) CYP induction: CYP3A4 |
| D01512 |
Befunolol hydrochloride (JAN); Bentos (TN) |
(P) unclassified |
| D01514 |
Etizolam (JP19/INN); Sedekopan (TN) |
(P) CYP induction: CYP3A4 |
| D01516 |
Tretinoin tocoferil (JAN); Tocoretinate |
(CI,P) unclassified |
| D01553 |
Manidipine hydrochloride (JP19); Manidipine dihydrochloride; Calslot (TN) |
(P) CYP induction: CYP3A4 |
| D01554 |
Pilsicainide hydrochloride hydrate (JP19); Pilsicainide hydrochloride; SUN 1165 (TN); Sunrythm (TN) |
(P) unclassified |
| D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) CYP induction: CYP3A4 |
| D01564 |
Rilmazafone hydrochloride hydrate (JP19); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochloride; Rhythmy (TN) |
(P) CYP induction: CYP3A4 |
| D01573 |
Etilefrine hydrochloride (JP19); Effortil (TN) |
(P) unclassified |
| D01593 |
Nimetazepam (JAN/INN); Erimin (TN) |
(P) unclassified |
| D01599 |
Gliclazide (JP19/INN); Glimicron (TN) |
(P) unclassified |
| D01603 |
Bethanidine sulfate (JAN/USAN); Tenathan (TN) |
(P) unclassified |
| D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
| D01613 |
Azasetron hydrochloride (JAN); Serotone (TN) |
(P) unclassified |
| D01615 |
Dexamethasone palmitate (JAN); Dexamethasone 21-palmitate; Limethason (TN) |
(P) CYP induction: CYP3A4 |
| D01617 |
Estradiol dipropionate (JAN); Ovahormon (TN) |
(P) CYP induction: CYP3A4 |
| D01619 |
Hydrocortisone butyrate (JP19/USP); Locoid (TN) |
(P) unclassified |
| D01620 |
Neticonazole hydrochloride (JAN); Atolant (TN) |
(P) unclassified |
| D01624 |
Sarpogrelate hydrochloride (JP19); Anplag (TN) |
(P) CYP induction: CYP3A4 |
| D01632 |
Dexamethasone dipropionate (USAN); Dexamethasone propionate (JAN); Hifmeta (TN) |
(P) CYP induction: CYP3A4 |
| D01637 |
Betamethasone dipropionate (JP19/USP); Diprolene (TN); Rinderon-DP (TN); Sernivo (TN) |
(P) unclassified |
| D01643 |
Aluminoparaaminosalicylate calcium hydrate (JAN); Aluminoparaaminosalicylate calcium pentahydrate; Aluminoparaaminosalicylate calcium; Alumino nippas calcium (TN) |
(P) unclassified |
| D01656 |
Brovincamine fumarate (JAN); Sabromin (TN) |
(P) unclassified |
| D01657 |
Lormetazepam (JAN/USAN/INN); Loramet (TN) |
(P) unclassified |
| D01663 |
Quinine ethylcarbonate (JP19) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D01664 |
Omoconazole nitrate (JAN/USAN) |
(P) unclassified |
| D01665 |
Voglibose (JP19/USAN/INN); Basen (TN) |
(P) unclassified |
| D01689 |
Loteprednol etabonate (JAN/USAN); Lotemax (TN) |
(P) unclassified |
| D01690 |
Vesnarinone (JAN/USAN/INN); Arkin Z (TN) |
(P) unclassified |
| D01692 |
Alfuzosin hydrochloride (JAN/USAN); Uroxatral (TN) |
(P) CYP induction: CYP3A4 |
| D01697 |
Colforsin daropate hydrochloride (JAN); Nkh 477; Adehl (TN) |
(P) unclassified |
| D01699 |
Darifenacin hydrobromide (JAN/USAN); Enablex (TN) |
(P) CYP induction: CYP3A4 |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) CYP induction: CYP3A4 |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) CYP induction: CYP3A4 |
| D01712 |
Theophylline sodium acetate (JAN) |
(P) unclassified |
| D01740 |
Barbital (JP19/INN) |
(P) unclassified |
| D01741 |
Celiprolol hydrochloride (JAN/USAN); Selectol (TN) |
(P) unclassified |
| D01744 |
Brotizolam (JP19/USAN/INN); Lendormin (TN) |
(P) CYP induction: CYP3A4 |
| D01745 |
Domperidone (JP19/USAN/INN); Motilium (TN) |
(P) CYP induction: CYP3A4 |
| D01747 |
Idarubicin hydrochloride (JP19/USP); Idamycin (TN) |
(CI,P) unclassified |
| D01758 |
Haloxazolam (JP19/INN); Somelin (TN) |
(P) unclassified |
| D01760 |
Ranimustine (JAN/INN); Cymerin (TN) |
(CI,P) unclassified |
| D01764 |
Diflucortolone valerate (JP19); Afusona (TN) |
(P) unclassified |
| D01769 |
Vindesine sulfate (JAN/USAN); Fildesin (TN) |
(CI,P) unclassified |
| D01775 |
Bifonazole (JP19/USAN/INN); Mycospor (TN) |
(P) unclassified |
| D01784 |
Carmofur (JP19/INN); Mifurol (TN) |
(CI,P) unclassified |
| D01785 |
Pirmenol hydrochloride hydrate (JAN) |
(P) unclassified |
| D01787 |
Sulthiame (USAN); Sultiame (JP19); Ospolot (TN) |
(P) unclassified |
| D01790 |
Oxaliplatin (JP19/USP/INN); Eloxatin (TN) |
(CI,P) unclassified |
| D01794 |
Bopindolol malonate (JAN); Sandonorm (TN) |
(P) unclassified |
| D01795 |
Tilisolol hydrochloride (JAN); Selecal (TN) |
(P) unclassified |
| D01804 |
Cadralazine (JP19/INN); Cadral (TN) |
(P) unclassified |
| D01806 |
Oxprenolol hydrochloride (JP19/USP); Okuspurecol (TN) |
(P) unclassified |
| D01807 |
Mebutamate (JAN/USAN); Capla (TN); Dormate (TN) |
(P) unclassified |
| D01820 |
Alclometasone dipropionate (JAN/USP); Aclovate (TN) |
(P) unclassified |
| D01825 |
Fluocinolone acetonide (JP19/USP/INN); Fluocet (TN); Retisert (TN); Synalar (TN) |
(P) unclassified |
| D01830 |
Arotinolol hydrochloride (JP19); Almarl (TN) |
(P) unclassified |
| D01832 |
Modafinil (JAN/USP/INN); Provigil (TN) |
(P) CYP induction: CYP3A4 |
| D01847 |
Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN); Rapiblyk (TN) |
(P) unclassified |
| D01849 |
Lercanidipine hydrochloride (JAN/USAN); Cardiovasc (TN) |
(P) unclassified |
| D01854 |
Mitiglinide calcium hydrate (JP19); Mitiglinide calcium dihydrate; Glufast (TN) |
(P) Enzyme induction: UGT |
| D01855 |
Mozavaptane hydrochloride (JAN) |
(P) CYP induction: CYP3A4 |
| D01856 |
Nifekalant hydrochloride (JAN); MS 551; Shinbit (TN) |
(P) unclassified |
| D01862 |
Pitavastatin calcium (JAN); NK 104; Livalo (TN) |
(P) unclassified |
| D01872 |
Doxapram hydrochloride (USP); Doxapram hydrochloride hydrate (JP19); Dopram (TN) |
(P) CYP induction: CYP3A4 |
| D01885 |
Pirarubicin (JP19/INN); Therarubicin (TN) |
(CI,P) unclassified |
| D01886 |
Hydrocortisone probutate (USAN); Hydrocortisone butyrate propionate (JAN); Hydrocortisone buteprate; Pandel (TN) |
(P) unclassified |
| D01887 |
Bunazosin hydrochloride (JP19); Detantol (TN) |
(P) unclassified |
| D01896 |
Cilostazol (JP19/USP/INN); Pletal (TN) |
(P) CYP induction: CYP3A4 |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) CYP induction: CYP3A4 |
| D01903 |
Docarpamine (JAN/INN); Tanadopa (TN) |
(P) unclassified |
| D01907 |
Fludarabine phosphate (JAN/USP); Fludara (TN) |
(CI,P) unclassified |
| D01908 |
Nilvadipine (JP19/USAN/INN); Nivadil (TN) |
(P) CYP induction: CYP3A4 |
| D01911 |
Aclarubicin hydrochloride (JP19); Aclacinon (TN) |
(CI,P) unclassified |
| D01933 |
Vatanidipine hydrochloride (JAN); AE 0047; Calbren (TN) |
(P) unclassified |
| D01935 |
Vinorelbine tartrate (USP); Vinorelbine ditartrate (JAN); KW 2307; Navelbine (TN) |
(CI,P) CYP induction: CYP3A4 |
| D01948 |
Dexamethasone valerate (JAN); Dexamethasone 17-valerate; DV-17; Voalla ointment (TN) |
(P) CYP induction: CYP3A4 |
| D01953 |
Estradiol benzoate (JP19/USP); Ovahormon (TN) |
(P) CYP induction: CYP3A4 |
| D01958 |
Indenolol hydrochloride (JP19) |
(P) unclassified |
| D01965 |
Silodosin (JP19/INN); KMD 3213; Rapaflo (TN); Urief (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D01969 |
Gallopamil hydrochloride (JAN) |
(P) unclassified |
| D01972 |
Lanatoside C (JAN/INN); Digilanogen C (TN) |
(P) unclassified |
| D01973 |
Eletriptan hydrobromide (JAN/USAN); Relpax (TN) |
(P) CYP induction: CYP3A4 |
| D01977 |
Gefitinib (JP19/USAN/INN); Iressa (TN) |
(CI,P) unclassified |
| D01980 |
Luliconazole (JAN/USAN/INN); Lulicon (TN); Luzu (TN) |
(P) unclassified |
| D01982 |
Tenofovir disoproxil fumarate (JAN/USAN); Viread (TN) |
(CI,P) unclassified |
| D01984 |
Esomeprazole magnesium (USP); Esomeprazole magnesium hydrate (JP19); Esomeprazole magnesium trihydrate; Nexium (TN) |
(P) unclassified |
| D01994 |
Mosapride citrate hydrate (JP19); Mosapride citrate dihydrate; Gasmotin (TN) |
(P) CYP induction: CYP3A4 |
| D01998 |
Prednisolone farnesylate (JAN); PNF 21; Farnerate (TN) |
(P) unclassified |
| D02002 |
Isoniazid sodium methanesulfonate hydrate (JAN); Isoniazid sodium methanesulfonate monohydrate; Isoniazid sodium methanesulfonate; IHMS; Neoiscotin (TN) |
(P) unclassified |
| D02004 |
Apomorphine hydrochloride (USP); Apomorphine hydrochloride hydrate (JAN); Apokyn (TN); Ixense (TN); Uprima (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) CYP induction: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(P) unclassified |
| D02016 |
Ramosetron hydrochloride (JAN); YM 060; Nasea (TN); Irribow (TN) |
(P) unclassified |
| D02020 |
Mitobronitol (JAN/INN) |
(CI,P) unclassified |
| D02032 |
Betamethasone butyrate propionate (JAN); Antebate (TN) |
(P) unclassified |
| D02041 |
Tropisetron hydrochloride (JAN); Navoban (TN) |
(P) unclassified |
| D02042 |
Olprinone hydrochloride hydrate (JAN); Coretec (TN) |
(P) unclassified |
| D02045 |
Benidipine hydrochloride (JP19); KW 3049; Coniel (TN) |
(P) CYP induction: CYP3A4 |
| D02066 |
Isoproterenol sulfate (USP); Isoprenaline sulfate (JAN); Luf-Iso (TN); Medihaler-Iso (TN) |
(P) unclassified |
| D02071 |
Scopolamine hydrobromide (USP); Scopolamine hydrobromide hydrate (JP19); Scopolamine hydrobromide trihydrate; Hysco (TN); Isopto hyoscine (TN) |
(P) unclassified |
| D02081 |
Metipranolol hydrochloride; Optipranolol (TN) |
(P) unclassified |
| D02084 |
Inamrinone ethylenelactate; Amrinone ethylenelactate; Inocor (TN) |
(P) unclassified |
| D02085 |
Milrinone lactate; Primacor (TN) |
(P) Enzyme induction: UGT |
| D02086 |
Lidocaine hydrochloride (JAN/USP); Dalcaine (TN); Xylocaine (TN) |
(P) CYP induction: CYP3A4 |
| D02087 |
Moricizine hydrochloride (USP); Ethmozine (TN) |
(P) unclassified |
| D02088 |
Tocainide hydrochloride (USP); Tonocard (TN) |
(P) unclassified |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) unclassified |
| D02097 |
Tiagabine hydrochloride (USP); Gabitril (TN) |
(P) unclassified |
| D02101 |
Codeine phosphate (USP); Codeine phosphate hydrate (JP19) |
(P) unclassified |
| D02102 |
Methadone hydrochloride (JAN/USP); Dolophine hydrochloride (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02106 |
Arsenic trioxide (JP19/USAN); Trisenox (TN) |
(CI,P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) CYP induction: CYP3A4 |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(CI,P) unclassified |
| D02129 |
Doxycycline hyclate (USP); Doxycycline hydrochloride hydrate (JP19); Doryx (TN); Lymepak (TN); Periostat (TN); Vibra-tabs (TN) |
(P) unclassified |
| D02130 |
Tropisetron (INN); Navoban (TN) |
(P) unclassified |
| D02131 |
Tegafur and uracil; Uftoral (TN) |
(CI,P) unclassified |
| D02135 |
Levodopa and benserazide hydrochloride; Madopar (TN) |
(P) unclassified |
| D02149 |
Epinephrine bitartrate (USP); Adrenaline bitartrate (JAN); Asmatane mist (TN); Medihaler-epi (TN) |
(P) unclassified |
| D02150 |
l-Isoprenaline hydrochloride (JP19); Proternol-L (TN) |
(P) unclassified |
| D02156 |
Prednisolone hemisuccinate (USP); Prednisolone succinate (JP19) |
(P) unclassified |
| D02165 |
Docetaxel (USP); Docetaxel hydrate (JP19); Docetaxel trihydrate; Taxotere (TN) |
(CI,P) CYP induction: CYP3A4 |
| D02166 |
Mitoxantrone hydrochloride (JAN/USP); Novantron (TN) |
(CI,P) unclassified |
| D02168 |
Topotecan hydrochloride (USAN); Nogitecan hydrochloride (JAN); Hycamtin (TN); Potactasol (TN) |
(CI,P) Transporter induction: ABCB1 |
| D02169 |
Croconazole hydrochloride (JP19); Pilzcin (TN) |
(P) unclassified |
| D02173 |
Galantamine hydrobromide (JAN/USP); Razadyne (TN); Reminyl (TN) |
(P) CYP induction: CYP3A4 |
| D02174 |
Dexamethasone acetate (JAN/USP); Decadronal (TN) |
(P) CYP induction: CYP3A4 |
| D02175 |
Compound oxycodone (JP19); Pavinal (TN) |
(P) CYP induction: CYP3A4 |
| D02177 |
Bleomycin sulfate (JP19/USP); Blenoxane (TN) |
(CI,P) unclassified |
| D02184 |
Erythromycin stearate (JP19/USP); Bristamycin (TN) |
(P) unclassified |
| D02185 |
Chloramphenicol sodium succinate (JP19/USP); Chloromycetin succinate (TN) |
(P) unclassified |
| D02197 |
Vincristine sulfate (JP19/USP); VCR; Marqibo (TN); Oncovin (TN); Vincasar (TN); Vincrex (TN) |
(CI,P) unclassified |
| D02205 |
Ethylmorphine hydrochloride hydrate (JP19); Ethylmorphine hydrochloride dihydrate |
(P) CYP induction: CYP3A4 |
| D02206 |
Buformin hydrochloride (JP19); Dibetos-B (TN) |
(P) unclassified |
| D02211 |
Dihydroergotamine mesylate (USP); Dihydroergotamine mesilate (JP19); Migranal (TN); Trudhesa (TN) |
(P) CYP induction: CYP3A4 |
| D02213 |
Metoclopramide hydrochloride (JAN); Metoclopramide dihydrochloride monohydrate; Primperan (TN); Reglan (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP19/USP); EPI; Ellence (TN) |
(CI,P) unclassified |
| D02219 |
Terbinafine hydrochloride (JP19/USP); Lamisil (TN) |
(P) CYP induction: CYP3A4 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) CYP induction: CYP3A4 |
| D02237 |
Guanethidine sulfate (USAN) |
(P) unclassified |
| D02239 |
Sparteine sulfate (JAN/USAN); Sparteine sulfate pentahydrate |
(P) unclassified |
| D02246 |
Biperiden hydrochloride (JP19/USP); Tasmolin (TN) |
(P) unclassified |
| D02247 |
Biperiden lactate (JAN/USP); Tasmolin (TN) |
(P) unclassified |
| D02252 |
Amobarbital sodium (JAN/USP); Amytal sodium (TN) |
(P) unclassified |
| D02253 |
Pentobarbital calcium (JP19); Ravona (TN) |
(P) unclassified |
| D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP19); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP19); Paxil (TN) |
(P) unclassified |
| D02261 |
Quinine hydrochloride hydrate (JP19); Quinine hydrochloride dihydrate |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02262 |
Quinine sulfate (USP); Quinine sulfate hydrate (JP19); Quinine hydrogen sulfate; Coco-quinine (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02268 |
Ergoloid mesylates (USP); Dihydroergotoxine mesilate (JP19); Circanol (TN); Hydergine (TN); Inorter (TN) |
(P) CYP induction: CYP3A4 |
| D02272 |
Quinidine sulfate (USP); Quinidine sulfate hydrate (JP19); Quinidex (TN) |
(P) CYP induction: CYP3A4 |
| D02286 |
Betamethasone benzoate (USP); Uticort (TN) |
(P) unclassified |
| D02287 |
Clocortolone pivalate (USP); Cloderm (TN) |
(P) unclassified |
| D02288 |
Hydrocortisone valerate (USP); Westcort (TN) |
(P) unclassified |
| D02289 |
Medrysone (USAN); HMS (TN) |
(P) unclassified |
| D02297 |
Emtricitabine and tenofovir disoproxil; Truvada (TN) |
(CI,P) unclassified |
| D02321 |
Amsacrine (USAN/INN); Amsidyl (TN) |
(CI,P) unclassified |
| D02323 |
Tolrestat (USAN/INN); Alredase (TN) |
(P) unclassified |
| D02338 |
Acebutolol (USAN/INN) |
(P) unclassified |
| D02340 |
Loxapine (USAN/INN); Adasuve (TN) |
(P) CYP induction: CYP3A4 |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) unclassified |
| D02356 |
Verapamil (USAN/INN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02358 |
Metoprolol (USAN/INN) |
(P) unclassified |
| D02360 |
Sertraline (INN) |
(P) CYP induction: CYP3A4 |
| D02361 |
Propiomazine (USAN/INN) |
(P) unclassified |
| D02363 |
Ketanserin (USAN/INN) |
(P) unclassified |
| D02368 |
Gemcitabine (USAN/INN) |
(CI,P) unclassified |
| D02374 |
Metipranolol (USAN/INN) |
(P) unclassified |
| D02375 |
Terbinafine (USAN/INN); Lamasil (TN) |
(P) CYP induction: CYP3A4 |
| D02389 |
Primidolol (USAN/INN) |
(P) unclassified |
| D02398 |
Estramustine phosphate sodium (USAN); Emcyt (TN) |
(CI,P) unclassified |
| D02404 |
Procaterol hydrochloride (USAN); Pro-Air (TN) |
(P) CYP induction: CYP3A4 |
| D02425 |
Carbutamide (INN); Invenol (TN) |
(P) unclassified |
| D02427 |
Glibornuride (USAN/INN); Glutril (TN) |
(P) unclassified |
| D02430 |
Gliquidone (INN); Glurenorm (TN) |
(P) unclassified |
| D02472 |
Atovaquone and proguanil hydrochloride; Malarone (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(CI) unclassified |
| D02497 |
Fosamprenavir (INN) |
(CI,P) CYP induction: CYP3A4 |
| D02498 |
Lopinavir and ritonavir; Kaletra (TN) |
(CI,P) unclassified |
| D02499 |
Enfuvirtide (USAN/INN); Fuzeon (TN) |
(CI,P) unclassified |
| D02501 |
Caspofungin acetate (JAN/USAN); Cancidas (TN) |
(P) unclassified |
| D02537 |
Dronedarone (INN) |
(P) unclassified |
| D02549 |
Rifamycin (USAN/INN); Rifamycin SV |
(P) unclassified |
| D02550 |
Rifalazil (USAN/INN); RLZ |
(P) unclassified |
| D02551 |
Rifametane (USAN/INN) |
(P) unclassified |
| D02552 |
Rifamexil (USAN/INN) |
(P) unclassified |
| D02553 |
Rifamide (USAN) |
(P) unclassified |
| D02554 |
Rifaximin (JAN/USAN/INN); Xifaxan (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) Transporter induction: ABCB1 |
| D02556 |
Ravuconazole (prop.INN) |
(P) unclassified |
| D02557 |
Chlormidazole (INN) |
(P) unclassified |
| D02562 |
Rasagiline mesylate (USAN); Rasagiline mesilate (JAN); Azilect (TN) |
(P) unclassified |
| D02564 |
Pargyline hydrochloride (USAN); Eutonyl (TN) |
(P) unclassified |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) CYP induction: CYP3A4 |
| D02570 |
Desvenlafaxine succinate (USAN); Desvenlafaxine succinate hydrate (JAN); Desvenlafaxine succinate monohydrate; Pristiq (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D02577 |
Flibanserin (USAN/INN); Addyi (TN) |
(P) CYP induction: CYP3A4 |
| D02582 |
Fenticonazole (INN) |
(P) unclassified |
| D02583 |
Fenticonazole nitrate (USAN); Lomexin (TN) |
(P) unclassified |
| D02584 |
Aliconazole (INN) |
(P) unclassified |
| D02585 |
Vibunazole; Bay N-7133 |
(P) unclassified |
| D02586 |
Alteconazole (INN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP19); Lanirapid (TN) |
(P) Transporter induction: ABCB1 |
| D02591 |
Dexamethasone acefurate (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D02592 |
Dexamethasone beloxil (USAN) |
(P) CYP induction: CYP3A4 |
| D02593 |
Pantoprazole sodium (USP); Pantoprazole sodium hydrate (JAN); Protonix (TN) |
(P) unclassified |
| D02600 |
Demoxepam (USAN/INN) |
(P) unclassified |
| D02614 |
Denopamine (JAN/INN); Kalgut (TN) |
(P) unclassified |
| D02615 |
Chlorpromazine hydrochloride, promethazine hydrochloride and phenobarbital; Vegetamin (TN) |
(P) unclassified |
| D02618 |
Butobarbital (BAN); Butethal; Neonal (TN) |
(P) unclassified |
| D02619 |
Carbromal (INN); Adalin (TN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) CYP induction: CYP3A4 |
| D02626 |
Bromperidol decanoate (USAN) |
(P) CYP induction: CYP3A4 |
| D02629 |
Fluspirilene (USAN/INN); Imap (TN) |
(P) unclassified |
| D02630 |
Penfluridol (USAN/INN); Semap (TN) |
(P) unclassified |
| D02632 |
Indisetron hydrochloride (JAN); Sinseron (TN) |
(P) unclassified |
| D02633 |
Lomerizine hydrochloride (JAN); Terranas (TN) |
(P) unclassified |
| D02666 |
Iloperidone (USAN/INN); Fanapt (TN) |
(P) CYP induction: CYP3A4 |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
| D02697 |
Valrubicin (USP/INN); Valstar (TN) |
(CI,P) unclassified |
| D02698 |
Teniposide (USP/INN); Vumon (TN) |
(CI,P) unclassified |
| D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D02717 |
Valnoctamide (USAN/INN); Axiquel (TN) |
(P) unclassified |
| D02731 |
Vardenafil dihydrochoride (USAN); Levitra (TN) |
(P) CYP induction: CYP3A4 |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) CYP induction: CYP3A4 |
| D02734 |
Abacavir succinate (USAN) |
(CI,P) unclassified |
| D02740 |
Lidocaine and prilocaine; Lidocaine and propitocaine; Emla (TN); Oraqix (TN) |
(P) CYP induction: CYP3A4 |
| D02746 |
Acecainide hydrochloride (USAN) |
(P) unclassified |
| D02756 |
Aclarubicin (USAN/INN); Aclacinomycin A; ACM |
(CI,P) unclassified |
| D02763 |
Actodigin (USAN/INN) |
(P) unclassified |
| D02765 |
Adaprolol maleate (USAN) |
(P) unclassified |
| D02766 |
Valpromide (INN); Depamide (TN) |
(P) unclassified |
| D02770 |
Adinazolam (USAN/INN) |
(P) unclassified |
| D02771 |
Adinazolam mesylate (USAN) |
(P) unclassified |
| D02815 |
Alitretinoin (USAN); Panretin (TN) |
(CI,P) unclassified |
| D02817 |
Allobarbital (USAN/INN) |
(P) unclassified |
| D02824 |
Almotriptan (USAN) |
(P) CYP induction: CYP3A4 |
| D02825 |
Almotriptan malate (USP); Axert (TN) |
(P) CYP induction: CYP3A4 |
| D02829 |
Alosetron hydrochloride (USAN); Lotrpnex (TN) |
(P) unclassified |
| D02834 |
Alprenoxime hydrochloride (USAN) |
(P) unclassified |
| D02841 |
Altretamine (USP/INN); Hexalen (TN) |
(CI,P) unclassified |
| D02861 |
Indinavir sulfate ethanolate (JAN); Crixivan (TN) |
(CI,P) CYP induction: CYP3A4 |
| D02867 |
Fosamprenavir calcium hydrate (JAN); Lexiva (TN) |
(CI,P) CYP induction: CYP3A4 |
| D02890 |
Amdoxovir (USAN/INN) |
(CI,P) unclassified |
| D02901 |
Amidephrine mesylate (USAN); Amidefrine mesilate (INN) |
(P) unclassified |
| D02908 |
Aminolevulinic acid hydrochloride (JAN/USAN); 5-Aminolevulinic acid hydrochloride; Levulan (TN); Ameluz (TN); Gleolan (TN) |
(CI,P) unclassified |
| D02910 |
Amiodarone (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) CYP induction: CYP3A4 |
| D02933 |
Anagrelide hydrochloride (USP); Agrylin (TN); Xagrid (TN) |
(CI,P) unclassified |
| D02964 |
Apaxifylline (USAN/INN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) CYP induction: CYP3A4 |
| D02969 |
Aprindine (USAN/INN) |
(P) unclassified |
| D02976 |
Arbutamine hydrochloride (USAN); Genesa (TN) |
(P) unclassified |
| D02994 |
Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN); Rituximab-abbs; Rituximab-pvvr; Rituximab-arrx; Rituxan (TN); Riabni (TN); Truximab (TN) |
(CI,P) unclassified |
| D02997 |
Asparaginase (USAN); L-Asparaginase (JAN); Asparaginase Erwinia chrysanthemi (USAN); Asparaginase erwinia chrysanthemi (recombinant)-rywn; Elspar (TN); Erwinaze (TN); Rylaze (TN) |
(CI,P) unclassified |
| D03001 |
Atevirdine mesylate (USAN) |
(CI,P) unclassified |
| D03021 |
Azacitidine (JAN/USAN/INN); Vidaza (TN) |
(CI,P) unclassified |
| D03023 |
Azaconazole (USAN/INN) |
(P) unclassified |
| D03037 |
Azimilide dihydrochloride (USAN) |
(P) unclassified |
| D03046 |
Cytarabine ocfosfate hydrate (JAN); Cytarabine ocfosphate hydrate; Fosteabine sodium monohydrate; Starasid (TN) |
(CI,P) unclassified |
| D03060 |
Batanopride hydrochloride (USAN) |
(P) unclassified |
| D03067 |
Belfosdil (USAN/INN) |
(P) unclassified |
| D03072 |
Bemarinone hydrochloride (USAN) |
(P) unclassified |
| D03075 |
Bemoradan (USAN/INN) |
(P) unclassified |
| D03083 |
Bentazepam (USAN/INN) |
(P) unclassified |
| D03089 |
Benzoctamine hydrochloride (USAN) |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(CI,P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(CI,P) unclassified |
| D03164 |
Bromindione (USAN/INN) |
(P) unclassified |
| D03165 |
Bromocriptine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D03170 |
Bucindolol hydrochloride (USAN) |
(P) unclassified |
| D03177 |
Bunolol hydrochloride (USAN) |
(P) unclassified |
| D03195 |
Butopamine (USAN/INN) |
(P) unclassified |
| D03198 |
Butoxamine hydrochloride (USAN) |
(P) unclassified |
| D03208 |
Aliskiren (USAN/INN); Rasilez (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D03213 |
Apixaban (JAN/USAN/INN); Eliquis (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D03215 |
Armodafinil (USAN/INN); Nuvigil (TN) |
(P) CYP induction: CYP3A4 |
| D03217 |
Avanafil (USAN/INN); Stendra (TN); Spedra (TN) |
(P) CYP induction: CYP3A4 |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(CI,P) CYP induction: CYP3A4 |
| D03225 |
Belotecan hydrochloride (USAN) |
(CI,P) unclassified |
| D03229 |
Bleomycin hydrochloride (JP19); BLM; Bleo (TN) |
(CI,P) unclassified |
| D03230 |
Insulin human (USP/INN); Insulin human (genetical recombination) (JP19); Insulin human (biosynthesis) (JAN); Insulin human (synthesis) (JAN); Humulin (TN) |
(P) unclassified |
| D03250 |
Insulin glargine (USAN/INN); Insulin glargine (genetical recombination) (JP19); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN); Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN); Insulin glargine-yfgn; Lantus (TN) |
(P) unclassified |
| D03252 |
Bosutinib (USAN) |
(CI,P) CYP induction: CYP3A4 |
| D03253 |
Brecanavir (USAN) |
(CI,P) unclassified |
| D03257 |
Trastuzumab (USAN/INN); Trastuzumab (genetical recombination) (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 1] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 2] (JAN); Trastuzumab (genetical recombination) [Trastuzumab biosimilar 3] (JAN); Trastuzumab-pkrb; Trastuzumab-anns; Trastuzumab-dkst; Trastuzumab-dttb; Trastuzumab-qyyp; Trastuzumab-anns; Trastuzumab-strf; Herceptin (TN); Hercessi (TN); Herzuma (TN); Kanjinti (TN); Ogivri (TN); Ontruzant (TN) |
(CI,P) unclassified |
| D03259 |
Gemtuzumab ozogamicin (USAN); Gemtuzumab ozogamicin (genetical recombination) (JAN); Gemtuzumab (INN); Mylotarg (TN) |
(CI,P) CYP induction: CYP3A4 |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(P) CYP induction: CYP3A4 |
| D03262 |
Kanamycin sulfate (JP19) |
(P) unclassified |
| D03264 |
Mazaticol hydrochloride hydrate (JAN); Mazaticol hydrochloride; Pentona (TN) |
(P) unclassified |
| D03278 |
Enviomycin sulfate (JP19); Tuberactin (TN) |
(P) unclassified |
| D03301 |
Prednisolone valerate acetate (JAN); PDL; Spirazon (TN) |
(P) unclassified |
| D03325 |
Mometasone furoate hydrate (JAN); Mometasone furoate monohydrate; Nasonex (TN) |
(P) CYP induction: CYP3A4 |
| D03327 |
Porfimer sodium (JAN/USAN/INN); Photofrin II; Photofrin (TN) |
(CI,P) unclassified |
| D03368 |
Calcium para-aminosalicylate (JP19); Nippas calcium (TN) |
(P) unclassified |
| D03371 |
Capravirine (USAN/INN) |
(CI,P) unclassified |
| D03415 |
Carvedilol phosphate (USAN); Carvedilol phosphate hydrate (JAN); Coreg CR (TN) |
(P) CYP induction: CYP3A4 |
| D03449 |
Cetamolol hydrochloride (USAN) |
(P) unclassified |
| D03455 |
Cetuximab (USAN/INN); Cetuximab (genetical recombination) (JAN); Erbitux (TN) |
(CI,P) unclassified |
| D03461 |
Chloramphenicol pantothenate complex (USAN/INN); Pantofenicol (TN) |
(P) unclassified |
| D03485 |
Ciclafrine hydrochloride (USAN) |
(P) unclassified |
| D03490 |
Cicloprolol hydrochloride (USAN) |
(P) unclassified |
| D03492 |
Cifenline (USAN); Cibenzoline (INN) |
(P) CYP induction: CYP3A4 |
| D03495 |
Cilansetron (USAN/INN) |
(P) unclassified |
| D03496 |
Cilansetron hydrochloride (USAN) |
(P) unclassified |
| D03504 |
Cinacalcet (USAN) |
(P) CYP induction: CYP3A4 |
| D03505 |
Cinacalcet hydrochloride (JAN/USAN); Sensipar (TN); Mimpara (TN) |
(P) CYP induction: CYP3A4 |
| D03526 |
Cisconazole (USAN/INN) |
(P) unclassified |
| D03536 |
Clentiazem maleate (JAN/USAN) |
(P) unclassified |
| D03541 |
Clocortolone acetate (USAN) |
(P) unclassified |
| D03546 |
Clofarabine (JAN/USAN/INN); Clolar (TN) |
(CI,P) unclassified |
| D03561 |
Cloprednol (USAN/INN); Cloradryn (TN) |
(P) unclassified |
| D03562 |
Clorazepate monopotassium (USAN) |
(P) unclassified |
| D03579 |
Codeine polistirex (USAN) |
(P) unclassified |
| D03580 |
Codeine sulfate (USP); Codeine sulfate trihydrate |
(P) unclassified |
| D03594 |
Cortivazol (USAN) |
(P) unclassified |
| D03631 |
Cyprazepam (USAN/INN) |
(P) unclassified |
| D03637 |
Cytarabine hydrochloride (USAN) |
(CI,P) unclassified |
| D03654 |
Darifenacin (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D03655 |
Darodipine (USAN/INN) |
(P) unclassified |
| D03656 |
Darunavir (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D03657 |
Dasantafil (USAN/INN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(CI,P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D03662 |
Dazopride fumarate (USAN) |
(P) unclassified |
| D03664 |
Debrisoquin sulfate (USAN); Declinax (TN) |
(P) unclassified |
| D03665 |
Decitabine (USAN/INN); Dacogen (TN) |
(CI,P) unclassified |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) unclassified |
| D03671 |
Deflazacort (USAN/INN); Emflaza (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D03682 |
Denileukin diftitox (USAN/INN); Denileukin difitox (genetical recombination) (JAN); Denileukin diftitox-cxdl; Ontak (TN); Remitoro (TN); Lymphir (TN) |
(CI,P) unclassified |
| D03696 |
Desonide (USP/INN); Desowen (TN); Verdeso (TN) |
(P) unclassified |
| D03697 |
Desoximetasone (USP/INN); Topicort (TN) |
(P) unclassified |
| D03725 |
Hydrocodone bitartrate (USP); Hydrocodone bitartrate hemipentahydrate; Dicodid (TN) |
(P) CYP induction: CYP3A4 |
| D03729 |
Dexpropranolol hydrochloride (USAN) |
(P) unclassified |
| D03731 |
Selegiline (USAN/INN); Emsam (TN) |
(P) CYP induction: CYP3A4 |
| D03732 |
Dexsotalol hydrochloride (USAN) |
(P) unclassified |
| D03737 |
Dextofisopam (USAN/INN) |
(P) unclassified |
| D03759 |
Diacetolol hydrochloride (USAN) |
(P) unclassified |
| D03783 |
Oxycodone terephthalate (USP) |
(P) CYP induction: CYP3A4 |
| D03785 |
Dichloralphenazone (USP) |
(P) unclassified |
| D03798 |
Dicumarol (USAN); Dicoumarol (INN) |
(P) unclassified |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) CYP induction: CYP3A4 |
| D03812 |
Diflucortolone (USAN) |
(P) unclassified |
| D03813 |
Diflucortolone pivalate (USAN) |
(P) unclassified |
| D03819 |
Digitalis (USP); Digiglusin (TN) |
(P) unclassified |
| D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) CYP induction: CYP3A4 |
| D03825 |
Dihydrocodeine bitartrate (USP) |
(P) unclassified |
| D03828 |
Pemetrexed disodium (USAN); Alimta (TN) |
(CI,P) unclassified |
| D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) CYP induction: CYP3A4 |
| D03833 |
Indinavir (USAN); Indinavir hydrate |
(CI,P) CYP induction: CYP3A4 |
| D03835 |
Fosamprenavir calcium (USAN); Lexiva (TN); Telzir (TN) |
(CI,P) CYP induction: CYP3A4 |
| D03837 |
Fosamprenavir sodium (USAN) |
(CI,P) CYP induction: CYP3A4 |
| D03839 |
Droxinavir hydrochloride (USAN) |
(CI,P) unclassified |
| D03840 |
Palinavir (USAN/INN) |
(CI,P) unclassified |
| D03842 |
Telinavir (USAN/INN) |
(CI,P) unclassified |
| D03843 |
Tipranavir disodium (USAN) |
(CI,P) unclassified |
| D03844 |
Phenytoin, phenobarbital and caffeine and sodium benzoate; Hydantol F (TN) |
(P) unclassified |
| D03852 |
Droperidol and fentanyl citrate; Innovar (TN) |
(P) CYP induction: CYP3A4 |
| D03879 |
Dobutamine (USAN/INN) |
(P) unclassified |
| D03880 |
Dobutamine lactobionate (USAN) |
(P) unclassified |
| D03881 |
Dobutamine tartrate (USAN) |
(P) unclassified |
| D03883 |
Doconazole (USAN/INN) |
(P) unclassified |
| D03891 |
Dopexamine (USAN/INN) |
(P) unclassified |
| D03892 |
Dopexamine hydrochloride (USAN); Dopacard (TN) |
(P) unclassified |
| D03899 |
Doxorubicin (USAN/INN); ADR; Adriblastina (TN) |
(CI,P) unclassified |
| D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) unclassified |
| D03917 |
Drospirenone (JAN/USP/INN); Slynd (TN); Slinda (TN) |
(P) CYP induction: CYP3A4 |
| D03936 |
Econazole (USAN/INN) |
(P) unclassified |
| D03958 |
Edrecolomab (USAN/INN); Panorex (TN) |
(CI,P) unclassified |
| D03961 |
Efaproxiral (USAN/INN) |
(CI,P) unclassified |
| D03962 |
Efaproxiral sodium (USAN) |
(CI,P) unclassified |
| D03975 |
Allylisopropylacetylurea; Apronal; Apronalide |
(P) unclassified |
| D03981 |
Elvucitabine (USAN/INN) |
(CI,P) unclassified |
| D03991 |
Encainide hydrochloride (USAN) |
(P) unclassified |
| D03994 |
Endralazine mesylate (USAN); Endralazine monomethanesulfonate; Migranal (TN) |
(P) unclassified |
| D03997 |
Enilconazole (USAN/INN) |
(P) unclassified |
| D04004 |
Enoximone (USAN/INN); Perfan (TN) |
(P) unclassified |
| D04018 |
Ephedrine sulfate (USP); Akovaz (TN); Corphedra (TN); Emerphed (TN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(CI,P) CYP induction: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D04048 |
Ropivacaine hydrochloride (USP); Ropivacaine hydrochloride hydrate (JAN); Anapeine (TN) |
(P) CYP induction: CYP3A4 |
| D04052 |
Epinephrine and lidocaine hydrochloride; Adrenaline and lidocaine hydrochloride; Xylocaine (TN) |
(P) CYP induction: CYP3A4 |
| D04056 |
Esomeprazole sodium (USAN); Nexium IV (TN) |
(P) unclassified |
| D04061 |
Estradiol acetate (USAN); Femring (TN) |
(P) CYP induction: CYP3A4 |
| D04063 |
Estradiol cypionate (USP) |
(P) CYP induction: CYP3A4 |
| D04064 |
Estradiol enanthate (USAN) |
(P) CYP induction: CYP3A4 |
| D04065 |
Estradiol undecylate (USAN/INN); Delestrec (TN) |
(P) CYP induction: CYP3A4 |
| D04066 |
Estramustine (USAN/INN) |
(CI,P) unclassified |
| D04070 |
Estrogens, conjugated (JAN/USP); Conjugated estrogens; Premarin (TN) |
(P) CYP induction: CYP3A4 |
| D04107 |
Etoposide phosphate (USAN); Etopophos (TN) |
(CI,P) unclassified |
| D04112 |
Etravirine (JAN/USAN/INN); Intelence (TN) |
(CI,P) CYP induction: CYP3A4 |
| D04121 |
Exenatide (JAN/USAN/INN); Byetta (TN) |
(P) unclassified |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) CYP induction: CYP3A4 |
| D04190 |
Flestolol sulfate (USAN) |
(P) unclassified |
| D04193 |
Flordipine (USAN/INN) |
(P) unclassified |
| D04197 |
Floxuridine (USP/INN); FUDR (TN) |
(CI,P) unclassified |
| D04201 |
Flucloronide (USAN); Fluclorolone acetonide (INN) |
(P) unclassified |
| D04208 |
Flumethasone (USAN); Flumetasone (INN) |
(P) unclassified |
| D04214 |
Flunisolide acetate (USAN) |
(P) CYP induction: CYP3A4 |
| D04217 |
Fluocortin butyl (USAN) |
(P) unclassified |
| D04218 |
Fluocortolone (USAN/INN) |
(P) unclassified |
| D04219 |
Fluocortolone caproate (USAN) |
(P) unclassified |
| D04221 |
Fluorometholone acetate (USP); Fluorometholone 17-acetate; Flarex (TN) |
(P) unclassified |
| D04225 |
Fluperolone acetate (USAN); Methral (TN) |
(P) unclassified |
| D04244 |
Formocortal (USAN/INN); Deflamene (TN) |
(P) unclassified |
| D04248 |
Fosazepam (USAN/INN) |
(P) unclassified |
| D04260 |
Fostedil (USAN/INN) |
(P) unclassified |
| D04265 |
Reserpine, hydralazine hydrochloride and hydrochlorothiazide |
(P) unclassified |
| D04266 |
Benzylhydrochlorothiazide, Reserpine and Carbazochrome; Behyd RA (TN) |
(P) unclassified |
| D04292 |
Galantamine (USAN/INN); Reminyl (TN) |
(P) CYP induction: CYP3A4 |
| D04300 |
Ganaxolone (USAN/INN); Ztalmy (TN) |
(P) CYP induction: CYP3A4 |
| D04313 |
Dihydrocodeine phosphate, dl-methylephedrine hydrochloride and Chlorpheniramine maleate; Huscode (TN) |
(P) unclassified |
| D04314 |
Gepirone hydrochloride (USAN); Exxua (TN) |
(P) CYP induction: CYP3A4 |
| D04338 |
Dihydrocodeine phosphate, ephedrine hydrochloride and ammmonium chloride; Sekicode (TN) |
(P) unclassified |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) CYP induction: CYP3A4 |
| D04370 |
Granisetron (JAN/USAN/INN); Sancuso (TN) |
(P) CYP induction: CYP3A4 |
| D04382 |
Guanethidine monosulfate (USP); Guanethidine sulfate (JP19); Ismelin (TN) |
(P) unclassified |
| D04386 |
Guanoclor sulfate (USAN); Vatensol (TN) |
(P) unclassified |
| D04398 |
Guanoxabenz (USAN/INN) |
(P) unclassified |
| D04399 |
Guanoxan sulfate (USAN); Envacar (TN) |
(P) unclassified |
| D04403 |
Guar gum (NF) |
(P) unclassified |
| D04409 |
Halobetasol propionate (USP); Ulobetasol propionate; Ultravate (TN) |
(P) unclassified |
| D04446 |
Betamethasone acetate and betamethasone sodium phosphate; Celestone soluspan (TN); Rinderon (TN) |
(P) CYP induction: CYP3A4 |
| D04447 |
Betamethasone and d-chlorpheniramine maleate; Celestamine (TN) |
(P) CYP induction: CYP3A4 |
| D04457 |
Hydroxyprogesterone caproate and estradiol dipropionate; EP Hormone (TN) |
(P) unclassified |
| D04458 |
Hydralazine polistirex (USAN) |
(P) unclassified |
| D04459 |
Progesterone and estradiol; Lutes (TN) |
(P) unclassified |
| D04460 |
Ethinylestradiol and ethynodiol diacetate; Edulen (TN); Zovia (TN) |
(P) unclassified |
| D04461 |
Hydrocodone polistirex (USAN) |
(P) CYP induction: CYP3A4 |
| D04462 |
Norethisterone and mestranol; Necon (TN) |
(P) unclassified |
| D04463 |
Norgestrel and ethinylestradiol tablets (JP19); Low-ogestrel (TN); Planovar (TN) |
(P) CYP induction: CYP3A4 |
| D04464 |
Chlormadinone acetate and mestranol; Lutedion (TN) |
(P) unclassified |
| D04465 |
Hydroxyprogesterone caproate and estradiol benzoate; Lutes (TN) |
(P) unclassified |
| D04466 |
Mestranol and lynestrenol; Lo-Lyndiol (TN) |
(P) unclassified |
| D04467 |
Hydrocortisone hemisuccinate (USP) |
(P) unclassified |
| D04475 |
Insulin aspart (USP/INN); Insulin aspart (genetical recombination) (JP19); Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN); Insulin X 14; Insulin aspart-szjj; nsulin aspart-xjhz; Merilog (TN); NovoRapid (TN); Novolog (TN); Kirsty (TN) |
(P) unclassified |
| D04477 |
Insulin lispro (USP/INN); Insulin lispro (genetical recombination) (JAN); Insulin lispro (genetical recombination) [Insulin lispro Biosimilar 1] (JAN); Insulin lispro-aabc; Humalog (TN); Lyumjev (TN) |
(P) unclassified |
| D04482 |
Ethinylestradiol and levonorgestrel; Ange (TN); Levora (TN); Lo/ovral (TN); Seasonique (TN); Triphasil-21 (TN); Trivora (TN) |
(P) CYP induction: CYP3A4 |
| D04483 |
Ethinylestradiol and norethisterone; Norethindrone and ethinyl estradiol; Synphase T28 (TN) |
(P) CYP induction: CYP3A4 |
| D04484 |
Desogestrel and ethinylestradiol; Marvelon21 (TN); Mercilon (TN); Ortho-cept (TN) |
(P) CYP induction: CYP3A4 |
| D04488 |
Ibopamine (USAN/INN) |
(P) unclassified |
| D04508 |
Imazodan hydrochloride (USAN) |
(P) unclassified |
| D04529 |
Indolidan (USAN/INN) |
(P) unclassified |
| D04531 |
Indoramin (USAN/INN) |
(P) unclassified |
| D04532 |
Indoramin hydrochloride (USAN) |
(P) unclassified |
| D04539 |
Insulin detemir (USAN/INN); Insulin detemir (genetical recombination) (JAN); Levemir (TN) |
(P) unclassified |
| D04540 |
Insulin glulisine (USAN/INN); Insulin glulisine (genetical recombination) (JAN); Apidra (TN) |
(P) unclassified |
| D04548 |
Insulin, neutral (USAN); Neutral insulin injection (INN) |
(P) unclassified |
| D04603 |
Ipilimumab (USAN/INN); Ipilimumab (genetical recombination) (JAN); Yervoy (TN) |
(CI,P) unclassified |
| D04624 |
Isoconazole (USAN/INN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) CYP induction: CYP3A4 |
| D04642 |
Itasetron (USAN/INN) |
(P) unclassified |
| D04645 |
Ixabepilone (JAN/USAN/INN); Ixempra (TN) |
(CI,P) CYP induction: CYP3A4 |
| D04650 |
Ketazolam (USAN/INN) |
(P) unclassified |
| D04657 |
Lacidipine (USAN/INN); Motens (TN) |
(P) unclassified |
| D04708 |
Levdobutamine lactobionate (USAN) |
(P) unclassified |
| D04710 |
Levobetaxolol hydrochloride (USAN); Betaxon (TN) |
(P) unclassified |
| D04716 |
Levomethadyl acetate (USAN); Levacetylmethadol (INN) |
(P) CYP induction: CYP3A4 |
| D04720 |
Levosimendan (USAN/INN); Simdax (TN) |
(P) unclassified |
| D04721 |
Levotofisopam (USAN/INN) |
(P) unclassified |
| D04733 |
Lidoflazine (USAN/INN); Angex (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) Transporter induction: ABCB1 |
| D04774 |
Lorajmine hydrochloride (USAN) |
(P) unclassified |
| D04778 |
Lorcainide hydrochloride (USAN) |
(P) unclassified |
| D04786 |
Loviride (USAN/INN) |
(CI,P) unclassified |
| D04813 |
Lidocaine hydrochloride and epinephrine bitartrate; Lidocaine hydrochloride and adrenaline bitartrate; Ora (TN); Lidosite (TN) |
(P) CYP induction: CYP3A4 |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) CYP induction: CYP3A4 |
| D04859 |
Maribavir (JAN/USAN/INN); Camvia (TN); Livtencity (TN) |
(CI,P) CYP induction: CYP3A4 |
| D04862 |
Masoprocol (USAN/INN); meso-Nordihydroguaiaretic acid; Actinex (TN) |
(CI,P) unclassified |
| D04872 |
Mechlorethamine hydrochloride (USP); Chlormethine hydrochloride; Mustargen (TN); Valchlor (TN) |
(CI,P) unclassified |
| D04882 |
Medazepam hydrochloride (USAN); Nobrium (TN) |
(P) unclassified |
| D04884 |
Medorinone (USAN/INN) |
(P) unclassified |
| D04888 |
Medroxalol (USAN/INN) |
(P) unclassified |
| D04889 |
Medroxalol hydrochloride (USAN) |
(P) unclassified |
| D04931 |
Mercaptopurine (INN); Mercaptopurine anhydrous; Purinethol (TN) |
(CI,P) unclassified |
| D04955 |
Sematilide hydrochloride (USAN) |
(P) unclassified |
| D04966 |
Metformin (USAN/INN) |
(P) unclassified |
| D04985 |
Methohexital (USP/INN) |
(P) unclassified |
| D04988 |
Methyl aminolevulinate hydrochloride (USAN); Metvixia (TN) |
(CI,P) unclassified |
| D05000 |
Methylprednisolone hemisuccinate (USP); Methylprednisolone succinate (JP19) |
(P) CYP induction: CYP3A4 |
| D05001 |
Methylprednisolone sodium phosphate (USAN) |
(P) CYP induction: CYP3A4 |
| D05002 |
Methylprednisolone suleptanate (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D05008 |
Metoclopramide hydrochloride (USP); Metoclopramide monohydrochloride monohydrate; Clopra (TN); Reglan (TN) |
(P) unclassified |
| D05011 |
Metoprolol fumarate (USP); Lopressor (TN) |
(P) unclassified |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) unclassified |
| D05028 |
Midazolam maleate (USAN) |
(P) CYP induction: CYP3A4 |
| D05029 |
Midostaurin (JAN/USAN/INN); Rydapt (TN) |
(CI,P) CYP induction: CYP3A4 |
| D05077 |
Moricizine (USAN); Moracizine (INN) |
(P) unclassified |
| D05087 |
Moxonidine (USAN/INN); Cynt (TN) |
(P) unclassified |
| D05127 |
Nebivolol (USAN/INN) |
(P) unclassified |
| D05134 |
Nelarabine (JAN/USAN/INN); Nelzarabine (USAN); Arranon (TN) |
(CI,P) unclassified |
| D05206 |
Norepinephrine bitartrate (USP); Levophed (TN) |
(P) unclassified |
| D05216 |
Oblimersen sodium (USAN); Genasense (TN) |
(CI,P) unclassified |
| D05259 |
Omeprazole magnesium (USP); Prilosec OTC (TN) |
(P) unclassified |
| D05261 |
Omeprazole sodium injection (JAN); Omeprazole sodium hydrate; Omepral (TN) |
(P) unclassified |
| D05268 |
Orconazole nitrate (USAN) |
(P) unclassified |
| D05312 |
Oxycodone (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D05333 |
Paclitaxel poliglumex (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D05343 |
Palonosetron hydrochloride (JAN/USP); Aloxi (TN) |
(P) CYP induction: CYP3A4 |
| D05345 |
Pamatolol sulfate (USAN) |
(P) unclassified |
| D05348 |
Pancopride (USAN/INN) |
(P) unclassified |
| D05350 |
Panitumumab (USAN/INN); Panitumumab (genetical recombination) (JAN); Vectibix (TN) |
(CI,P) unclassified |
| D05353 |
Pantoprazole (USAN/INN) |
(P) unclassified |
| D05366 |
Procaterol hydrochloride hydrate (JP19); Meptin (TN) |
(P) CYP induction: CYP3A4 |
| D05367 |
Parconazole hydrochloride (USAN) |
(P) unclassified |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(CI,P) unclassified |
| D05387 |
Pegaspargase (JAN/USAN/INN); Oncaspar (TN) |
(CI,P) unclassified |
| D05403 |
Pelrinone hydrochloride (USAN) |
(P) unclassified |
| D05429 |
Aminophylline hydrate (JP19) |
(P) unclassified |
| D05442 |
Perhexiline maleate (USAN) |
(P) unclassified |
| D05446 |
Pertuzumab (USAN/INN); Pertuzumab (genetical recombination) (JAN); Perjeta (TN) |
(CI,P) unclassified |
| D05457 |
Phenprocoumon (USAN/INN); Liquamar (TN) |
(P) unclassified |
| D05460 |
Phenyl aminosalicylate (USAN); Fenamisal (INN); Pheny-pas-tebamin (TN) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP19) |
(P) CYP induction: CYP3A4 |
| D05482 |
Pinacidil (USAN); Pinacidil hydrate; Pindac (TN) |
(P) unclassified |
| D05522 |
Pixantrone (USAN/INN); Pixuvri (TN) |
(CI,P) unclassified |
| D05538 |
Mozenavir (INN) |
(CI,P) unclassified |
| D05575 |
Pramipexole (USAN/INN) |
(P) unclassified |
| D05587 |
Practolol (USAN) |
(P) unclassified |
| D05589 |
Pralatrexate (JAN/USAN/INN); 10-Propargyl-10-deazaaminopterin; Folotyn (TN) |
(CI,P) unclassified |
| D05594 |
Pramlintide (USAN/INN) |
(P) unclassified |
| D05595 |
Pramlintide acetate (USAN); Symlin (TN) |
(P) unclassified |
| D05601 |
Prednicarbate (USP/INN); Dermatop (TN) |
(P) unclassified |
| D05602 |
Prednimustine (USAN/INN) |
(CI,P) unclassified |
| D05606 |
Prenalterol hydrochloride (USAN) |
(P) unclassified |
| D05612 |
Prinoxodan (USAN/INN) |
(P) unclassified |
| D05621 |
Progabide (USAN/INN); Gabren (TN) |
(P) unclassified |
| D05681 |
Quinine ascorbate (USAN); Quinine biascorbate |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D05705 |
Rauwolfia serpentina (USP); Rauwolfia extract; Himolfia (TN) |
(P) unclassified |
| D05710 |
Reclazepam (USAN/INN) |
(P) unclassified |
| D05719 |
Resocortol butyrate (USAN) |
(P) unclassified |
| D05729 |
Rimexolone (USP/INN); Vexol (TN) |
(P) unclassified |
| D05744 |
Roflumilast (JAN/USAN/INN); Daliresp (TN); Zoryve (TN) |
(P) CYP induction: CYP3A4 |
| D05768 |
Rotigotine (JAN/USAN/INN); Neupro (TN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05792 |
Salmeterol (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D05800 |
Saperconazole (USAN/INN) |
(P) unclassified |
| D05807 |
Satraplatin (USAN/INN) |
(CI,P) unclassified |
| D05822 |
Semustine (USAN/INN) |
(CI,P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) CYP induction: CYP3A4 |
| D05932 |
Streptozocin (JAN/USAN/INN); Streptozotocin; Zanosar (TN) |
(CI,P) unclassified |
| D05942 |
Sulazepam (USAN/INN) |
(P) unclassified |
| D05987 |
Synthetic conjugated estrogens, B (USAN); Enjuvia (TN) |
(P) CYP induction: CYP3A4 |
| D06060 |
Teludipine hydrochloride (USAN) |
(P) unclassified |
| D06066 |
Temoporfin (USAN/INN) |
(CI,P) unclassified |
| D06067 |
Temozolomide (JP19/USAN/INN); Temodal (TN); Temodar (TN) |
(CI,P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06074 |
Tenofovir (USAN); Tenofovir hydrate |
(CI,P) unclassified |
| D06103 |
Theophylline (USP); Theophylline monohydrate; Accurbron (TN) |
(P) unclassified |
| D06104 |
Theophylline sodium glycinate (USP); Asbron (TN) |
(P) unclassified |
| D06109 |
Thioguanine (USP); Thioguanine hydrate; Tabloid (TN) |
(CI,P) unclassified |
| D06129 |
Tiapamil hydrochloride (USAN) |
(P) unclassified |
| D06130 |
Tiazofurin (USAN); Tiazofurine (INN) |
(CI,P) unclassified |
| D06162 |
Tiprenolol hydrochloride (USAN) |
(P) unclassified |
| D06171 |
Tixocortol pivalate (USAN) |
(P) unclassified |
| D06172 |
Tocainide (USAN/INN) |
(P) unclassified |
| D06176 |
Tolamolol (USAN/INN) |
(P) unclassified |
| D06177 |
Tolbutamide sodium, sterile |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06213 |
Treprostinil (JAN/USAN/INN); Remodulin (TN) |
(P) unclassified |
| D06216 |
Triamcinolone acetonide sodium phosphate (USAN) |
(P) unclassified |
| D06231 |
Triflubazam (USAN/INN) |
(P) unclassified |
| D06234 |
Trimazosin hydrochloride (USAN); Trimazosin hydrochloride monohydrate |
(P) unclassified |
| D06253 |
Tropanserin hydrochloride (USAN) |
(P) unclassified |
| D06265 |
Uracil mustard (USAN); Uramustine (INN) |
(CI,P) unclassified |
| D06272 |
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN); Nexavar (TN) |
(CI,P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) CYP induction: CYP3A4 |
| D06304 |
Vindesine (USAN/INN) |
(CI,P) unclassified |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) CYP induction: CYP3A4 |
| D06320 |
Vorinostat (JAN/USAN); Zolinza (TN) |
(CI,P) Enzyme induction: UGT |
| D06328 |
Xamoterol (USAN) |
(P) unclassified |
| D06329 |
Xamoterol fumarate (USAN) |
(P) unclassified |
| D06353 |
Zacopride hydrochloride (USAN) |
(P) unclassified |
| D06363 |
Ziconotide (USAN/INN); Prialt (TN) |
(P) unclassified |
| D06373 |
Zinoconazole hydrochloride (USAN) |
(P) unclassified |
| D06386 |
Zorubicin hydrochloride (USAN) |
(CI,P) unclassified |
| D06396 |
Renzapride (INN) |
(P) unclassified |
| D06397 |
Estramustine phosphate sodium hydrate (JAN); Estramustine phosphate sodium monohydrate; Estracyt (TN); Emcyt (TN) |
(CI,P) unclassified |
| D06399 |
Tegafur, gimeracil and oteracil potassium; Ts-1 (TN); Teysuno (TN) |
(CI,P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06404 |
Liraglutide (USAN/INN); Liraglutide (genetical recombination) (JAN); Victoza (TN) |
(P) unclassified |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN); Remitch (TN) |
(P) CYP induction: CYP3A4 |
| D06407 |
Vandetanib (JAN/USAN/INN); Caprelsa (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06409 |
Bevacizumab (USAN); Bevacizumab (genetical recombination) (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 1] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 2] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 3] (JAN); Bevacizumab (genetical recombination) [Bevacizumab biosimilar 4] (JAN); Bevacizumab-awwb; Bevacizumab-bvzr; Bevacizumab-maly; Bevacizumab-adcd; Bevacizumab-tnjn; Bevacizumab-nwgd; Avastin (TN); Alymsys (TN); Mvasi (TN); Vegzelma (TN); Zirabev (TN) |
(CI,P) unclassified |
| D06412 |
Aliskiren fumarate (JAN/USAN); Aliskiren hemifumarate; Tekturna (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(CI,P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D06478 |
Darunavir ethanolate (JAN); Prezista (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06503 |
Pemetrexed sodium hydrate (JAN); Pemetrexed disodium heptahydrate; Alimta (TN) |
(CI,P) unclassified |
| D06517 |
Pirmenol hydrochloride (USAN); Pirmavar (TN) |
(P) unclassified |
| D06553 |
Alogliptin benzoate (JAN/USAN); Vipidia (TN); Nesina (TN) |
(P) unclassified |
| D06573 |
Carisbamate (USAN) |
(P) unclassified |
| D06580 |
Dexelvucitabine (USAN/INN); Reverset (TN) |
(CI,P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) CYP induction: CYP3A4 |
| D06622 |
Nebivolol hydrochloride (USAN); Bystolic (TN) |
(P) unclassified |
| D06623 |
Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate; Zyprexa (TN) |
(P) unclassified |
| D06630 |
Pramiconazole (USAN/INN) |
(P) unclassified |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(CI,P) unclassified |
| D06645 |
Sitagliptin phosphate (USAN); Sitagliptin phosphate hydrate (JP19); Sitagliptin phosphate monohydrate; Januvia (TN) |
(P) unclassified |
| D06646 |
Epanolol (USAN/INN) |
(P) unclassified |
| D06652 |
Tedisamil (USAN) |
(P) unclassified |
| D06653 |
Tedisamil sesquifumarate (USAN) |
(P) unclassified |
| D06657 |
Tremelimumab (USAN/INN); Tremelimumab (genetical recombination) (JAN); Tremelimumab-actl; CP 675206; Imjudo (TN) |
(CI,P) unclassified |
| D06665 |
Vernakalant hydrochloride (USAN) |
(P) unclassified |
| D06670 |
Maraviroc (JAN/INN); Selzentry (TN) |
(CI,P) CYP induction: CYP3A4 |
| D06673 |
Meprednisone (USP/INN) |
(P) unclassified |
| D06676 |
Raltegravir (INN); MK-0518 |
(CI,P) unclassified |
| D06677 |
Elvitegravir (JAN/USAN); Vitekta (TN) |
(CI,P) unclassified |
| D06699 |
Japanese valerian (JP19); Powdered japanese valerian (JP19) |
(P) unclassified |
| D06876 |
Hydrocortisone aceponate (INN); Efficort (TN) |
(P) unclassified |
| D06881 |
Acetyldigitoxin (INN); Acylanid (TN) |
(P) unclassified |
| D06883 |
Sertaconazole (INN) |
(P) unclassified |
| D06887 |
Talbutal (INN); Lotusate (TN) |
(P) unclassified |
| D07057 |
Abacavir (INN) |
(CI,P) unclassified |
| D07064 |
Acenocoumarol (INN); Acenocoumarin; Mini-sintrom (TN) |
(P) unclassified |
| D07071 |
Mannosulfan (INN) |
(CI,P) unclassified |
| D07073 |
Dexamethasone cipecilate (JAN/INN) |
(P) CYP induction: CYP3A4 |
| D07077 |
Ambrisentan (JAN/INN); Letairis (TN); Volibris (TN) |
(P) unclassified |
| D07080 |
Vildagliptin (JAN/USAN/INN); Equa (TN); Galvus (TN) |
(P) unclassified |
| D07082 |
Dabigatran etexilate mesylate (USAN); Dabigatran etexilate methanesulfonate (JAN); Dabigatran etexilate mesilate; Pradaxa (TN) |
(P) Transporter induction: ABCB1 |
| D07085 |
Bendamustine hydrochloride (JAN/USAN); Treanda (TN); Ribomustin (TN) |
(CI,P) unclassified |
| D07086 |
Rivaroxaban (JAN/USAN/INN); Xarelto (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D07100 |
Amrubicin hydrochloride (JAN/USAN); Calsed (TN) |
(CI,P) unclassified |
| D07113 |
Loperamide oxide (INN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D07116 |
Alclometasone (INN) |
(P) unclassified |
| D07117 |
Metahexamide (INN) |
(P) unclassified |
| D07118 |
Glisoxepide (INN) |
(P) unclassified |
| D07124 |
Alfuzosin (INN); Xatral (TN) |
(P) CYP induction: CYP3A4 |
| D07129 |
Alosetron (INN) |
(P) unclassified |
| D07131 |
Ethyl biscoumacetate (INN) |
(P) unclassified |
| D07132 |
Buprenorphine (JAN/INN); Temgesic (TN) |
(P) CYP induction: CYP3A4 |
| D07133 |
Raltegravir potassium (JAN/USAN); Isentress (TN) |
(CI,P) unclassified |
| D07135 |
Clorindione (INN); G-25766 |
(P) unclassified |
| D07136 |
Diphenadione (INN) |
(P) unclassified |
| D07137 |
Tioclomarol (INN) |
(P) unclassified |
| D07139 |
Cloricromen (INN) |
(P) unclassified |
| D07147 |
Gitoformate (INN) |
(P) unclassified |
| D07148 |
Oxedrine (BAN); (+/-)-Synephrine |
(P) unclassified |
| D07149 |
Dimetofrine (INN) |
(P) unclassified |
| D07150 |
Gepefrine (INN) |
(P) unclassified |
| D07151 |
Cafedrine (BAN) |
(P) unclassified |
| D07155 |
Theodrenaline (INN) |
(P) unclassified |
| D07156 |
Alprenolol (INN) |
(P) unclassified |
| D07165 |
Ivabradine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D07166 |
Methoserpidine (INN) |
(P) unclassified |
| D07167 |
Bietaserpine (prop.INN) |
(P) unclassified |
| D07168 |
Tolonidine (INN) |
(P) unclassified |
| D07169 |
Guanazodine (INN) |
(P) unclassified |
| D07170 |
Dihydralazine (INN) |
(P) unclassified |
| D07171 |
Sitaxentan (USAN/INN) |
(P) unclassified |
| D07175 |
Palonosetron (INN); Aloxi (TN) |
(P) CYP induction: CYP3A4 |
| D07181 |
Mepindolol (INN) |
(P) unclassified |
| D07182 |
Tertatolol (INN) |
(P) unclassified |
| D07183 |
Cloranolol (INN) |
(P) unclassified |
| D07184 |
Talinolol (INN) |
(P) unclassified |
| D07185 |
Fendiline (INN) |
(P) unclassified |
| D07192 |
Benfluorex (INN/BAN); Mediaxal (TN) |
(P) unclassified |
| D07193 |
Flutrimazole (INN) |
(P) unclassified |
| D07201 |
Fluprednidene (INN) |
(P) unclassified |
| D07202 |
Halometasone (INN) |
(P) unclassified |
| D07203 |
Methylprednisolone aceponate (INN); Advantan (TN) |
(P) CYP induction: CYP3A4 |
| D07218 |
Metergoline (INN) |
(P) unclassified |
| D07226 |
Fesoterodine (INN) |
(P) CYP induction: CYP3A4 |
| D07230 |
Prednylidene (INN) |
(P) unclassified |
| D07246 |
Tiocarlide (INN) |
(P) unclassified |
| D07247 |
Terizidone (INN); Terivalidin (TN) |
(P) unclassified |
| D07248 |
Morinamide (INN) |
(P) unclassified |
| D07252 |
Trofosfamide (INN) |
(CI,P) unclassified |
| D07253 |
Treosulfan (JAN/USAN/INN); Grafapex (TN); Ovastat (TN) |
(CI,P) unclassified |
| D07254 |
Triaziquone (INN) |
(CI,P) unclassified |
| D07255 |
Fotemustine (INN/BAN); Muphoran (TN) |
(CI,P) unclassified |
| D07256 |
Etoglucid (INN) |
(CI,P) unclassified |
| D07257 |
Lonidamine (INN); Doridamina (TN) |
(CI,P) unclassified |
| D07258 |
Mitoguazone (INN) |
(CI,P) unclassified |
| D07283 |
Esketamine (USAN/INN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D07298 |
Barbexaclone (INN); Maliasin (TN) |
(P) unclassified |
| D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) CYP induction: CYP3A4 |
| D07300 |
Beclamide (INN) |
(P) unclassified |
| D07314 |
Pinazepam (INN); Domar (TN) |
(P) unclassified |
| D07315 |
Camazepam (INN) |
(P) unclassified |
| D07316 |
Captodiame (BAN) |
(P) unclassified |
| D07317 |
Emylcamate (INN) |
(P) unclassified |
| D07318 |
Mephenoxalone (INN); Dorsiflex (TN) |
(P) unclassified |
| D07319 |
Gedocarnil (INN) |
(P) unclassified |
| D07320 |
Etifoxine (INN/BAN) |
(P) unclassified |
| D07321 |
Vinylbital (INN); Vinylbitone |
(P) unclassified |
| D07322 |
Vinbarbital (INN) |
(P) unclassified |
| D07323 |
Cyclobarbital (INN) |
(P) unclassified |
| D07324 |
Proxibarbal (INN); Centralgol (TN) |
(P) unclassified |
| D07325 |
Chloralodol (INN); Chlorhexadol |
(P) unclassified |
| D07326 |
Loprazolam (INN); Dormonoct (TN) |
(P) unclassified |
| D07327 |
Doxefazepam (INN) |
(P) unclassified |
| D07328 |
Cinolazepam (INN); Gerodorm (TN) |
(P) unclassified |
| D07329 |
Pyrithyldione (INN) |
(P) unclassified |
| D07330 |
Clomethiazole (INN); Distraneurine (TN) |
(P) unclassified |
| D07331 |
Hexapropymate (INN); Merinax (TN) |
(P) unclassified |
| D07332 |
Methylpentynol (INN); Meparfynol; Methylparafynol; Atemorin (TN) |
(P) unclassified |
| D07333 |
Niaprazine (INN); Nopron (TN) |
(P) unclassified |
| D07402 |
Levocetirizine (USAN/INN); Xazal (TN) |
(P) CYP induction: CYP3A4 |
| D07407 |
Rupatadine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D07428 |
Bunaftine (INN) |
(P) unclassified |
| D07441 |
Amantadine (INN) |
(P) unclassified |
| D07448 |
Amitriptyline (INN); Laroxyl (TN) |
(P) CYP induction: CYP3A4 |
| D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) CYP induction: CYP3A4 |
| D07455 |
Anagrelide (INN/BAN) |
(CI,P) unclassified |
| D07457 |
Anisindione (INN); Miradon (TN) |
(P) unclassified |
| D07460 |
Apomorphine (BAN); Uprima (TN) |
(P) unclassified |
| D07464 |
Paramethasone (INN); Dillar (TN) |
(P) unclassified |
| D07465 |
Arotinolol (INN) |
(P) unclassified |
| D07471 |
Atazanavir (INN); Reyataz (TN) |
(CI,P) unclassified |
| D07472 |
Pemetrexed (INN); Alimta (TN); Pemetrexed (TN); Pemfexy (TN) |
(CI,P) unclassified |
| D07474 |
Atorvastatin (INN); Lipitor (TN); Sortis (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D07481 |
Azasetron (INN) |
(P) unclassified |
| D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) CYP induction: CYP3A4 |
| D07495 |
Beclometasone (INN) |
(P) unclassified |
| D07496 |
Befunolol (INN) |
(P) unclassified |
| D07501 |
Bendamustine (INN); Treanda (TN) |
(CI,P) unclassified |
| D07507 |
Zidovudine and lamivudine; Combivir (TN) |
(CI,P) unclassified |
| D07508 |
Benfluorex hydrochloride; Mediator (TN) |
(P) unclassified |
| D07509 |
Benidipine (INN) |
(P) CYP induction: CYP3A4 |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) CYP induction: CYP3A4 |
| D07526 |
Betaxolol (INN) |
(P) unclassified |
| D07535 |
Bleomycin (INN); BLM |
(CI,P) unclassified |
| D07537 |
Bopindolol (INN); Sandonorm (TN) |
(P) unclassified |
| D07538 |
Bosentan (INN) |
(P) CYP induction: CYP3A4 |
| D07545 |
Brovincamine (INN); Sarbromin (TN) |
(P) unclassified |
| D07546 |
Bucladesine (INN) |
(P) unclassified |
| D07552 |
Bupivacaine (USAN/INN); Bucaine (TN); Exparel (TN) |
(P) CYP induction: CYP3A4 |
| D07555 |
Acetyldigoxin; Cedigossima (TN) |
(P) unclassified |
| D07556 |
beta-Acetyldigoxin; Acetyldigoxin beta isomer; Corotal (TN) |
(P) unclassified |
| D07567 |
Aminolevulinic acid |
(CI,P) unclassified |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP19); Unisia (TN) |
(P) CYP induction: CYP3A4 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07585 |
Isopropylantipyrine, ergotamine tartrate and anhydrous caffeine; Cleamine A (TN) |
(P) CYP induction: CYP3A4 |
| D07590 |
Bupranolol (INN) |
(P) unclassified |
| D07593 |
Buspirone (INN); Gen-Buspirone (TN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) unclassified |
| D07598 |
Butoconazole (INN); Gynofort (TN) |
(P) unclassified |
| D07603 |
Caffeine citrate (USP); Cafcit (TN) |
(P) unclassified |
| D07607 |
Capreomycin (INN) |
(P) unclassified |
| D07608 |
Carazolol (INN); Conducton (TN); Suacron [veterinary] (TN) |
(P) unclassified |
| D07624 |
Carteolol (INN) |
(P) unclassified |
| D07660 |
Celiprolol (INN) |
(P) unclassified |
| D07661 |
Cerivastatin (INN) |
(P) CYP induction: CYP3A4 |
| D07667 |
Cevimeline (INN) |
(P) CYP induction: CYP3A4 |
| D07671 |
Chlormethine (INN); Mechlorethamine |
(CI,P) unclassified |
| D07674 |
Chloramphenicol stearate; Quemicetina (TN) |
(P) unclassified |
| D07675 |
Chloramphenicol succinate |
(P) unclassified |
| D07676 |
Chlormidazole hydrochloride; Unfungicid (TN) |
(P) unclassified |
| D07682 |
Clazosentan sodium (JAN/USAN); Pivlaz (TN) |
(P) unclassified |
| D07704 |
Citalopram (USP/INN); Citadur (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D07705 |
Citalopram hydrochloride; Seropram (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D07710 |
Clarithromycin lactobionate; Klacid (TN) |
(P) CYP induction: CYP3A4 |
| D07714 |
Climazolam (INN); Climasol [veterinary] (TN) |
(P) unclassified |
| D07715 |
Clobetasol (INN); Clobecort Amex (TN) |
(P) unclassified |
| D07717 |
Clobetasone (INN) |
(P) unclassified |
| D07719 |
Clocortolone (INN) |
(P) unclassified |
| D07724 |
Magnesium clofibrate (INN); Clofibric acid magnesium salt |
(P) unclassified |
| D07725 |
Clomethiazole edisilate; Heminevrin (TN) |
(P) unclassified |
| D07727 |
Clomipramine (INN); Anafranil (TN) |
(P) CYP induction: CYP3A4 |
| D07729 |
Clopidogrel (USP/INN); Plavix (TN) |
(P) unclassified |
| D07736 |
Cloricromen hydrohloride; Proendotel (TN) |
(P) unclassified |
| D07740 |
Codeine hydrochloride; Bisoltus (TN) |
(P) unclassified |
| D07749 |
Cortisone (INN) |
(P) unclassified |
| D07752 |
Croconazole (INN) |
(P) unclassified |
| D07757 |
Cyclobarbital calcium (BAN); Phanodorn calcium (TN) |
(P) unclassified |
| D07760 |
Cyclophosphamide (INN); Cytoxan (TN) |
(CI,P) CYP induction: CYP3A4 |
| D07772 |
Dacarbazine citrate |
(CI,P) unclassified |
| D07776 |
Daunorubicin (INN); DM; DaunoXome (TN) |
(CI,P) unclassified |
| D07782 |
Delavirdine (INN) |
(CI,P) unclassified |
| D07784 |
Delorazepam (INN); Dadumir (TN) |
(P) unclassified |
| D07793 |
Desvenlafaxine (INN); Khedezla (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D07796 |
Dexamethasone 21-acetate; Dexamethasone acetate anhydrous; Decaject-L.A. (TN) |
(P) CYP induction: CYP3A4 |
| D07797 |
Dexamethasone isonicotinate; Dexamethasone 21-isonicotinate; Voren [veterinary] (TN) |
(P) CYP induction: CYP3A4 |
| D07798 |
Dexamethasone sodium hemisulfate; Dexamethasone 21-sodium sulfate |
(P) CYP induction: CYP3A4 |
| D07799 |
Dexamethasone 21-tebutate; Dexamethasone tertiary butyl acetate; Dexamedium [veterinary] (TN) |
(P) CYP induction: CYP3A4 |
| D07800 |
Dexamethasone 21-valerate; Voalla (TN); Zalucs (TN) |
(P) CYP induction: CYP3A4 |
| D07801 |
Dexamethasone phenylpropionate; Dexafort [veterinary] (TN) |
(P) CYP induction: CYP3A4 |
| D07802 |
Dexamethasone phosphate; Decadron-phosphate (TN) |
(P) CYP induction: CYP3A4 |
| D07827 |
Diflorasone (INN); Murode (TN) |
(P) unclassified |
| D07830 |
Dihydralazine sulfate; Dihydralazine hydrogen sulfate; Nepresol (TN) |
(P) unclassified |
| D07831 |
Dihydrocodeine (INN); Remedacen (TN) |
(P) unclassified |
| D07832 |
Dihydrocodeine thiocyanate; Paracodin (TN) |
(P) unclassified |
| D07837 |
Dihydroergotamine (INN); Neomigran (TN) |
(P) CYP induction: CYP3A4 |
| D07838 |
Dihydroergotamine tartrate; Divegal (TN) |
(P) CYP induction: CYP3A4 |
| D07839 |
Dihydroergotoxine; Co-Dergocrin (TN) |
(P) CYP induction: CYP3A4 |
| D07845 |
Diltiazem (INN); Surazem (TN) |
(P) CYP induction: CYP3A4 |
| D07866 |
Docetaxel (JAN/INN); Taxotere (TN) |
(CI,P) CYP induction: CYP3A4 |
| D07867 |
Dolasetron (INN) |
(P) unclassified |
| D07868 |
Domperidone maleate |
(P) CYP induction: CYP3A4 |
| D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) CYP induction: CYP3A4 |
| D07870 |
Dopamine (INN); Medopa (TN) |
(P) unclassified |
| D07871 |
Dorzolamide (INN); Trusopt (TN) |
(P) CYP induction: CYP3A4 |
| D07873 |
Doxapram (INN); Docatone (TN) |
(P) CYP induction: CYP3A4 |
| D07874 |
Doxazosin (INN); Cardura XL (TN) |
(P) unclassified |
| D07882 |
Eberconazole (INN) |
(P) unclassified |
| D07883 |
Eflornithine (INN) |
(CI,P) unclassified |
| D07884 |
Eberconazole nitrate; Ebernet (TN) |
(P) unclassified |
| D07886 |
Efonidipine (INN) |
(P) unclassified |
| D07887 |
Eletriptan (INN) |
(P) CYP induction: CYP3A4 |
| D07894 |
Encainide (INN) |
(P) unclassified |
| D07897 |
Enviomycin (INN) |
(P) unclassified |
| D07901 |
Epirubicin (INN); Farmorubicin (TN) |
(CI,P) unclassified |
| D07905 |
Ergometrine (INN) |
(P) CYP induction: CYP3A4 |
| D07906 |
Ergotamine (INN) |
(P) CYP induction: CYP3A4 |
| D07907 |
Erlotinib (INN) |
(CI,P) CYP induction: CYP3A4 |
| D07913 |
Escitalopram (INN); Esertia (TN) |
(P) CYP induction: CYP3A4 |
| D07916 |
Esmolol (INN) |
(P) unclassified |
| D07917 |
Esomeprazole (INN); Inexium paranova (TN) |
(P) unclassified |
| D07918 |
Estradiol hemihydrate; Estrasorb (TN); Vagifem (TN) |
(P) CYP induction: CYP3A4 |
| D07919 |
Estradiol 17 beta-hemisuccinate; 17beta-Estradiol hemisuccinate; Eutocol (TN) |
(P) CYP induction: CYP3A4 |
| D07925 |
Ethambutol (INN); Servambutol (TN) |
(P) unclassified |
| D07928 |
Ethinylestradiol propanesulfonate; Turisteron (TN) |
(P) CYP induction: CYP3A4 |
| D07929 |
Ethylmorphine (BAN) |
(P) CYP induction: CYP3A4 |
| D07930 |
Etifoxine hydrochloride; Stresam (TN) |
(P) unclassified |
| D07931 |
Etilefrine (INN); Corcanfol (TN) |
(P) unclassified |
| D07933 |
Etofylline (INN); Oxyphyllin (TN) |
(P) unclassified |
| D07943 |
Fendiline hydrochloride; Sensit (TN) |
(P) unclassified |
| D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) CYP induction: CYP3A4 |
| D07962 |
Flecainide (INN) |
(P) unclassified |
| D07966 |
Fludarabine (INN); Fluradosa (TN) |
(CI,P) unclassified |
| D07967 |
Fludrocortisone (INN); Astonin-H (TN) |
(P) unclassified |
| D07969 |
Fluindione (INN); Previsccan (TN) |
(P) unclassified |
| D07971 |
Flunarizine (INN); Sibelium (TN) |
(P) unclassified |
| D07972 |
Fluocortin (INN) |
(P) unclassified |
| D07973 |
Fluocortolone 21-pivalate; Fluocortolone pivalate; Ultradil (TN) |
(P) unclassified |
| D07974 |
Fluorouracil sodium salt |
(CI,P) unclassified |
| D07980 |
Fluprednidene acetate; Fluprednidene 21-acetate; Decoderm (TN) |
(P) unclassified |
| D07981 |
Fluticasone (INN); Fluticaps (TN) |
(P) CYP induction: CYP3A4 |
| D07983 |
Fluvastatin (INN); Fluvas (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 |
| D07993 |
Fosphenytoin (INN) |
(P) unclassified |
| D08009 |
Gallopamil (INN) |
(P) unclassified |
| D08020 |
Lorcainide (INN) |
(P) unclassified |
| D08024 |
Vosaroxin (USAN); Voreloxin |
(CI,P) unclassified |
| D08030 |
Guanethidine (INN) |
(P) unclassified |
| D08031 |
Guanfacine (INN); Estulic (TN) |
(P) CYP induction: CYP3A4 |
| D08035 |
Haloperidol lactate; Haldol (TN) |
(P) CYP induction: CYP3A4 |
| D08044 |
Hydralazine (INN); Hidral (TN) |
(P) unclassified |
| D08045 |
Hydrocodone (INN); Dihydrocodeinone |
(P) CYP induction: CYP3A4 |
| D08046 |
Hydrocodone hydrochloride; Dihydrocodeinone hydrochloride; Dicodid (TN) |
(P) CYP induction: CYP3A4 |
| D08048 |
Hydroquinidine (DCF); Dihydroquinidine |
(P) unclassified |
| D08049 |
Hydroquinidine hydrochloride; Idrochinidine (TN); Serecor (TN) |
(P) unclassified |
| D08050 |
Hydroxychloroquine (INN); Polirreumin (TN) |
(P) CYP induction: CYP3A4 |
| D08054 |
Hydroxyzine (INN); Marex (TN) |
(P) unclassified |
| D08057 |
Ibopamine hydrochloride; Scandine (TN) |
(P) unclassified |
| D08060 |
Ibutilide (INN) |
(P) unclassified |
| D08062 |
Idarubicin (INN); Zavedos (TN) |
(CI,P) unclassified |
| D08066 |
Imatinib (INN); Glamox (TN) |
(CI,P) CYP induction: CYP3A4 |
| D08070 |
Imipramine (INN); Tofranil (TN) |
(P) CYP induction: CYP3A4 |
| D08071 |
Imipramine pamoate (USP); Imipramine embonate; Tofranil-pm (TN) |
(P) CYP induction: CYP3A4 |
| D08074 |
Penbutolol (INN) |
(P) unclassified |
| D08078 |
Indenolol (INN) |
(P) unclassified |
| D08086 |
Irinotecan (INN); Biotecan (TN) |
(CI,P) unclassified |
| D08090 |
Isoprenaline (INN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) CYP induction: CYP3A4 |
| D08099 |
Ketanserin tartrate; Sufrexal (TN) |
(P) unclassified |
| D08108 |
Lapatinib (INN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08111 |
Lercanidipine (INN); Lercanil (TN) |
(P) unclassified |
| D08115 |
Levobunolol (INN) |
(P) unclassified |
| D08116 |
Levobupivacaine (INN); Novabupi (TN) |
(P) CYP induction: CYP3A4 |
| D08118 |
Levocetirizine dihydrochloride (USP); Levocetirizine hydrochloride (JAN); Xyzal (TN) |
(P) CYP induction: CYP3A4 |
| D08120 |
Levofloxacin (INN); Cravit (TN); Levaquin (TN) |
(P) unclassified |
| D08127 |
Lidocaine hydrochloride monohydrate; Lidocaine (TN); Zingo (TN) |
(P) CYP induction: CYP3A4 |
| D08144 |
Loperamide (INN); Diamide (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08145 |
Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) |
(P) unclassified |
| D08147 |
Loteprednol (INN) |
(P) unclassified |
| D08148 |
Loxapine hydrochloride; Desconex (TN) |
(P) CYP induction: CYP3A4 |
| D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) CYP induction: CYP3A4 |
| D08157 |
Mazaticol (INN) |
(P) unclassified |
| D08170 |
Melatonin (JAN); Melatonina (TN); Melatobel (TN) |
(P) unclassified |
| D08173 |
Melphalan hydrochloride; Alkeran (TN); Evomela (TN) |
(CI,P) unclassified |
| D08180 |
Mephentermine (INN) |
(P) unclassified |
| D08192 |
Metaraminol (INN) |
(P) unclassified |
| D08194 |
Deserpidine (INN); Halmonyl (TN) |
(P) unclassified |
| D08195 |
Methadone (BAN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08201 |
Methoxamine (BAN) |
(P) unclassified |
| D08204 |
Methyl aminolevulinate |
(CI,P) unclassified |
| D08205 |
Methyldopa (INN); Aldomet (TN) |
(P) unclassified |
| D08207 |
Methylergometrine (INN); Ergotyl (TN) |
(P) CYP induction: CYP3A4 |
| D08212 |
Trimazosin (INN) |
(P) unclassified |
| D08215 |
Mexiletine (INN) |
(P) unclassified |
| D08216 |
Mianserin (INN); Tolvon (TN) |
(P) CYP induction: CYP3A4 |
| D08217 |
Mibefradil (INN) |
(P) unclassified |
| D08220 |
Midodrine (INN) |
(P) unclassified |
| D08224 |
Mitoxantrone (INN); Misostol (TN) |
(CI,P) unclassified |
| D08227 |
Mometasone (INN) |
(P) CYP induction: CYP3A4 |
| D08229 |
Montelukast (INN); Brondilat (TN) |
(P) CYP induction: CYP3A4 |
| D08236 |
Mosapride (INN); Mosart (TN) |
(P) CYP induction: CYP3A4 |
| D08254 |
Endralazine (INN) |
(P) unclassified |
| D08255 |
Naratriptan (INN); Naramig (TN) |
(P) CYP induction: CYP3A4 |
| D08259 |
Nelfinavir (INN); Viracept (TN) |
(CI,P) CYP induction: CYP3A4 |
| D08270 |
Nicardipine (INN); Cardene (TN) |
(P) CYP induction: CYP3A4 |
| D08276 |
Nimustine (INN) |
(CI,P) unclassified |
| D08283 |
Nordazepam (INN); Calmday (TN) |
(P) CYP induction: CYP3A4 |
| D08284 |
Norepinephrine hydrochoride; (-)-Noradrenaline hydrochloride; Arterenol (TN) |
(P) unclassified |
| D08286 |
Norfenefrine (INN) |
(P) unclassified |
| D08290 |
Oblimersen (INN) |
(CI,P) unclassified |
| D08291 |
Ofloxacin hydrochloride; Tarivid (TN) |
(P) CYP induction: CYP3A4 |
| D08294 |
Olprinone (INN) |
(P) unclassified |
| D08296 |
Omoconazole (INN) |
(P) unclassified |
| D08308 |
Oxedrine tartrate; Dacryoboraline (TN) |
(P) unclassified |
| D08309 |
Oxedrine hydrochloride; Ocuton (TN) |
(P) unclassified |
| D08313 |
Oxiconazole (INN) |
(P) unclassified |
| D08315 |
Oxilofrine hydrochloride; Carnigen (TN) |
(P) unclassified |
| D08318 |
Oxprenolol (INN) |
(P) unclassified |
| D08339 |
Pergolide (INN); Permax (TN) |
(P) unclassified |
| D08340 |
Perhexiline (INN) |
(P) unclassified |
| D08351 |
Phenformin (BAN) |
(P) unclassified |
| D08352 |
Phenformin hydrochloride; Debei (TN) |
(P) unclassified |
| D08354 |
Phenindione (INN); Hedulin (TN) |
(P) unclassified |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08365 |
Phenylephrine (INN); Phenylephrine Minims (TN) |
(P) unclassified |
| D08366 |
Phenylephrine tartrate; L-Phenylephrine tartrate; Boraline (TN) |
(P) unclassified |
| D08377 |
Pilsicainide (INN) |
(P) unclassified |
| D08378 |
Pioglitazone (INN); Actos (TN) |
(P) unclassified |
| D08386 |
Pirarubicin hydrochloride; Pinorubin (TN); Therarubicin (TN) |
(CI,P) unclassified |
| D08394 |
Pirmenol (INN) |
(P) unclassified |
| D08395 |
Piroheptine (INN) |
(P) unclassified |
| D08408 |
Pranlukast (INN); Azlaire (TN) |
(P) CYP induction: CYP3A4 |
| D08411 |
Prazosin (INN); Minipress (TN) |
(P) unclassified |
| D08412 |
Prednisolone pivalate; Prednisolone 21-pivalate; Ultracortenol (TN) |
(P) unclassified |
| D08413 |
Prednisolone sodium metazoate (USAN); Prednisolone metasulfobenzoate sodium; Prednisolone 21-(sodium 3-sulfobenzoate); Predenema (TN) |
(P) unclassified |
| D08414 |
Prednisolone 21-(sodium tetrahydrophthalate); Prednisolone sodium tetrahydrophthalate; Fenicort (TN) |
(P) unclassified |
| D08415 |
Prednisolone steaglate (BAN); Prednisolone 21-steaglate; Sintisone (TN) |
(P) unclassified |
| D08416 |
Prednisone acetate; Prednisone 21-acetate |
(P) unclassified |
| D08421 |
Procainamide (INN) |
(P) unclassified |
| D08423 |
Procarbazine (INN) |
(CI,P) unclassified |
| D08424 |
Procaterol (INN); Meptin (TN) |
(P) CYP induction: CYP3A4 |
| D08435 |
Propafenone (INN) |
(P) CYP induction: CYP3A4 |
| D08439 |
Propiomazine maleate; Propavan (TN) |
(P) unclassified |
| D08441 |
Propiverine (INN) |
(P) CYP induction: CYP3A4 |
| D08443 |
Propranolol (INN) |
(P) unclassified |
| D08453 |
Pargyline (INN) |
(P) unclassified |
| D08456 |
Quetiapine (INN); Norsic (TN) |
(P) CYP induction: CYP3A4 |
| D08458 |
Quinidine (BAN) |
(P) CYP induction: CYP3A4 |
| D08459 |
Quinidine phenylethylbarbiturate; Quinidine 5-ethyl 5-phenyl barbiturate; Natisedine (TN) |
(P) CYP induction: CYP3A4 |
| D08460 |
Quinine (BAN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08461 |
Quinine dihydrochloride |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08463 |
Rabeprazole (INN); Eraloc (TN) |
(P) CYP induction: CYP3A4 |
| D08466 |
Ramosetron (INN) |
(P) unclassified |
| D08469 |
Rasagiline (USAN/INN); Azilect (TN) |
(P) unclassified |
| D08476 |
Resocortol (INN) |
(P) unclassified |
| D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) unclassified |
| D08480 |
Rifamycin sodium (USAN); Rifamycin SV sodium salt; Aemcolo (TN); Otofa (TN); Rifocina (TN) |
(P) unclassified |
| D08481 |
Rilmazafone (INN) |
(P) CYP induction: CYP3A4 |
| D08482 |
Rilmenidine (INN); Hyperium (TN) |
(P) unclassified |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) CYP induction: CYP3A4 |
| D08489 |
Ropinirole (USAN/INN); Ropitor (TN) |
(P) unclassified |
| D08490 |
Ropivacaine (INN); Naropin (TN) |
(P) CYP induction: CYP3A4 |
| D08491 |
Rosiglitazone (INN); Gaudil (TN) |
(P) unclassified |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP19); Cosopt (TN) |
(P) CYP induction: CYP3A4 |
| D08497 |
Rupatadine fumarate (JAN/USAN); Rinialer (TN); Rupafin (TN) |
(P) CYP induction: CYP3A4 |
| D08508 |
Sarpogrelate (INN) |
(P) CYP induction: CYP3A4 |
| D08510 |
Sertaconazole nitrate; Ertaczo (TN); Zalain (TN) |
(P) unclassified |
| D08514 |
Sildenafil (INN); Aphrodil (TN) |
(P) CYP induction: CYP3A4 |
| D08516 |
Sitagliptin (USAN/INN) |
(P) unclassified |
| D08517 |
Sitaxentan sodium (USAN); Thelin (TN) |
(P) unclassified |
| D08522 |
Solifenacin (INN) |
(P) CYP induction: CYP3A4 |
| D08524 |
Sorafenib (USAN/INN) |
(CI,P) unclassified |
| D08525 |
Sotalol (INN); Darob mite (TN) |
(P) unclassified |
| D08531 |
Streptomycin (INN) |
(P) unclassified |
| D08535 |
Sulconazole (INN) |
(P) unclassified |
| D08552 |
Sunitinib (INN) |
(CI,P) CYP induction: CYP3A4 |
| D08556 |
Tacrolimus (INN); Prograf (TN) |
(P) CYP induction: CYP3A4 |
| D08559 |
Tamoxifen (INN); Tamoplex (TN) |
(P) CYP induction: CYP3A4 |
| D08572 |
Tertatolol hydrochloride; Artex (TN) |
(P) unclassified |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) unclassified |
| D08584 |
Thioacetazone (INN); Amithiozone; Citazone (TN) |
(P) unclassified |
| D08588 |
Tiagabine (INN); Gabitril (TN) |
(P) unclassified |
| D08598 |
Tilisolol (INN) |
(P) unclassified |
| D08600 |
Timolol (INN); Betimol (TN) |
(P) unclassified |
| D08603 |
Tioguanine (INN); Lanvis (TN) |
(CI,P) unclassified |
| D08605 |
Tipranavir (INN); Aptivus (TN) |
(CI,P) unclassified |
| D08610 |
Tixocortol (INN) |
(P) unclassified |
| D08616 |
Teneligliptin (INN) |
(P) CYP induction: CYP3A4 |
| D08618 |
Topotecan (BAN); Hycamtin (TN) |
(CI,P) Transporter induction: ABCB1 |
| D08620 |
Toremifene (INN); Fareston (TN) |
(P) CYP induction: CYP3A4 |
| D08623 |
Tramadol (INN); Amanda (TN) |
(P) CYP induction: CYP3A4 |
| D08626 |
Trazodone (INN); Trittico (TN) |
(P) CYP induction: CYP3A4 |
| D08628 |
Treprostinil monosodium salt; Treprostinil sodium; Trepulmix (TN); Yutrepia (TN) |
(P) unclassified |
| D08634 |
Triclofos (INN); Neguvon [veterinary] (TN) |
(P) unclassified |
| D08638 |
Trihexyphenidyl (INN); Apo-trihex (TN) |
(P) unclassified |
| D08660 |
Ulobetasol (INN); Halobetasol |
(P) unclassified |
| D08662 |
Urapidil hydrochloride; Ebrantil (TN) |
(P) unclassified |
| D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
| D08668 |
Vardenafil (USAN/INN); Levitra (TN) |
(P) CYP induction: CYP3A4 |
| D08670 |
Venlafaxine (INN); Efectin (TN) |
(P) unclassified |
| D08675 |
Vinblastine (INN) |
(CI,P) CYP induction: CYP3A4 |
| D08679 |
Vincristine (INN); Tecnocris (TN) |
(CI,P) unclassified |
| D08680 |
Vinorelbine (INN); Navelbine (TN) |
(CI,P) CYP induction: CYP3A4 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) unclassified |
| D08686 |
Ziconotide acetate; Prialt (TN) |
(P) unclassified |
| D08690 |
Zolpidem (INN); Sanval (TN) |
(P) CYP induction: CYP3A4 |
| D08695 |
dl-Methylephedrine hydrochloride, dihydrocodeine phosphate, diprophylline, diphenhydramine salicylate, acetaminophen and bromovalerylurea; Coughcode N (TN) |
(P) unclassified |
| D08697 |
Platycodon fluidextract, glycyrrhiza extract, plantago herb extract, peony root extract and dihydrocodeine phosphate; Opisezol codeine (TN) |
(P) unclassified |
| D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) CYP induction: CYP3A4 |
| D08774 |
Amoxicillin hydrate, clarithromycin and lansoprazole; Lansap (TN); Prevpac (TN) |
(P) CYP induction: CYP3A4 |
| D08775 |
Abacavir sulfate and lamivudine; Epzicom (TN) |
(CI,P) unclassified |
| D08843 |
Albiglutide (USAN); Albiglutide (genetical recombination) (JAN); Tanzeum (TN) |
(P) unclassified |
| D08854 |
Amrubicin (USAN/INN) |
(CI,P) unclassified |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) CYP induction: CYP3A4 |
| D08860 |
Apremilast (JAN/USAN); Otezla (TN) |
(P) unclassified |
| D08870 |
Belinostat (USAN/INN); Beleodaq (TN) |
(CI,P) CYP induction: CYP3A4 |
| D08879 |
Brivaracetam (JAN/USAN/INN); Briviact (TN) |
(P) unclassified |
| D08880 |
Carfilzomib (JAN/USAN/INN); Kyprolis (TN) |
(CI,P) unclassified |
| D08881 |
Cediranib (USAN/INN) |
(CI,P) unclassified |
| D08883 |
Cediranib maleate (JAN/USAN) |
(CI,P) unclassified |
| D08892 |
Clevidipine (USAN/INN); Clevidipine butyrate; Cleviprex (TN) |
(P) unclassified |
| D08897 |
Dapagliflozin (JAN/USAN/INN); Forxiga (TN) |
(P) unclassified |
| D08898 |
Darinaparsin (JAN/USAN); Darvias (TN) |
(CI,P) unclassified |
| D08900 |
Ridaforolimus (JAN/USAN/INN); Deforolimus |
(CI,P) unclassified |
| D08903 |
Dexlansoprazole (INN/USAN); Dexilant (TN) |
(P) CYP induction: CYP3A4 |
| D08914 |
Eribulin mesylate (USAN); Eribulin mesilate (JP19); Halaven (TN) |
(CI,P) CYP induction: CYP3A4 |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) CYP induction: CYP3A4 |
| D08933 |
Inotuzumab ozogamicin (USAN/INN); Inotuzumab ozogamicin (genetical recombination) (JAN); Besponsa (TN) |
(CI,P) unclassified |
| D08950 |
Neratinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D08953 |
Nilotinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D08956 |
Omacetaxine mepesuccinate (USAN); Homoharringtonine; Synribo (TN) |
(CI,P) unclassified |
| D08964 |
Perampanel (JAN/USAN); Fycompa (TN) |
(P) unclassified |
| D08966 |
Phenylephrine bitartrate (USP) |
(P) unclassified |
| D08969 |
Pimavanserin tartrate (USAN); Nuplazide (TN) |
(P) CYP induction: CYP3A4 |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) CYP induction: CYP3A4 |
| D08988 |
Rolapitant hydrochloride (USAN); Varubi (TN) |
(P) CYP induction: CYP3A4 |
| D08996 |
Saxagliptin (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09012 |
Telaprevir (JAN/USAN/INN); Incivek (TN); Incivo (TN) |
(P) CYP induction: CYP3A4 |
| D09013 |
Teplizumab (USAN/INN); Teplizumab-mzwv; Tzield (TN) |
(P) unclassified |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) Transporter induction: ABCB1 |
| D09032 |
Vinflunine ditartrate (USAN); Javlor (TN) |
(CI,P) unclassified |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(P) CYP induction: CYP3A4 |
| D09187 |
Estradiol and levonorgestrel; Wellnara (TN); Climara pro (TN) |
(P) CYP induction: CYP3A4 |
| D09188 |
Estradiol and norethindrone; Menoaid (TN); Activella (TN); Combipatch (TN) |
(P) CYP induction: CYP3A4 |
| D09207 |
Catumaxomab (INN); Removab (TN) |
(CI,P) unclassified |
| D09215 |
Eslicarbazepine (USAN/INN) |
(P) unclassified |
| D09217 |
Sitimagene ceradenovec (INN) |
(CI,P) unclassified |
| D09314 |
Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN); Arzerra (TN); Kesimpta (TN) |
(CI,P) unclassified |
| D09318 |
Indacaterol (USAN/INN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D09321 |
Obinutuzumab (USAN/INN); Obinutuzumab (genetical recombination) (JAN); Gazyva (TN) |
(CI,P) unclassified |
| D09325 |
Blinatumomab (USAN/INN); Blinatumomab (genetical recombination) (JAN); Blincyto (TN) |
(CI,P) unclassified |
| D09337 |
Elotuzumab (USAN); Elotuzumab (genetical recombination) (JAN); Empliciti (TN) |
(CI,P) unclassified |
| D09338 |
Entinostat (JAN/USAN/INN) |
(CI,P) unclassified |
| D09339 |
Esomeprazole potassium (USAN) |
(P) unclassified |
| D09347 |
Fostamatinib (USAN) |
(P) CYP induction: CYP3A4 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) CYP induction: CYP3A4 |
| D09365 |
Palovarotene (JAN/USAN/INN); Sohonos (TN) |
(P) CYP induction: CYP3A4 |
| D09371 |
Ramucirumab (USAN); Ramucirumab (genetical recombination) (JAN); Cyramza (TN) |
(CI,P) unclassified |
| D09388 |
Tasimelteon (USAN/INN); Hetlioz (TN) |
(P) CYP induction: CYP3A4 |
| D09535 |
Mirabegron (JAN/USAN/INN); Myrbetriq (TN) |
(P) CYP induction: CYP3A4 |
| D09544 |
Ozenoxacin (JAN/USAN/INN); Xepi (TN) |
(P) CYP induction: CYP3A4 |
| D09566 |
Linagliptin (JAN/USAN/INN); Tradjenta (TN) |
(P) unclassified |
| D09569 |
Ezogabine (USAN); Retigabine (INN); Potiga (TN) |
(P) unclassified |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) Transporter induction: ABCB1 |
| D09574 |
Aflibercept (USAN/INN); Aflibercept (genetical recombination) (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 1] (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 2] (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 3] (JAN); Aflibercept (genetical recombination) [Aflibercept biosimilar 4] (JAN); Ziv-aflibercept; Aflibercept-mrbb; Eylea (TN); Zaltrap (TN); Ahzantive (TN) |
(CI,P) unclassified |
| D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(CI,P) unclassified |
| D09592 |
Canagliflozin (USAN/INN); Canagliflozin hydrate (JAN); Invokana (TN) |
(P) Transporter induction: ABCB1 |
| D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) CYP induction: CYP3A4 |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) unclassified |
| D09621 |
Gisadenafil (USAN/INN) |
(P) unclassified |
| D09622 |
Gisadenafil besylate (USAN) |
(P) unclassified |
| D09629 |
Imetelstat (USAN/INN) |
(CI,P) unclassified |
| D09630 |
Imetelstat sodium (USAN); Rytelo (TN) |
(CI,P) unclassified |
| D09634 |
Lersivirine (USAN/INN) |
(CI,P) unclassified |
| D09637 |
Lomitapide (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) CYP induction: CYP3A4 |
| D09654 |
Pixantrone dimaleate (USAN); Pixuvri (TN) |
(CI,P) unclassified |
| D09666 |
Selumetinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D09670 |
Sotatercept (USAN/INN); Sotatercept (genetical recombination) (JAN); sotatercept-csrk; Winrevair (TN); Airwin (TN) |
(P) unclassified |
| D09676 |
Tecarfarin (USAN/INN) |
(P) unclassified |
| D09677 |
Tecarfarin sodium (USAN) |
(P) unclassified |
| D09683 |
Tivozanib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D09692 |
Veliparib (JAN/USAN/INN) |
(CI,P) unclassified |
| D09698 |
Vilazodone (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09699 |
Vilazodone hydrochloride (USAN); Viibryd (TN) |
(P) CYP induction: CYP3A4 |
| D09701 |
Abiraterone acetate (JAN/USP); Zytiga (TN) |
(P) CYP induction: CYP3A4 |
| D09702 |
Albaconazole (USAN/INN) |
(P) unclassified |
| D09720 |
Rilpivirine (JAN/USAN/INN); Rekambys (TN) |
(CI,P) unclassified |
| D09724 |
Afatinib (USAN/INN) |
(CI,P) Transporter induction: ABCB1 |
| D09727 |
Insulin degludec (USAN/INN); Insulin degludec (genetical recombination) (JAN); Tresiba (TN) |
(P) unclassified |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(CI,P) CYP induction: CYP3A4 |
| D09729 |
Lixisenatide (JAN/USAN/INN); Adlyxin (TN); Lyxumia (TN) |
(P) unclassified |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(CI,P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(CI,P) CYP induction: CYP3A4 |
| D09733 |
Afatinib dimaleate (USAN); Afatinib maleate (JAN); Gilotrif (TN); Giotrif (TN) |
(CI,P) Transporter induction: ABCB1 |
| D09741 |
Drospirenone and ethinylestradiol; Drospirenone and ethinylestradiol betadex; Angeliq (TN); Yaz (TN); Flexyess (TN) |
(P) CYP induction: CYP3A4 |
| D09742 |
Lansoprazole, amoxicillin hydrate and metronidazole; Lampion (TN) |
(P) CYP induction: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP19); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D09744 |
Pioglitazone hydrochloride and metformin hydrochloride (JP19); Pioglitazone and metformin; Metact (TN) |
(P) unclassified |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) CYP induction: CYP3A4 |
| D09749 |
Itasetron hydrochloride hydrate (JAN) |
(P) unclassified |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) CYP induction: CYP3A4 |
| D09755 |
Cabazitaxel (USAN/INN); Jevtana (TN) |
(CI,P) unclassified |
| D09756 |
Teneligliptin hydrobromide hydrate (JAN) |
(P) CYP induction: CYP3A4 |
| D09761 |
Mogamulizumab (USAN); Mogamulizumab (genetical recombination) (JAN); Mogamulizumab-kpkc; Poteligeo (TN) |
(CI,P) unclassified |
| D09763 |
Dapagliflozin propanediol (USAN); Dapagliflozin propylene glycolate hydrate (JP19); Dapagliflozin propandiol monohydrate; Forxiga (TN); Farxiga (TN) |
(P) unclassified |
| D09765 |
Vorapaxar (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09766 |
Vorapaxar sulfate (JAN/USAN); Zontivity (TN) |
(P) CYP induction: CYP3A4 |
| D09773 |
Isoniazid glucuronate sodium (JAN) |
(P) unclassified |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) CYP induction: CYP3A4 |
| D09785 |
Delamanid (JAN/USAN); Deltyba (TN) |
(P) CYP induction: CYP3A4 |
| D09789 |
Kirenidipine hydrochloride (JAN) |
(P) unclassified |
| D09794 |
Norepinephrine hydrochloride (JAN); (+/-)-Noradrenaline hydrochloride |
(P) unclassified |
| D09796 |
Hydrocortisone caproate (JAN) |
(P) unclassified |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) Transporter inhibition: SLCO1B1 SLCO1B3 |
| D09807 |
Difethiarol (JAN); Difethialone |
(P) unclassified |
| D09843 |
Beradilol monoethyl maleate (JAN); TZC-5665 |
(P) unclassified |
| D09847 |
Metildigoxin (INN); Medigoxin (BAN) |
(P) Transporter induction: ABCB1 |
| D09848 |
Pioglitazone hydrochloride and glimepiride tablets (JP19); Pioglitazone and glimepiride; Duetact (TN); Sonias (TN) |
(P) unclassified |
| D09872 |
Bedaquiline (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09873 |
Bedaquiline fumarate (JAN/USAN); Sirturo (TN) |
(P) CYP induction: CYP3A4 |
| D09876 |
Cariprazine hydrochloride (JAN/USAN); Vraylar (TN) |
(P) CYP induction: CYP3A4 |
| D09883 |
Dacomitinib (INN) |
(CI,P) unclassified |
| D09889 |
Dulaglutide (USAN/INN); Dulaglutide (genetical recombination) (JAN); Trulicity (TN) |
(P) unclassified |
| D09893 |
Eliglustat (USAN/INN) |
(P) Transporter induction: ABCB1 |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(P) Transporter induction: ABCB1 |
| D09906 |
Fosdevirine (USAN/INN) |
(CI,P) unclassified |
| D09919 |
Lenvatinib (USAN/INN) |
(CI,P) Transporter induction: ABCB1 |
| D09920 |
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN); Lenvima (TN) |
(CI,P) Transporter induction: ABCB1 |
| D09932 |
Moxetumomab pasudotox (USAN/INN); Moxetumomab pasudotox-tdfk; Lumoxiti (TN) |
(CI,P) unclassified |
| D09935 |
Navitoclax (JAN/USAN/INN) |
(CI,P) unclassified |
| D09936 |
Navitoclax dihydrochloride (USAN) |
(CI,P) unclassified |
| D09939 |
Olaratumab (USAN/INN); Olaratumab (genetical recombination) (JAN); Lartruvo (TN) |
(CI,P) unclassified |
| D09950 |
Ponatinib (USAN/INN) |
(CI,P) unclassified |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(CI,P) unclassified |
| D09955 |
Quizartinib (USAN/INN) |
(CI,P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(CI,P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(CI,P) unclassified |
| D09959 |
Ruxolitinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(CI,P) CYP induction: CYP3A4 |
| D09966 |
Talimogene laherparepvec (USAN); Talminogene laherparepvec; Imlygic (TN); Oncovex (TN) |
(CI,P) unclassified |
| D09970 |
Tofacitinib (USAN); Tasocitinib |
(P) CYP induction: CYP3A4 |
| D09980 |
Trastuzumab emtansine (USAN/INN); Trastuzumab emtansine (genetical recombination) (JAN); Ado-trastuzumab emtansine; Kadcyla (TN) |
(CI,P) unclassified |
| D09989 |
Vardenafil hydrochloride (USP) |
(P) CYP induction: CYP3A4 |
| D09992 |
Vismodegib (USAN/INN); Erivedge (TN) |
(CI,P) unclassified |
| D09994 |
Selexipag (JAN/USAN/INN); Uptravi (TN) |
(P) CYP induction: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(CI,P) unclassified |
| D09997 |
Cariprazine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D09999 |
Tramadol hydrochloride and acetaminophen; Tramcet (TN) |
(P) CYP induction: CYP3A4 |
| D10018 |
Necitumumab (USAN/INN); Necitumumab (genetical recombination) (JAN); Portrazza (TN) |
(CI,P) unclassified |
| D10019 |
Panobinostat lactate (JAN); Farydak (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10021 |
Efinaconazole (JAN/USAN/INN); Clenafin (TN); Jublia (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10025 |
Semaglutide (USAN/INN); Semaglutide (genetical recombination) (JAN); Ozempic (TN) |
(P) unclassified |
| D10027 |
Udenafil (USAN/INN) |
(P) unclassified |
| D10062 |
Cabozantinib (USAN); Cabometyx (TN); Cometriq (TN) |
(CI,P) unclassified |
| D10064 |
Dabrafenib (USAN) |
(CI,P) CYP induction: CYP3A4 |
| D10065 |
Daclatasvir (USAN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10066 |
Dolutegravir (USAN); Tivicay (TN) |
(CI,P) unclassified |
| D10079 |
Rucaparib (USAN/INN) |
(CI,P) unclassified |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(CI,P) unclassified |
| D10096 |
Calaspargase pegol (USAN); Calaspargase pegol-mknl; Asparlas (TN) |
(CI,P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10105 |
Daclatasvir dihydrochloride (USAN); Daclatasvir hydrochloride (JAN); Daklinza (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10113 |
Dolutegravir sodium (JAN/USAN); Tivicay (TN) |
(CI,P) unclassified |
| D10119 |
Sonidegib (USAN/INN); Erismodegib |
(CI,P) unclassified |
| D10120 |
Esomeprazole strontium (USAN); Esomeprazole strontium tetrahydrate |
(P) unclassified |
| D10130 |
Ixazomib (USAN) |
(CI,P) unclassified |
| D10131 |
Ixazomib citrate (JAN/USAN); Ninlaro (TN) |
(CI,P) unclassified |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10138 |
Regorafenib (USAN/INN); Stivarga (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10140 |
Niraparib (USAN) |
(CI,P) unclassified |
| D10157 |
Rucaparib phosphate (USAN) |
(CI,P) unclassified |
| D10158 |
Safinamide (USAN/INN) |
(P) unclassified |
| D10159 |
Alogliptin benzoate and pioglitazone hydrochloride; Liovel (TN); Oseni (TN); Incresync (TN) |
(P) unclassified |
| D10170 |
Tedatioxetine (USAN) |
(P) unclassified |
| D10171 |
Tedatioxetine hydrobromide (USAN) |
(P) unclassified |
| D10175 |
Trametinib (USAN) |
(CI,P) unclassified |
| D10176 |
Trametinib dimethyl sulfoxide (JAN/USAN); Mekinist (TN); Spexotras (TN) |
(CI,P) unclassified |
| D10184 |
Vortioxetine (USAN); Brintellix (TN) |
(P) unclassified |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) unclassified |
| D10188 |
Naldemedine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10190 |
Tivozanib hydrochloride (USAN); Tivozanib hydrochloride monohydrate; Fotivda (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10191 |
Safinamide mesylate (USAN); Safinamide mesilate (JAN); Safinamide methanesulfonate; Xadago (TN); Equfina (TN) |
(P) unclassified |
| D10194 |
Remimazolam besylate (USAN); Remimazolam besilate (JAN); Anerem (TN); Byfavo (TN) |
(P) unclassified |
| D10195 |
Luseogliflozin hydrate (JAN); Lusefi (TN) |
(P) unclassified |
| D10196 |
Ipragliflozin (INN) |
(P) unclassified |
| D10200 |
Ipragliflozin L-proline (JAN); Suglat (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10222 |
Gemcitabine elaidate (USAN/INN) |
(CI,P) unclassified |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(CI,P) unclassified |
| D10229 |
Masitinib (INN) |
(CI,P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP19); Aimix (TN) |
(P) CYP induction: CYP3A4 |
| D10244 |
Metformin hydrochloride and rosiglitazone maleate; Avandamet (TN) |
(P) unclassified |
| D10246 |
Omeprazole, clarithromycin and amoxicillin; Omeclamox-pak (TN) |
(P) CYP induction: CYP3A4 |
| D10251 |
Glimepiride and rosiglitazone maleate; Avandaryl (TN) |
(P) unclassified |
| D10253 |
Alogliptin benzoate and metformin hydrochloride; Kazano (TN); Vipdomet (TN) |
(P) unclassified |
| D10255 |
Anagrelide hydrochloride hydrate (JAN); Anagrelide hydrochloride monohydrate; Agrylin (TN) |
(CI,P) unclassified |
| D10258 |
Simvastatin and sitagliptin phosphate; Juvisync (TN) |
(P) unclassified |
| D10261 |
Metformin hydrochloride and sitagliptin phosphate; Janumet (TN) |
(P) unclassified |
| D10262 |
Saxagliptin hydrochloride; Onglyza (TN) |
(P) CYP induction: CYP3A4 |
| D10263 |
Metformin hydrochloride and saxagliptin hydrochloride; Kombiglyze (TN) |
(P) CYP induction: CYP3A4 |
| D10264 |
Linagliptin and metformin hydrochloride; Jentaduet (TN) |
(P) Transporter induction: ABCB1 |
| D10265 |
Glipizide and metformin hydrochloride; Metaglip (TN) |
(P) unclassified |
| D10266 |
Glyburide and metformin hydrochloride; Glibenclamide and metformin hydrochloride; Glucovance (TN) |
(P) unclassified |
| D10267 |
Methyldopa and hydrochlorothiazide |
(P) unclassified |
| D10293 |
Carbidopa, levodopa and entacapone; Stalevo (TN) |
(P) unclassified |
| D10306 |
Avatrombopag (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10307 |
Avatrombopag maleate (JAN/USAN); Doptelet (TN) |
(P) CYP induction: CYP3A4 |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) CYP induction: CYP3A4 |
| D10313 |
Ertugliflozin (USAN/INN) |
(P) unclassified |
| D10315 |
Momelotinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10316 |
Nivolumab (USAN/INN); Nivolumab (genetical recombination) (JAN); Opdivo (TN) |
(CI,P) unclassified |
| D10319 |
Panobinostat (USAN/INN); Farydak (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10355 |
Aripiprazole cavoxil (USAN) |
(P) CYP induction: CYP3A4 |
| D10358 |
Momelotinib dihydrochloride (USAN) |
(CI,P) CYP induction: CYP3A4 |
| D10364 |
Aripiprazole lauroxil (USAN); Aristada (TN) |
(P) CYP induction: CYP3A4 |
| D10366 |
Sofosbuvir (JAN/USAN/INN); Sovaldi (TN) |
(CI) Transporter induction: ABCB1 |
| D10367 |
Etirinotecan pegol (USAN/INN) |
(CI,P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(CI,P) unclassified |
| D10385 |
Ezetimibe and atorvastatin; Atozet (TN); Liptruzet (TN) |
(P) CYP induction: CYP3A4 |
| D10396 |
Nintedanib esylate (USAN); Nintedanib ethanesulfonate (JAN); Ofev (TN) |
(CI,P) Transporter induction: ABCB1 / Enzyme induction: UGT |
| D10405 |
Cobimetinib (USAN/INN) |
(CI,P) unclassified |
| D10422 |
Etirinotecan pegol tetrahydrochloride (USAN) |
(CI,P) unclassified |
| D10427 |
Etirinotecan pegol tetratriflutate (USAN) |
(CI,P) unclassified |
| D10428 |
Tenofovir alafenamide (USAN/INN) |
(CI,P) Transporter induction: ABCB1 |
| D10430 |
Treprostinil diolamine (USAN); Orenitram (TN) |
(P) unclassified |
| D10433 |
Vibegron (JAN/USAN/INN); Beova (TN); Gemtesa (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10434 |
Vintafolide (USAN/INN) |
(CI,P) unclassified |
| D10446 |
Margetuximab (USAN/INN); Margetuximab-cmkb; Margenza (TN) |
(CI,P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(CI,P) unclassified |
| D10459 |
Empagliflozin (JAN/USAN/INN); Jardiance (TN) |
(P) Transporter induction: ABCB1 |
| D10461 |
Dienogest and estradiol valerate; Natazia (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) CYP induction: CYP3A4 |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) CYP induction: CYP3A4 |
| D10481 |
Nintedanib (USAN/INN); Ofev (TN) |
(CI,P) Transporter induction: ABCB1 / Enzyme induction: UGT |
| D10500 |
Metformin hydrochloride and repaglinide; Prandimet (TN) |
(P) unclassified |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) CYP induction: CYP3A4 |
| D10502 |
Gemigliptin (INN) |
(P) unclassified |
| D10503 |
Ethacizine |
(P) unclassified |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP induction: CYP3A4 |
| D10513 |
Clopidogrel sulfate and aspirin; Clopidogrel and acetylsalicyclic acid; Complavin (TN) |
(P) CYP induction: CYP3A4 |
| D10514 |
Dacomitinib (USAN); Dacomitinib hydrate (JAN); Vizimpro (TN) |
(CI,P) unclassified |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) CYP induction: CYP3A4 |
| D10517 |
Crisantaspase (JAN/INN); Enrylaze (TN); Erwinase (TN) |
(CI,P) unclassified |
| D10519 |
Rabeprazole, amoxicillin and clarithromycin; Rabecure (TN) |
(P) CYP induction: CYP3A4 |
| D10520 |
Rabeprazole, amoxicillin and metronidazole; Rabefine (TN) |
(P) CYP induction: CYP3A4 |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) CYP induction: CYP3A4 |
| D10525 |
Valsartan and cilnidipine; Atedio (TN) |
(P) CYP induction: CYP3A4 |
| D10526 |
Trifluridine and tipiracil hydrochloride; Lonsurf (TN) |
(CI,P) unclassified |
| D10527 |
Acetylsalicylic acid and lansoprazole; Acetylsalicylic acid and lansoprazole; Takelda (TN) |
(P) CYP induction: CYP3A4 |
| D10528 |
Aldosterone (INN) |
(P) unclassified |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) CYP induction: CYP3A4 |
| D10542 |
Alectinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10548 |
Cabotegravir (JAN/USAN/INN); Vocabria (TN); Apretude (TN) |
(CI,P) unclassified |
| D10549 |
Cabotegravir sodium (JAN/USAN); Vocabria (TN) |
(CI,P) unclassified |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(CI,P) unclassified |
| D10555 |
Duvelisib (USAN/INN) |
(CI,P) unclassified |
| D10559 |
Dinutuximab (USAN/INN); Dinutuximab (genetical recombination) (JAN); Unituxin (TN) |
(CI,P) unclassified |
| D10560 |
Idelalisib (JAN/USAN/INN); Zydelig (TN) |
(CI,P) unclassified |
| D10561 |
Fabomotizole (INN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(CI,P) unclassified |
| D10568 |
Pitavastatin calcium hydrate (JP19); Pitabastatin calcium pentahydrate; Livalo (TN) |
(P) unclassified |
| D10570 |
Insulin degludec (genetical recombination) and insulin aspart (genetical recombination); Ryzodeg (TN) |
(P) unclassified |
| D10571 |
Rilpivirine hydrochloride, tenofovir disoproxil fumarate and emtricitabine; Complera (TN); Eviplera (TN) |
(CI,P) unclassified |
| D10572 |
Fosnetupitant and palonosetron hydrochloride; Netupitant and palonosetron hydrochloride; Akynzeo (TN) |
(P) CYP induction: CYP3A4 |
| D10574 |
Pembrolizumab (USAN); Pembrolizumab (genetical recombination) (JAN); Keytruda (TN) |
(CI,P) unclassified |
| D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(CI) Transporter induction: ABCB1 |
| D10586 |
Dapagliflozin and metformin; Xigduo xr (TN) |
(P) unclassified |
| D10587 |
Canagliflozin and metformin; Invokamet (TN) |
(P) unclassified |
| D10588 |
Empagliflozin and linagliptin; Glyxambi (TN) |
(P) Transporter induction: ABCB1 |
| D10590 |
Norgestimate and ethinyl estradiol; Mononessa (TN); Trinessa (TN) |
(P) unclassified |
| D10591 |
Clonidine and chlorthalidone; Clorpres (TN) |
(P) unclassified |
| D10596 |
Pemetrexed sodium hemipentahydrate (JAN); Pemetrexed disodium hemipentahydrate |
(CI,P) unclassified |
| D10600 |
Dolutegravir, abacavir and lamivudine; Triumeq (TN) |
(CI,P) unclassified |
| D10604 |
Binimetinib (JAN/USAN/INN); Mektovi (TN) |
(CI,P) unclassified |
| D10605 |
Tenofovir alafenamide fumarate (JAN/USAN); Tenofovir alafenamide hemifumarate; Vemlidy (TN) |
(CI,P) Transporter induction: ABCB1 |
| D10612 |
Benzhydrocodone (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10615 |
Cobimetinib fumarate (USAN); Cobimetinib hemifumarate; Cotellic (TN) |
(CI,P) unclassified |
| D10624 |
Doravirine (JAN/USAN/INN); Pifeltro (TN) |
(CI,P) unclassified |
| D10627 |
Esketamine hydrochloride (JAN/USAN); Spravato (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D10630 |
Fedratinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) CYP induction: CYP3A4 |
| D10636 |
Glasdegib (USAN/INN) |
(CI,P) unclassified |
| D10642 |
Irinotecan sucrosofate (USAN) |
(CI,P) unclassified |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(CI) unclassified |
| D10652 |
Palbociclib isethionate (USAN) |
(CI,P) unclassified |
| D10662 |
Rimegepant (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10663 |
Rimegepant sulfate (USAN); Rimegepant sulfate hydrate (JAN); Nurtec odt (TN); Vydura (TN) |
(P) CYP induction: CYP3A4 |
| D10669 |
Sotagliflozin (USAN/INN); Inpefa (TN) |
(P) unclassified |
| D10673 |
Ubrogepant (USAN/INN); Ubrelvy (TN) |
(P) CYP induction: CYP3A4 |
| D10675 |
Valbenazine (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(CI,P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(CI,P) unclassified |
| D10692 |
Benzhydrocodone hydrochloride (USAN) |
(P) CYP induction: CYP3A4 |
| D10696 |
Capmatinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10708 |
Fostemsavir tromethamine (USAN); Fostemsavir trometamol; Rukobia (TN) |
(CI,P) Transporter induction: ABCB1 |
| D10709 |
Gilteritinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10711 |
Pemafibrate (JAN); Parmodia (TN) |
(CI,P) Transporter inhibition: SLCO1B1 SLCO1B3 |
| D10722 |
Pretomanid (USAN/INN) |
(P) unclassified |
| D10729 |
Sonidegib phosphate (USAN); Sonidegib diphosphate; Odomzo (TN) |
(CI,P) unclassified |
| D10732 |
Talazoparib (USAN/INN) |
(CI,P) unclassified |
| D10733 |
Talazoparib tosylate (USAN); Talazoparib tosilate (JAN); Talzenna (TN) |
(CI,P) unclassified |
| D10742 |
Rolapitant (USAN/INN); Varubi (TN) |
(P) CYP induction: CYP3A4 |
| D10743 |
Vildagliptin and metformin hydrochloride |
(P) unclassified |
| D10745 |
Ombitasvir, paritaprevir and ritonavir; Technivie (TN) |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D10749 |
Pitolisant (USAN/INN); Wakix (TN); Ozawade (TN) |
(P) unclassified |
| D10750 |
Isavuconazole (INN); Cresemba (TN) |
(P) unclassified |
| D10752 |
Empagliflozin and metformin; Synjardy (TN) |
(P) unclassified |
| D10753 |
Atazanavir and cobicistat; Evotaz (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10754 |
Lamivudine and raltegravir; Lamivudine and raltegravir potassium; Dutrebis (TN) |
(CI,P) unclassified |
| D10755 |
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide; Genvoya (TN) |
(CI,P) Transporter induction: ABCB1 |
| D10756 |
Elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil; Stribild (TN) |
(CI,P) unclassified |
| D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(CI,P) unclassified |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10766 |
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN); Tagrisso (TN) |
(CI,P) unclassified |
| D10772 |
Lascufloxacin hydrochloride (JAN); Lasvic (TN) |
(P) unclassified |
| D10773 |
Atezolizumab (USAN/INN); Atezolizumab (genetical recombination) (JAN); Tecentriq (TN) |
(CI,P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) CYP induction: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) CYP induction: CYP3A4 |
| D10777 |
Daratumumab (USAN); Daratumumab (genetical recombination) (JAN); Darzalex (TN) |
(CI,P) unclassified |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10787 |
Daunorubicin citrate; Daunoxome (TN) |
(CI,P) unclassified |
| D10797 |
Copanlisib hydrochloride (USAN) |
(CI,P) unclassified |
| D10798 |
Copanlisib hydrochloride hydrate (JAN); Aliqopa (TN) |
(CI,P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) Transporter inhibition: SLCO1B1 SLCO1B3 |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D10808 |
Durvalumab (USAN/INN); Durvalumab (genetical recombination) (JAN); Imfinzi (TN) |
(CI,P) unclassified |
| D10811 |
Fentanyl hydrochloride (JAN); Ionsys (TN) |
(P) CYP induction: CYP3A4 |
| D10817 |
Avelumab (USAN/INN); Avelumab (genetical recombination) (JAN); Bavencio (TN) |
(CI,P) unclassified |
| D10823 |
Clopidogrel hydrochloride |
(P) unclassified |
| D10824 |
Clopidogrel besilate; Clopidogrel besylate |
(P) unclassified |
| D10825 |
Opicapone (JAN/USAN/INN); Ongentys (TN) |
(P) unclassified |
| D10826 |
Saxagliptin and dapagliflozin; Qtern (TN) |
(P) unclassified |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10829 |
Rasagiline tartrate; Rasagiline (TN) |
(P) unclassified |
| D10832 |
Darunavir and cobicistat; Prezcobix (TN); Rezolsta (TN) |
(CI,P) unclassified |
| D10834 |
Tenofovir disoproxil phosphate |
(CI,P) unclassified |
| D10835 |
Emtricitabine and tenofovir alafenamide; Descovy (TN) |
(CI,P) Transporter induction: ABCB1 |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(CI,P) Transporter induction: ABCB1 |
| D10838 |
Abacavir, lamivudine and zidovudine; Trizivir (TN) |
(CI,P) unclassified |
| D10839 |
Norelgestromin and ethinyl estradiol; Evra (TN); Xulane (TN); Zafemy (TN) |
(P) unclassified |
| D10851 |
Efavirenz, emtricitabine and tenofovir disoproxil; Atripla (TN) |
(CI,P) unclassified |
| D10858 |
Rociletinib (USAN/INN) |
(CI,P) unclassified |
| D10859 |
Olmutinib (USAN/INN) |
(CI,P) unclassified |
| D10865 |
Bexagliflozin (USAN); Brenzavvy (TN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10867 |
Copanlisib (USAN/INN) |
(CI,P) unclassified |
| D10874 |
Daprodustat (JAN/USAN/INN); Duvroq (TN); Jesduvroq (TN) |
(P) unclassified |
| D10878 |
Gepotidacin (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10879 |
Gepotidacin mesylate (USAN); Gepotidacin mesilate hydrate (JAN); Blujepa (TN) |
(P) CYP induction: CYP3A4 |
| D10883 |
Ribociclib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10888 |
Relugolix (JAN/USAN/INN); Orgovyx (TN) |
(P) Transporter induction: ABCB1 |
| D10889 |
Momelotinib hydrochloride hydrate (JAN); Momelotinib dihydrochloride monohydrate; Ojjaara (TN); Omjjara (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(CI,P) unclassified |
| D10895 |
Fosaprepitant (INN) |
(P) CYP induction: CYP3A4 |
| D10897 |
Teneligliptin and canagliflozin; Teneligliptin and canagliflozin; Canalia (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10898 |
Neratinib maleate; Nerlynx (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10901 |
Enasidenib (USAN/INN) |
(CI,P) unclassified |
| D10909 |
Bictegravir (USAN/INN) |
(CI,P) unclassified |
| D10910 |
Bictegravir sodium (JAN/USAN) |
(CI,P) unclassified |
| D10915 |
Cannabidiol (JAN/USAN/INN); CBD; Epidiolex (TN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D10930 |
Etrasimod (USAN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D10932 |
Etripamil (USAN/INN); Cardamyst (TN) |
(P) CYP induction: CYP3A4 |
| D10954 |
Mirvetuximab soravtansine (USAN/INN); Mirvetuximab soravtansine (genetical recombination) (JAN); Mirvetuximab soravtansine-gynx; Elahere (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10960 |
Nirogacestat (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D10967 |
Ozanimod hydrochloride (JAN/USAN); Zeposia (TN) |
(P) unclassified |
| D10973 |
Padeliporfin (USAN/INN) |
(CI,P) unclassified |
| D10979 |
Ribociclib succinate (USAN); Kisqali (TN) |
(CI,P) CYP induction: CYP3A4 |
| D10982 |
Rucaparib camsylate (USAN); Rubraca (TN) |
(CI,P) unclassified |
| D10985 |
Sacituzumab govitecan (USAN/INN); Sacituzumab govitecan (genetical recombination) (JAN); Sacituzumab govitecan-hziy; Trodelvy (TN) |
(CI,P) unclassified |
| D10989 |
Sofpironium bromide (JAN/USAN/INN); Ecclock (TN); Sofdra (TN) |
(P) CYP induction: CYP3A4 |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(CI,P) unclassified |
| D10994 |
Upadacitinib (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D10995 |
Upadacitinib tartrate (USAN) |
(P) CYP induction: CYP3A4 |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) CYP induction: CYP3A4 |
| D11000 |
Vamorolone (USAN/INN); Agamree (TN) |
(P) CYP induction: CYP3A4 |
| D11009 |
Indacaterol acetate (JAN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D11011 |
Alpelisib (JAN/USAN/INN); Piqray (TN); Vijoice (TN) |
(CI,P) unclassified |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(CI,P) unclassified |
| D11014 |
Glecaprevir and pibrentasvir; Mavyret (TN) |
(CI) Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) CYP induction: CYP3A4 |
| D11023 |
Evogliptin (INN) |
(P) unclassified |
| D11032 |
Plitidepsin (INN) |
(CI,P) unclassified |
| D11034 |
Insulin glargine and lixisenatide; Insulin glargine (genetical recombination) and lixisenatide; Soliqua (TN) |
(P) unclassified |
| D11039 |
Bictegravir, emtricitabine and tenofovir alafenamide; Biktarvy (TN) |
(CI,P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) CYP induction: CYP3A4 |
| D11043 |
Ertugliflozin pidolate; Ertugliflozin L-pyroglutamic acid; Steglatro (TN) |
(P) unclassified |
| D11044 |
Enasidenib mesylate (USAN); Idhifa (TN) |
(CI,P) unclassified |
| D11045 |
Darolutamide (JAN/USAN/INN); Nebeqa (TN) |
(P) unclassified |
| D11046 |
Delgocitinib (JAN/USAN/INN); Corectim (TN); Anzupgo (TN) |
(P) CYP induction: CYP3A4 |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) CYP induction: CYP3A4 |
| D11049 |
Epacadostat (JAN/USAN/INN) |
(CI,P) unclassified |
| D11050 |
Isatuximab (USAN/INN); Isatuximab (genetical recombination) (JAN); Isatuximab-irfc; Sarclisa (TN) |
(CI,P) unclassified |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11056 |
Mirtazapine hydrate (JAN) |
(P) CYP induction: CYP3A4 |
| D11061 |
Osilodrostat (USAN/INN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D11062 |
Osilodrostat phosphate (JAN/USAN); Isturisa (TN) |
(P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D11066 |
Ertugliflozin and sitagliptin; Steglujan (TN) |
(P) unclassified |
| D11067 |
Ertugliflozin and metformin; Segluromet (TN) |
(P) unclassified |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(CI,P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) unclassified |
| D11073 |
Tepotinib hydrochloride (USAN); Tepotinib hydrochloride hydrate (JAN); Tepmetko (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(CI,P) unclassified |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) CYP induction: CYP3A4 |
| D11095 |
Atorvastatin calcium propylene glycol solvate |
(P) CYP induction: CYP3A4 / Transporter inhibition: SLCO1B1 SLCO1B3 / Transporter induction: ABCB1 |
| D11107 |
Glasdegib maleate (JAN); Daurismo (TN) |
(CI,P) unclassified |
| D11108 |
Cemiplimab (USAN); Cemiplimab (genetical recombination) (JAN); Cemiplimab-rwlc; Libtayo (TN) |
(CI,P) unclassified |
| D11114 |
Esomeprazole magnesium dihydrate |
(P) unclassified |
| D11115 |
Olmutinib hydrochloride (USAN) |
(CI,P) unclassified |
| D11137 |
Larotrectinib (USAN/INN) |
(CI,P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(CI,P) unclassified |
| D11139 |
Savolitinib (JAN/USAN/INN) |
(CI,P) unclassified |
| D11140 |
Sitravatinib (USAN/INN) |
(CI,P) unclassified |
| D11141 |
Tucatinib (USAN/INN); Tukysa (TN) |
(CI,P) unclassified |
| D11144 |
Axicabtagene ciloleucel (USAN); Yescarta (TN) |
(CI,P) unclassified |
| D11146 |
Tabelecleucel (USAN); Ebvallo (TN) |
(CI,P) unclassified |
| D11150 |
Cenobamate (JAN/USAN/INN); Xcopri (TN) |
(P) CYP induction: CYP3A4 |
| D11158 |
Leniolisib (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11159 |
Leniolisib phosphate (JAN/USAN); Joenja (TN) |
(P) CYP induction: CYP3A4 |
| D11222 |
Selinexor (USAN/INN); Xpovio (TN) |
(CI,P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D11246 |
Dapivirine (USAN/INN) |
(CI,P) unclassified |
| D11251 |
Icotinib |
(CI,P) unclassified |
| D11252 |
Fexinidazole (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11253 |
Bermekimab (USAN) |
(CI,P) unclassified |
| D11270 |
Pexidartinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D11271 |
Pexidartinib hydrochloride (JAN/USAN); Turalio (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11279 |
Avapritinib (USAN/INN); Ayvakit (TN); Ayvakyt (TN) |
(CI,P) unclassified |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(CI,P) unclassified |
| D11288 |
Rivoceranib (USAN/INN); Apatinib |
(CI,P) unclassified |
| D11289 |
Rivoceranib mesylate (USAN); Alitan (TN) |
(CI,P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11313 |
Atogepant (USAN); Qulipta (TN); Aquipta (TN) |
(P) CYP induction: CYP3A4 |
| D11314 |
Difamilast (JAN/USAN); Adquey (TN); Moizerto (TN) |
(P) CYP induction: CYP3A4 |
| D11322 |
Umbralisib (USAN/INN) |
(CI,P) unclassified |
| D11323 |
Umbralisib tosylate (USAN); Ukoniq (TN) |
(CI,P) unclassified |
| D11330 |
Voxelotor (USAN); Oxbryta (TN) |
(P) CYP induction: CYP3A4 |
| D11338 |
Loncastuximab tesirine (USAN); Loncastuximab tesirine (genetical recombination) (JAN); Loncastuximab tesirine-lpyl; Zynlonta (TN) |
(CI,P) unclassified |
| D11342 |
Dorzagliatin (USAN) |
(P) unclassified |
| D11352 |
Pemetrexed tromethamine (USAN) |
(CI,P) unclassified |
| D11353 |
Ripretinib (JAN/USAN); Qinlock (TN) |
(CI,P) unclassified |
| D11358 |
Tagraxofusp (USAN/INN); Tagraxofusp (genetical recombination) (JAN); Tagraxofusp-erzs; Elzonris (TN) |
(CI,P) unclassified |
| D11360 |
Tirzepatide (JAN/USAN); Mounjaro (TN); Zepbound (TN) |
(P) unclassified |
| D11366 |
Dostarlimab (USAN); Dostarlimab (genetical recombination) (JAN); Dostarlimab-gxly; Jemperli (TN) |
(CI,P) unclassified |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(CI,P) unclassified |
| D11375 |
Trastuzumab duocarmazine (USAN/INN) |
(CI,P) unclassified |
| D11382 |
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide; Symtuza (TN) |
(CI,P) Transporter induction: ABCB1 |
| D11386 |
Tisagenlecleucel-T (USAN); Tisagenlecleucel (INN); Kymriah (TN) |
(CI,P) unclassified |
| D11389 |
Dutasteride and tamsulosin; Jalyn (TN) |
(P) CYP induction: CYP3A4 |
| D11390 |
Daunorubicin and cytarabine; Vyxeos (TN) |
(CI,P) unclassified |
| D11391 |
Tenofovir disoproxil maleate |
(CI,P) unclassified |
| D11392 |
Efavirenz, lamivudine and tenofovir disoproxil fumarate; Symfi (TN) |
(CI,P) unclassified |
| D11393 |
Rituximab and hyaluronidase; Rituxan hycela (TN) |
(CI,P) unclassified |
| D11395 |
Lamivudine and tenofovir disoproxil; Cimduo (TN); Temixys (TN) |
(CI,P) unclassified |
| D11396 |
Doravirine, lamivudine and tenofovir disoproxil; Delstrigo (TN) |
(CI,P) unclassified |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) unclassified |
| D11403 |
Asciminib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D11404 |
Asciminib hydrochloride (JAN/USAN); Scemblix (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11406 |
Risdiplam (JAN/USAN/INN); Evrysdi (TN) |
(P) CYP induction: CYP3A4 |
| D11416 |
Naxitamab (USAN); Naxitamab (genetical recombination) (JAN); Naxitamab-gqgk; Danyelza (TN) |
(CI,P) unclassified |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(CI,P) unclassified |
| D11426 |
Pamiparib (USAN/INN) |
(CI,P) unclassified |
| D11437 |
Parsaclisib (USAN/INN) |
(CI,P) unclassified |
| D11441 |
Aprocitentan (USAN/INN); Tryvio (TN) |
(P) unclassified |
| D11444 |
Tazemetostat (USAN/INN) |
(CI,P) Transporter induction: ABCB1 |
| D11453 |
Nirogacestat hydrobromide (USAN); Ogsiveo (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11460 |
Siponimod (USAN/INN) |
(P) unclassified |
| D11463 |
Mosunetuzumab (USAN/INN); Mosunetuzumab (genetical recombination) (JAN); Mosunetuzumab-axgb; Lunsumio (TN) |
(CI,P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(CI,P) Transporter induction: ABCB1 |
| D11487 |
Tislelizumab (USAN/INN); Tislelizumab (genetical recombination) (JAN); Tislelizumab-jsgr; Tevimbra (TN) |
(CI,P) unclassified |
| D11490 |
Pitolisant hydrochloride (JAN/USAN); Wakix (TN) |
(P) unclassified |
| D11506 |
Parsaclisib hydrochloride (JAN/USAN) |
(CI,P) unclassified |
| D11510 |
Mavorixafor (USAN); Xolremdi (TN) |
(P) CYP induction: CYP3A4 |
| D11521 |
Lamivudine, nevirapine and zidovudine |
(CI,P) Enzyme induction: UGT |
| D11522 |
Dolutegravir and lamivudine; Dovato (TN) |
(CI,P) unclassified |
| D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(CI,P) unclassified |
| D11527 |
Zolbetuximab (USAN/INN); Zolbetuximab (genetical recombination) (JAN); Vyloy (TN) |
(CI,P) unclassified |
| D11529 |
Trastuzumab deruxtecan (USAN/INN); Trastuzumab deruxtecan (genetical recombination) (JAN); Fam-trastuzumab deruxtecan-nxki; Enhertu (TN) |
(CI,P) unclassified |
| D11534 |
Odronextamab (USAN); Odronextamab (genetical recombination) (JAN); Ordspono (TN) |
(CI,P) unclassified |
| D11541 |
Sitravatinib malate (USAN) |
(CI,P) unclassified |
| D11553 |
Lidocaine and tetracaine; Pliaglis (TN); Synera (TN) |
(P) unclassified |
| D11556 |
Idecabtagene vicleucel (USAN); Abecma (TN) |
(CI,P) unclassified |
| D11560 |
Trastuzumab and hyaluronidase; Trastuzumab and hyaluronidase-oysk; Herceptin hylecta (TN) |
(CI,P) unclassified |
| D11567 |
Insulin degludec and liraglutide; Xultophy (TN) |
(P) unclassified |
| D11572 |
Beclomethasone dipropionate monohydrate; Beconase aq (TN) |
(P) CYP induction: CYP3A4 |
| D11573 |
Oxycodone and ibuprofen |
(P) CYP induction: CYP3A4 |
| D11576 |
Naproxen and esomeprazole magnesium; Vimovo (TN) |
(P) unclassified |
| D11589 |
Infigratinib (USAN/INN) |
(CI,P) unclassified |
| D11595 |
Belantamab mafodotin (USAN); Belantamab mafodotin (genetical recombination) (JAN); Belantamab mafodotin-blmf; Blenrep (TN) |
(CI,P) unclassified |
| D11601 |
Tafasitamab (USAN/INN); Tafasitamab (genetical recombination) (JAN); Tafasitamab-cxix; Monjuvi (TN); Minjuvi (TN) |
(CI,P) unclassified |
| D11611 |
Infigratinib phosphate (USAN); Truseltiq (TN) |
(CI,P) unclassified |
| D11616 |
Aspirin and omeprazole; Yosprala (TN) |
(P) unclassified |
| D11617 |
Eletriptan hydrobromide monohydrate |
(P) CYP induction: CYP3A4 |
| D11619 |
Desvenlafaxine succinate anhydrous |
(P) Enzyme induction: UGT |
| D11628 |
Benzhydrocodone and acetaminophen; Apadaz (TN) |
(P) CYP induction: CYP3A4 |
| D11631 |
Lefamulin (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11632 |
Lefamulin acetate (USAN); Xenleta (TN) |
(P) CYP induction: CYP3A4 |
| D11644 |
Lurbinectedin (USAN/INN); Zepzelca (TN) |
(CI,P) unclassified |
| D11652 |
Tenapanor (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11653 |
Tenapanor hydrochloride (JAN/USAN); Ibsrela (TN); Phozevel (TN); Xphozah (TN) |
(P) CYP induction: CYP3A4 |
| D11656 |
Azelastine hydrochloride and fluticasone propionate; Dymista (TN) |
(P) CYP induction: CYP3A4 |
| D11658 |
Duvelisib hydrate (JAN); Copiktra (TN) |
(CI,P) unclassified |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11661 |
Bendamustine hydrochloride hydrate (JAN); Bendamustine hydrochloride monohydrate; Treakisym (TN) |
(CI,P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11671 |
Elacestrant (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11672 |
Elacestrant hydrochloride (USAN); Elacestrant dihydrochloride; Orserdu (TN) |
(P) CYP induction: CYP3A4 |
| D11675 |
Mirdametinib (USAN); Gomekli (TN); Ezmekly (TN) |
(CI,P) unclassified |
| D11706 |
Omeprazole and sodium bicarbonate; Zegerid (TN) |
(P) unclassified |
| D11710 |
Phentermine and topiramate; Qsymia (TN) |
(P) CYP induction: CYP3A4 |
| D11711 |
Dapagliflozin, metformin and saxagliptin; Qternmet xr (TN) |
(P) unclassified |
| D11712 |
Pralsetinib (USAN/INN); Gavreto (TN) |
(CI,P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11717 |
Tepotinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D11720 |
Acalabrutinib maleate (USAN) |
(CI,P) unclassified |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(CI,P) unclassified |
| D11768 |
Pacritinib (USAN/INN); Vonjo (TN) |
(CI,P) CYP induction: CYP3A4 |
| D11784 |
Vonoprazan (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D11785 |
Oteseconazole (USAN/INN); Vivijoa (TN) |
(P) unclassified |
| D11788 |
Remimazolam (USAN/INN); Byfavo (TN) |
(P) unclassified |
| D11793 |
Zuranolone (JAN/USAN/INN); Zurzuvae (TN) |
(P) CYP induction: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11807 |
Imeglimin hydrochloride (JAN); Twymeeg (TN) |
(P) unclassified |
| D11814 |
Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN); Tisotumab vedotin-tftv; Tivdak (TN) |
(CI,P) unclassified |
| D11815 |
Belumosudil (USAN) |
(P) CYP induction: CYP3A4 |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) CYP induction: CYP3A4 |
| D11827 |
Retifanlimab (USAN); Retifanlimab (genetical recombination) (JAN); Retifanlimab-dlwr; Zynyz (TN) |
(CI,P) unclassified |
| D11833 |
Glofitamab (USAN/INN); Glofitamab (genetical recombination) (JAN); Glofitamab-gxbm; Columvi (TN) |
(CI,P) unclassified |
| D11834 |
Vorasidenib (USAN/INN) |
(CI,P) unclassified |
| D11835 |
Vorasidenib citrate (USAN); Vorasidenib citric acid hydrate (JAN); Voranigo (TN) |
(CI,P) unclassified |
| D11839 |
Foslevodopa (JAN/USAN/INN) |
(P) unclassified |
| D11848 |
Decitabine and cedazuridine; Inqovi (TN) |
(CI,P) unclassified |
| D11851 |
Butalbital, acetaminophen, caffeine and codeine phosphate |
(P) unclassified |
| D11856 |
Empagliflozin, linagliptin and metformin hydrochloride; Trijardy xr (TN) |
(P) unclassified |
| D11860 |
Butalbital, aspirin, caffeine and codeine; Fiorinal with codeine (TN) |
(P) CYP induction: CYP3A4 |
| D11865 |
Melphalan flufenamide (USAN/INN) |
(CI,P) unclassified |
| D11866 |
Deuruxolitinib (USAN) |
(P) unclassified |
| D11867 |
Deuruxolitinib phosphate (USAN); Leqselvi (TN) |
(P) unclassified |
| D11870 |
Melphalan flufenamide hydrochloride (USAN); Pepaxto (TN); Pepaxti (TN) |
(CI,P) unclassified |
| D11879 |
Foscarbidopa hydarate (JAN) |
(P) unclassified |
| D11880 |
Brexucabtagene autoleucel (USAN); Tecartus (TN) |
(CI,P) unclassified |
| D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) CYP induction: CYP3A4 |
| D11885 |
Surufatinib (USAN/INN) |
(CI,P) unclassified |
| D11886 |
Daridorexant (USAN/INN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11894 |
Amivantamab (USAN/INN); Amivantamab (genetical recombination) (JAN); Amivantamab-vmjw; Rybrevant (TN) |
(CI,P) unclassified |
| D11895 |
Niraparib tosylate (USAN); Niraparib tosilate hydrate (JAN); Niraparib tosylate monohydrate; Zejula (TN) |
(CI,P) unclassified |
| D11913 |
Oportuzumab monatox (USAN) |
(CI,P) unclassified |
| D11923 |
Lobeglitazone (INN) |
(P) unclassified |
| D11924 |
Beinaglutide (INN) |
(P) unclassified |
| D11934 |
Pertuzumab, trastuzumab and hyaluronidase; Pertuzumab (genetical recombination), trastuzumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Pertuzumab, trastuzumab and hyaluronidase-zzxf; Phesgo (TN) |
(CI,P) unclassified |
| D11942 |
Inavolisib (USAN/INN); Itovebi (TN) |
(CI,P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(CI,P) unclassified |
| D11967 |
Daratumumab and hyaluronidase; Daratumumab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Daratumumab and hyaluronidase-fihj; Darzalex faspro (TN); Darzquro (TN) |
(CI,P) unclassified |
| D11968 |
Teneligliptin hydrobromide (JAN) |
(P) CYP induction: CYP3A4 |
| D11969 |
Mobocertinib succinate (JAN); Exkivity (TN) |
(CI,P) unclassified |
| D11977 |
Fruquintinib (JAN/USAN); Fruzaqla (TN) |
(CI,P) unclassified |
| D11980 |
Lazertinib (USAN/INN) |
(CI,P) CYP induction: CYP3A4 |
| D11990 |
Lisocabtagene maraleucel (USAN/INN); Breyanzi (TN) |
(CI,P) unclassified |
| D12001 |
Mobocertinib (USAN/INN) |
(CI,P) unclassified |
| D12005 |
Treprostinil palmitil (USAN/INN) |
(P) unclassified |
| D12011 |
Zanidatamab (USAN/INN); Zanidatamab (genetical recombination) (JAN); Zanidatamab-hrii; Ziihera (TN) |
(CI,P) unclassified |
| D12047 |
Drospirenone and estetrol; Nextstellis (TN); Drovelis (TN); Lydisilka (TN); Alyssa (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(CI,P) CYP induction: CYP3A4 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(CI,P) unclassified |
| D12057 |
Foscarbidopa (USAN/INN) |
(P) unclassified |
| D12058 |
Elranatamab (USAN); Elranatamab (genetical recombination) (JAN); Elranatamab-bcmm; Elrexfio (TN) |
(CI,P) unclassified |
| D12120 |
Brensocatib (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D12123 |
Elinzanetant (USAN/INN); Lynkuet (TN) |
(P) CYP induction: CYP3A4 |
| D12130 |
Drospirenone, ethinyl estradiol and levomefolate calcium; Beyaz (TN); Safyral (TN); Tydemy (TN) |
(P) CYP induction: CYP3A4 |
| D12160 |
Orelabrutinib (USAN/INN) |
(CI,P) unclassified |
| D12161 |
Lenacapavir (USAN/INN) |
(CI,P) Transporter induction: ABCB1 |
| D12162 |
Lenacapavir sodium (JAN/USAN); Sunlenca (TN) |
(CI,P) Transporter induction: ABCB1 |
| D12164 |
Sabatolimab (USAN/INN); Sabatolimab (genetical recombination) (JAN) |
(CI,P) unclassified |
| D12177 |
Teclistamab (USAN/INN); Teclistamab (genetical recombination) (JAN); Teclistamab-cqyv; Tecvayli (TN) |
(CI,P) unclassified |
| D12180 |
Talquetamab (USAN/INN); Talquetamab (genetical recombination) (JAN); Talquetamab-tgvs; Talvey (TN) |
(CI,P) unclassified |
| D12184 |
Patritumab deruxtecan (USAN/INN); Patritumab deruxtecan (genetical recombination) (JAN) |
(CI,P) unclassified |
| D12202 |
Toripalimab (USAN/INN); Toripalimab-tpzi; Loqtorzi (TN) |
(CI,P) unclassified |
| D12216 |
Imlunestrant (USAN) |
(P) CYP induction: CYP3A4 |
| D12217 |
Imlunestrant tosylate (USAN); Imlunestrant tosilate (JAN); Inluriyo (TN) |
(P) CYP induction: CYP3A4 |
| D12222 |
Linvoseltamab (USAN); Linvoseltamab (genetical recombination) (JAN); Linvoseltamab-gcpt; Lynozyfic (TN) |
(CI,P) unclassified |
| D12234 |
Tarlatamab (USAN); Tarlatamab (genetical recombination) (JAN); Tarlatamab-dlle; Imdelltra (TN) |
(CI,P) unclassified |
| D12238 |
Vimseltinib (USAN/INN) |
(CI,P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(CI,P) CYP induction: CYP3A4 |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) Transporter inhibition: SLCO1B1 SLCO1B3 |
| D12258 |
Aumolertinib (USAN/INN) |
(CI,P) unclassified |
| D12259 |
Aumolertinib mesylate (USAN); Aumseqa (TN) |
(CI,P) unclassified |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) unclassified |
| D12266 |
Pelabresib (USAN/INN); Pelabresib hydrate |
(CI,P) unclassified |
| D12269 |
Nirmatrelvir and ritonavir; Paxlovid (TN) |
(CI,P) CYP induction: CYP3A4 |
| D12285 |
Remibrutinib (JAN/USAN/INN); Rhapsido (TN) |
(P) CYP induction: CYP3A4 |
| D12291 |
Tovorafenib (JAN/USAN/INN); Ojemda (TN) |
(CI,P) unclassified |
| D12294 |
Sitagliptin phosphate (JAN) |
(P) unclassified |
| D12296 |
Tebentafusp (USAN/INN); Tebentafusp-tebn; Kimmtrak (TN) |
(CI,P) unclassified |
| D12301 |
Adagrasib (USAN/INN); Krazati (TN) |
(CI,P) CYP induction: CYP3A4 |
| D12311 |
Bortezomib hydrate (JAN) |
(CI,P) unclassified |
| D12312 |
Codeine phosphate and chlorpheniramine maleate; Tuxarin (TN) |
(P) unclassified |
| D12313 |
Chlorpheniramine polistirex and codeine polistirex; Tuzistra (TN) |
(P) CYP induction: CYP3A4 |
| D12315 |
Ciltacabtagene autoleucel (USAN/INN); Carvykti (TN) |
(CI,P) unclassified |
| D12326 |
Opelconazole (USAN/INN) |
(P) unclassified |
| D12334 |
Nivolumab and relatlimab; Nivolumab and relatlimab-rmbw; Opdualag (TN) |
(CI,P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(CI,P) unclassified |
| D12354 |
Pralsetinib hydrate (JAN) |
(CI,P) unclassified |
| D12358 |
Insulin icodec (USAN/INN); Insulin icodec (genetical recombination) (JAN); Insulin icodec-abae; Awiqli (TN) |
(P) unclassified |
| D12359 |
Datopotamab deruxtecan (USAN/INN); Datopotamab deruxtecan (genetical recombination) (JAN); Datopotamab deruxtecan-dlnk; Datroway (TN) |
(CI,P) unclassified |
| D12364 |
Taletrectinib adipate (JAN/USAN); Ibtrozi (TN) |
(P) unclassified |
| D12368 |
Epcoritamab (USAN/INN); Epcoritamab (genetical recombination) (JAN); Epcoritamab-bysp; Epkinly (TN); Tepkinly (TN) |
(CI,P) unclassified |
| D12396 |
Sebetralstat (JAN/USAN/INN); Ekterly (TN) |
(P) CYP induction: CYP3A4 |
| D12403 |
Venlafaxine besylate monohydrate; Venlafaxine besylate (TN) |
(P) unclassified |
| D12410 |
Landiolol (USAN/INN) |
(P) unclassified |
| D12438 |
Pitavastatin calcium and ezetimibe; Livazebe (TN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(CI,P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D12483 |
Olutasidenib (JAN/USAN/INN); Rezlidhia (TN) |
(CI,P) CYP induction: CYP3A4 |
| D12484 |
Carfloglitazar (INN) |
(P) unclassified |
| D12486 |
Finasteride and tadalafil; Entadfi (TN) |
(P) CYP induction: CYP3A4 |
| D12497 |
Drospirenone and estradiol; Angeliq (TN) |
(P) CYP induction: CYP3A4 |
| D12529 |
Orforglipron calcium (JAN/USAN); Foundayo (TN) |
(P) CYP induction: CYP3A4 |
| D12531 |
Nadofaragene firadenovec (USAN/INN); Nadofaragene firadenovec-vncg; Adstiladrin (TN) |
(CI,P) unclassified |
| D12536 |
Orforglipron (USAN) |
(P) CYP induction: CYP3A4 |
| D12544 |
Vortioxetine hemihydrobromide (USAN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(CI,P) unclassified |
| D12594 |
Tirabrutinib (USAN/INN) |
(CI,P) unclassified |
| D12609 |
Dasatinib laurylsulfate (USAN) |
(CI,P) CYP induction: CYP3A4 / Enzyme induction: UGT |
| D12611 |
Vornorexant hydrate (JAN) |
(P) CYP induction: CYP3A4 |
| D12628 |
Vepdegestrant (JAN/USAN/INN); Veppanu (TN) |
(P) CYP induction: CYP3A4 |
| D12629 |
Treprostinil phosphate (USAN); Treprostinil biphosphate |
(P) unclassified |
| D12634 |
Donislecel (USAN); Lantidra (TN) |
(P) unclassified |
| D12637 |
Darunavir hydrate |
(CI,P) CYP induction: CYP3A4 |
| D12653 |
Niraparib and abiraterone; Akeega (TN) |
(CI,P) unclassified |
| D12703 |
Linagliptin hydrate (JAN); Linagliptin hemihydrate |
(P) unclassified |
| D12704 |
Acalabrutinib maleate hydrate (JAN); Acalabrutinib maleate monohydrate; Calquence (TN) |
(CI,P) unclassified |
| D12728 |
Revumenib (USAN/INN) |
(CI,P) unclassified |
| D12729 |
Revumenib citrate (USAN); Revumenib monocitrate monohydrate; Revuforj (TN) |
(CI,P) unclassified |
| D12733 |
Dordaviprone (USAN/INN) |
(P) CYP induction: CYP3A4 |
| D12734 |
Dordaviprone hydrochloride (JAN/USAN); Dordaviprone dihydrochloride; Modeyso (TN) |
(P) CYP induction: CYP3A4 |
| D12746 |
Brensocatib hydrate (JAN); Brensocatib monohydrate; Brinsupri (TN) |
(P) CYP induction: CYP3A4 |
| D12750 |
Sugemalimab (INN); Cejemly (TN) |
(CI,P) unclassified |
| D12751 |
Serplulimab (USAN/INN); Hetronifly (TN) |
(CI,P) unclassified |
| D12752 |
Darunavir propylene glycolate |
(CI,P) CYP induction: CYP3A4 |
| D12753 |
Ifinatamab deruxtecan (USAN/INN); Ifinatamab deruxtecan (genetical recombination) (JAN) |
(CI,P) unclassified |
| D12756 |
Vonoprazan and amoxicillin; Voquezna (TN) |
(P) CYP induction: CYP3A4 |
| D12789 |
Baxdrostat (JAN/USAN/INN); Baxfendy (TN) |
(P) CYP induction: CYP3A4 |
| D12816 |
Dexlansoprazole sesquihydrate |
(P) CYP induction: CYP3A4 |
| D12833 |
Lifileucel (USAN/INN); Amtagvi (TN) |
(CI,P) unclassified |
| D12839 |
Sasanlimab (USAN/INN); Sasanlimab (genetical recombination) (JAN) |
(CI,P) unclassified |
| D12854 |
Nilotinib laurylsulfate (USAN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D12879 |
Zongertinib (JAN/USAN/INN); Hernexeos (TN) |
(CI,P) unclassified |
| D12956 |
Firmonertinib (USAN/INN) |
(CI,P) unclassified |
| D12957 |
Firmonertinib mesylate (USAN) |
(CI,P) unclassified |
| D12963 |
Macitentan and tadalafil; Opsynvi (TN); Yuvanci (TN) |
(CI,P) unclassified |
| D12975 |
Nerandomilast (JAN/USAN/INN); Jascayd (TN) |
(P) unclassified |
| D12994 |
Idroxioleic acid (USAN/INN) |
(CI,P) unclassified |
| D12995 |
Idroxioleate sodium (USAN) |
(CI,P) unclassified |
| D13008 |
Nilotinib D-tartrate (USAN); Nilotinib tartrate; Danziten (TN) |
(CI,P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
| D13015 |
Enavogliflozin (INN) |
(P) unclassified |
| D13018 |
Elsulfavirine (INN) |
(CI,P) unclassified |
| D13020 |
Labuvirtide (INN); Albuvirtide |
(CI,P) unclassified |
| D13021 |
Resminostat (INN) |
(CI,P) unclassified |
| D13022 |
Obecabtagene autoleucel (USAN/INN); Aucatzyl (TN) |
(CI,P) unclassified |
| D13026 |
Atogepant hydrate (JAN); Aquipta (TN) |
(P) CYP induction: CYP3A4 |
| D13029 |
Bemarituzumab (USAN/INN); Bemarituzumab (genetical recombination) (JAN) |
(CI,P) unclassified |
| D13055 |
Sitagliptin hydrochloride; Sitagliptin monohydrochloride monohydrate; Brynovin (TN) |
(P) unclassified |
| D13098 |
Sevabertinib (USAN) |
(CI,P) unclassified |
| D13099 |
Milsaperidone (USAN); Bysanti (TN) |
(P) CYP induction: CYP3A4 |
| D13116 |
Sevabertinib hydrate (JAN); Hyrnuo (TN) |
(CI,P) unclassified |
| D13120 |
Avutometinib and defactinib; Avmapki fakzynja (TN) |
(P) CYP induction: CYP3A4 |
| D13147 |
Pemetrexed dipotassium heptahydrate; Axtle (TN) |
(CI,P) unclassified |
| D13166 |
Vimseltinib dihydrate; Romvimza (TN) |
(CI,P) unclassified |
| D13168 |
Pembrolizumab and berahyaluronidase alfa; Pembrolizumab and berahyaluronidase alfa-pmph; Keytruda qlex (TN) |
(CI,P) unclassified |
| D13183 |
Brexpiprazole fumarate hydrate (JAN) |
(P) CYP induction: CYP3A4 |
| D13189 |
Alimatravir (USAN) |
(CI,P) unclassified |
| D13229 |
Amivantamab (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Rybrofaz (TN) |
(CI,P) unclassified |
| D13231 |
Dimdazenil (INN) |
(P) unclassified |
| D13232 |
Senaparib (INN) |
(CI,P) unclassified |
| D13233 |
Envafolimab (INN) |
(CI,P) unclassified |
| D13234 |
Camrelizumab (INN) |
(CI,P) unclassified |
| D13235 |
Mifanertinib (INN) |
(CI,P) unclassified |
| D13236 |
Tunlametinib (INN) |
(CI,P) unclassified |
| D13245 |
Insulin icodec (genetical recombination) and semaglutide (genetical recombination); Kyinsu (TN) |
(P) unclassified |
| D13246 |
Doravirine and islatravir; Idvynso (TN) |
(CI,P) unclassified |
| D13256 |
Cabozantinib laurylsulfate (USAN) |
(CI,P) unclassified |
| D13304 |
Tenofovir alafenamide monofumarate (USAN) |
(CI,P) unclassified |
| D13308 |
Nilotinib butanedisulfonate (USAN) |
(P) CYP induction: CYP3A4 / Transporter induction: ABCB1 |
